View Filing Data

Document And Entity Information	12 Months Ended
Document And Entity Information	Dec. 31, 2010
Entity Registrant Name	MEDICAL PROPERTIES TRUST INC
Entity Central Index Key	0001287865
Document Type	Other
Document Period End Date	Dec. 31, 2010
Amendment Flag	false
Entity Filer Category	Large Accelerated Filer
MPT Operating Partnership, L.P. [Member]
Entity Registrant Name	MPT Operating Partnership, L.P.
Entity Central Index Key	0001524607
Document Type	Other
Document Period End Date	Dec. 31, 2010
Amendment Flag	false
Entity Filer Category	Non-accelerated Filer

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2010	Dec. 31, 2009
Real Estate Assets [Abstract]
Land	$ 96,894	$ 87,888
Buildings and improvements	893,741	774,022
Construction in progress and other	6,730	291
Intangible lease assets	35,004	24,097
Mortgage loans	165,000	200,164
Real estate held for sale		89,973
Gross investment in real estate assets	1,197,369	1,176,435
Accumulated depreciation	(68,662)	(47,965)
Accumulated amortization	(7,432)	(5,133)
Net investment in real estate assets	1,121,275	1,123,337
Cash and cash equivalents	98,408	15,307
Interest and rent receivables	26,176	19,845
Straight-line rent receivables	28,912	27,539
Other loans	50,985	110,842
Other assets	23,058	13,028
Total Assets	1,348,814	1,309,898
Liabilities
Debt, net	369,970	576,678
Accounts payable and accrued expenses	35,974	29,247
Deferred revenue	23,137	15,350
Lease deposits and other obligations to tenants	20,157	17,048
Total liabilities	449,238	638,323
Commitments and Contingencies
Equity
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding
Common stock, $0.001 par value. Authorized 150,000 shares; issued and outstanding -110,225 shares at December 31, 2010 and 78,725 shares at December 31, 2009	110	79
Additional paid-in capital	1,051,785	759,721
Distributions in excess of net income	(148,530)	(88,093)
Accumulated other comprehensive loss	(3,641)
Treasury shares, at cost	(262)	(262)
Total Medical Properties Trust, Inc. stockholders' equity	899,462	671,445
Non-controlling interests	114	130
Total Equity	899,576	671,575
Total Liabilities and Equity	1,348,814	1,309,898
Common Units [Member]
Equity
Total Medical Properties Trust, Inc. stockholders' equity	110	79
MPT Operating Partnership, L.P. [Member]
Real Estate Assets [Abstract]
Land	96,894	87,888
Buildings and improvements	893,741	774,022
Construction in progress and other	6,730	291
Intangible lease assets	35,004	24,097
Mortgage loans	165,000	200,164
Real estate held for sale		89,973
Gross investment in real estate assets	1,197,369	1,176,435
Accumulated depreciation	(68,662)	(47,965)
Accumulated amortization	(7,432)	(5,133)
Net investment in real estate assets	1,121,275	1,123,337
Cash and cash equivalents	98,408	15,307
Interest and rent receivables	26,176	19,845
Straight-line rent receivables	28,912	27,539
Other loans	50,985	110,842
Other assets	23,058	13,028
Total Assets	1,348,814	1,309,898
Liabilities
Debt, net	369,970	576,678
Accounts payable and accrued expenses	13,658	13,208
Deferred revenue	23,137	15,350
Payable due to Medical Properties Trust, Inc.	21,943	15,742
Lease deposits and other obligations to tenants	20,157	17,048
Total liabilities	448,865	638,026
Commitments and Contingencies
Equity
General Partner - issued and outstanding - 1,102 units at December 31, 2010 and 787 units at December 31, 2009	9,035	6,717
Accumulated other comprehensive loss	(3,641)
Total Medical Properties Trust, Inc. stockholders' equity		671,872
Total MPT Operating Partnership capital	899,835	671,742
Non-controlling interests	114	130
Total capital	899,949	671,872
Total Liabilities and Equity	1,348,814	1,309,898
MPT Operating Partnership, L.P. [Member] \| Common Units [Member]
Equity
Limited Partners Capital	894,441	664,952
Total Medical Properties Trust, Inc. stockholders' equity	$ 894,441	664,952
MPT Operating Partnership, L.P. [Member] \| LTIP Units [Member]
Equity
Limited Partners Capital		$ 73

Consolidated Balance Sheets (Parenthetical) - $ / shares shares in Thousands	Dec. 31, 2010	Dec. 31, 2009
Equity
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000	10,000
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	150,000	150,000
Common stock, shares issued	110,225	78,725
Common stock, shares outstanding	110,225	78,725
MPT Operating Partnership, L.P. [Member]
Equity
General Partner, units issued	1,102	787
General Partner, units outstanding	1,102	787
MPT Operating Partnership, L.P. [Member] \| Common Units [Member]
Equity
Limited Partners, units issued	109,123	77,938
Limited Partners, units outstanding	109,123	77,938
MPT Operating Partnership, L.P. [Member] \| LTIP Units [Member]
Equity
Limited Partners, units issued	94	63
Limited Partners, units outstanding	94	63

Consolidated Statements Of Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Revenues
Rent billed	$ 92,785	$ 81,865	$ 74,146
Straight-line rent	2,074	8,221	3,742
Interest and fee income	26,988	28,723	29,182
Total revenues	121,847	118,809	107,070
Expenses
Real estate depreciation and amortization	24,486	22,628	22,385
Loan impairment charge	12,000
Property-related	4,407	3,802	4,242
General and administrative	28,535	21,096	19,515
Total operating expense	69,428	47,526	46,142
Operating income	52,419	71,283	60,928
Other income (expense)
Interest and other income	1,518	43	86
Debt refinancing costs	(6,716)
Interest expense	(33,993)	(37,656)	(42,424)
Net other expenses	(39,191)	(37,613)	(42,338)
Income from continuing operations	13,228	33,670	18,590
Income from discontinued operations	9,784	2,697	14,143
Net income	23,012	36,367	32,733
Net income attributable to non-controlling interests	(99)	(37)	(33)
Net income attributable to MPT common stockholders/Operating Partnership partners	$ 22,913	$ 36,330	$ 32,700
Earnings per share/unit - basic
Income from continuing operations attributable to MPT common stockholders/Operating Partnership partners	$ 0.12	$ 0.41	$ 0.27
Income from discontinued operations attributable to MPT common stockholders/Operating Partnership partners	0.10	0.04	0.23
Net income attributable to MPT common stockholders/Operating Partnership partners	$ 0.22	$ 0.45	$ 0.50
Weighted average shares/units outstanding - basic	100,706	78,117	62,027
Earnings per share/unit - diluted
Income from continuing operations attributable to MPT common stockholders/Operating Partnership partners	$ 0.12	$ 0.41	$ 0.27
Income from discontinued operations attributable to MPT common stockholders - diluted per share	0.10	0.04	0.23
Net income attributable to MPT common stockholders/Operating Partnership partners	$ 0.22	$ 0.45	$ 0.50
Weighted average shares/units outstanding - diluted	100,708	78,117	62,035
MPT Operating Partnership, L.P. [Member]
Revenues
Rent billed	$ 92,785	$ 81,865	$ 74,146
Straight-line rent	2,074	8,221	3,742
Interest and fee income	26,988	28,723	29,182
Total revenues	121,847	118,809	107,070
Expenses
Real estate depreciation and amortization	24,486	22,628	22,385
Loan impairment charge	12,000
Property-related	4,407	3,802	4,242
General and administrative	28,460	21,033	19,515
Total operating expense	69,353	47,463	46,142
Operating income	52,494	71,346	60,928
Other income (expense)
Interest and other income	1,518	43	86
Debt refinancing costs	(6,716)
Interest expense	(33,993)	(37,656)	(42,424)
Net other expenses	(39,191)	(37,613)	(42,338)
Income from continuing operations	13,303	33,733	18,590
Income from discontinued operations	9,784	2,697	14,143
Net income	23,087	36,430	32,733
Net income attributable to non-controlling interests	(99)	(37)	(33)
Net income attributable to MPT common stockholders/Operating Partnership partners	$ 22,988	$ 36,393	$ 32,700
Earnings per share/unit - basic
Income from continuing operations attributable to MPT common stockholders/Operating Partnership partners	$ 0.12	$ 0.41	$ 0.27
Income from discontinued operations attributable to MPT common stockholders/Operating Partnership partners	0.10	0.04	0.23
Net income attributable to MPT common stockholders/Operating Partnership partners	$ 0.22	$ 0.45	$ 0.50
Weighted average shares/units outstanding - basic	100,706	78,117	62,027
Earnings per share/unit - diluted
Income from continuing operations attributable to MPT common stockholders/Operating Partnership partners	$ 0.12	$ 0.41	$ 0.27
Income from discontinued operations attributable to MPT common stockholders - diluted per share	0.10	0.04	0.23
Net income attributable to MPT common stockholders/Operating Partnership partners	$ 0.22	$ 0.45	$ 0.50
Weighted average shares/units outstanding - diluted	100,708	78,117	62,035

Consolidated Statements Of Equity - USD ($) shares in Thousands, $ in Thousands	MPT Operating Partnership, L.P. [Member] General Partner [Member]	MPT Operating Partnership, L.P. [Member] Common Units [Member]	MPT Operating Partnership, L.P. [Member] LTIPs [Member]	MPT Operating Partnership, L.P. [Member] Accumulated Other Comprehensive Loss [Member]	MPT Operating Partnership, L.P. [Member] Non-Controlling Interests [Member]	MPT Operating Partnership, L.P. [Member]	Common Units [Member]	Additional Paid-In Capital [Member]	Distribution In Excess Of Net Income [Member]	Accumulated Other Comprehensive Loss [Member]	Treasury Stock [Member]	Non-Controlling Interests [Member]	Total
Balance, Value at Dec. 31, 2007	$ 5,195	$ 514,179	$ 111		$ 77	$ 519,562	$ 52	$ 548,086	$ (28,626)		$ (262)	$ 77	$ 519,327
Balance, Shares at Dec. 31, 2007	520	51,612					52,133
Comprehensive income:
Net income	$ 327	$ 31,988	385		33	32,700			32,700			33	32,700
Comprehensive income	327	31,988	$ 385		33	32,733			32,700			33	32,733
Deferred stock units issued to directors								48	(48)
Stock vesting and amortization of stock-based compensation	$ 64	$ 6,322				6,386		6,386					6,386
Stock vesting and amortization of stock-based compensation, shares	3	270	32				273
Purchase of Wichita Partnership					145	145						145	145
Proceeds from offering (net of offering costs)	$ 1,283	$ 127,048				128,331	$ 13	128,318					128,331
Proceeds from offering (net of offering costs), shares	127	12,524					12,650
Distributions to non-controlling interests					(12)	(12)						(12)	(12)
Dividends declared	$ (640)	$ (63,017)	$ (310)			(63,967)			63,967				63,967
Issuance of convertible debt	$ 34	$ 3,366				3,400		3,400					3,400
Balance, Shares at Dec. 31, 2008	650	64,406	32				65,056
Balance, Value at Dec. 31, 2008	$ 6,263	$ 619,886	$ 186		243	626,578	$ 65	686,238	(59,941)		(262)	243	626,343
Comprehensive income:
Net income	364	35,856	174		36	36,393			36,330			36	36,330
Comprehensive income	364	35,856	$ 174		36	36,430			36,330			36	36,366
Deferred stock units issued to directors							$ 1	5	(4)				2
Deferred stock units issued to directors, shares							52
Stock vesting and amortization of stock-based compensation	$ 55	$ 5,433				5,488		5,488					5,488
Stock vesting and amortization of stock-based compensation, shares	3	295	31				246
Proceeds from offering (net of offering costs)	$ 680	$ 67,323				68,003	$ 13	67,990					68,003
Proceeds from offering (net of offering costs), shares	134	13,237					13,371
Distributions to non-controlling interests					(149)	(149)						(149)	(149)
Dividends declared	$ (645)	$ (63,546)	$ (287)			(64,478)			64,478				64,478
Balance, Shares at Dec. 31, 2009	787	77,938	63				78,725
Balance, Value at Dec. 31, 2009	$ 6,717	$ 664,952	$ 73		130	671,872	$ 79	759,721	(88,093)		(262)	130	671,445
Comprehensive income:
Net income	230	22,601	157		99	$ 22,988			22,913			99	22,913
Unrealized loss on interest rate swaps				$ (3,641)						$ (3,641)			(3,641)
Comprehensive income	230	22,601	$ 157	(3,641)	99				22,913	(3,641)		99	19,371
Stock vesting and amortization of stock-based compensation	$ 66	$ 6,550						6,616					6,616
Stock vesting and amortization of stock-based compensation, shares	7	693	31				700
Proceeds from offering (net of offering costs)	$ 2,882	$ 285,184					$ 31	288,035					288,066
Proceeds from offering (net of offering costs), shares	308	30,492					30,800
Extinguishment of convertible debt	$ (26)	$ (2,560)						2,587					2,587
Distributions to non-controlling interests					(115)							(115)	(115)
Dividends declared	$ (834)	$ (82,286)	$ (230)						83,350				83,350
Balance, Shares at Dec. 31, 2010	1,102	109,123	94				110,225
Balance, Value at Dec. 31, 2010	$ 9,035	$ 894,441		$ (3,641)	$ 114		$ 110	$ 1,051,785	$ (148,530)	$ (3,641)	$ (262)	$ 114	$ 899,462

Consolidated Statements Of Equity (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Dividends declared per common share	$ 0.8	$ 0.8	$ 1.01
MPT Operating Partnership, L.P. [Member]
Dividends declared per common share	$ 0.8	$ 0.8	$ 1.01

Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Operating activities
Net income	$ 23,012	$ 36,367	$ 32,733
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	26,312	26,309	26,535
Amortization and write-off of deferred financing costs and debt discount	6,110	5,824	7,961
Premium paid on extinguishment of debt	3,833
Straight-line rent revenue	(4,932)	(9,536)	(9,402)
Share-based compensation expense	6,616	5,488	6,386
(Gain) loss from sale of real estate	(10,566)	(278)	(9,305)
Deferred revenue and fee income	(4,393)	(847)	(7,583)
Provision for uncollectible receivables and loans	14,400		5,700
Rent and interest income added to loans		(921)	(5,556)
Straight-line rent write-off	3,694	1,111	14,037
Payment of interest on early prepayment of debt	(7,324)
Other adjustments	(30)	(246)	(57)
Decrease (increase) in:
Interest and rent receivable	(5,490)	(2,433)	(4,392)
Other assets	(566)	126	5,249
Accounts payable and accrued expenses	(3,177)	1,700	4,757
Deferred revenue	13,138	87	2,854
Net cash provided by operating activities	60,637	62,751	69,917
Investing activities
Real estate acquired	(137,808)	(421)	(430,710)
Proceeds from sale of real estate	97,669	15,000	89,959
Principal received on loans receivable	90,486	4,305	71,941
Investment in loans receivable	(11,637)	(23,243)	(95,567)
Construction in progress	(6,638)
Other investments	(9,291)	(7,777)	(4,286)
Net cash provided by (used for) investing activities	22,781	(12,136)	(368,663)
Financing activities
Proceeds from term debt, net of discount	148,500		119,001
Payments of term debt	(216,765)	(1,232)	(860)
Payment of deferred financing costs	(6,796)	232	(6,072)
Revolving credit facilities, net	(137,200)	(55,800)	38,014
Distributions paid	(77,087)	(61,649)	(65,098)
Lease deposits and other obligations to tenants	3,667	3,390	2,963
Proceeds from sale of common shares, net of offering costs	288,066	68,003	128,331
Other	(2,702)
Net cash provided by (used in) financing activities	(317)	(47,056)	216,279
Increase (decrease) in cash and cash equivalents for the year	83,101	3,559	(82,467)
Cash and cash equivalents at beginning of year	15,307	11,748	94,215
Cash and cash equivalents at end of year	98,408	15,307	11,748
Interest paid, including capitalized interest of $63 in 2011, $63 in 2010, and $- in 2009	29,679	33,272	31,277
Supplemental schedule of non-cash financing activities:
Other common stock transactions		5	48
MPT Operating Partnership, L.P. [Member]
Operating activities
Net income	23,087	36,430	32,733
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	26,312	26,309	26,535
Amortization and write-off of deferred financing costs and debt discount	6,110	5,824	7,961
Premium paid on extinguishment of debt	3,833
Straight-line rent revenue	(4,932)	(9,536)	(9,402)
Share-based compensation expense	6,616	5,488	6,386
(Gain) loss from sale of real estate	(10,566)	(278)	(9,305)
Deferred revenue and fee income	(4,393)	(847)	(7,583)
Provision for uncollectible receivables and loans	14,400		5,700
Rent and interest income added to loans		(921)	(5,556)
Straight-line rent write-off	3,694	1,111	14,037
Payment of interest on early prepayment of debt	(7,324)
Other adjustments	(30)	(246)	(57)
Decrease (increase) in:
Interest and rent receivable	(5,490)	(2,433)	(4,392)
Other assets	(566)	126	5,249
Accounts payable and accrued expenses	(3,252)	1,642	4,778
Deferred revenue	13,138	87	2,854
Net cash provided by operating activities	60,637	62,756	69,938
Investing activities
Real estate acquired	(137,808)	(421)	(430,710)
Proceeds from sale of real estate	97,669	15,000	89,959
Principal received on loans receivable	90,486	4,305	71,941
Investment in loans receivable	(11,637)	(23,243)	(95,567)
Construction in progress	(6,638)
Other investments	(9,291)	(7,777)	(4,286)
Net cash provided by (used for) investing activities	22,781	(12,136)	(368,663)
Financing activities
Proceeds from term debt, net of discount	148,500		119,001
Payments of term debt	(216,765)	(1,232)	(860)
Payment of deferred financing costs	(6,796)	232	(6,072)
Revolving credit facilities, net	(137,200)	(55,800)	38,014
Distributions paid	(77,087)	(61,649)	(65,098)
Lease deposits and other obligations to tenants	3,667	3,390	2,963
Proceeds from sale of common shares, net of offering costs	288,066	68,003	128,331
Other	(2,702)
Net cash provided by (used in) financing activities	(317)	(47,056)	216,279
Increase (decrease) in cash and cash equivalents for the year	83,101	3,564	(82,446)
Cash and cash equivalents at beginning of year	15,307	11,743	94,189
Cash and cash equivalents at end of year	98,408	15,307	11,743
Interest paid, including capitalized interest of $63 in 2011, $63 in 2010, and $- in 2009	$ 29,679	33,272	31,277
Supplemental schedule of non-cash financing activities:
Other common stock transactions		$ 5	$ 48

Consolidated Statements Of Cash Flows (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Interest paid, capitalized	$ 63
MPT Operating Partnership, L.P. [Member]
Interest paid, capitalized	$ 63

Organization	12 Months Ended
Organization	Dec. 31, 2010
Organization [Abstract]
Organization	1. Organization Medical Properties Trust, Inc., a Maryland corporation, was formed on August 27, 2003 under the General Corporation Law of Maryland for the purpose of engaging in the business of investing in, owning, and leasing commercial real estate. Our operating partnership subsidiary, MPT Operating Partnership, L.P. (the "Operating Partnership"), through which we conduct all of our operations, was formed in September 2003. Through another wholly-owned subsidiary, Medical Properties Trust, LLC, we are the sole general partner of the Operating Partnership. At present, we directly own substantially all of the limited partnership interests in the Operating Partnership and have elected to report our required disclosures and that of the Operating Partnership on a combined basis except where material differences exist. MPT Finance Corporation is a wholly owned subsidiary of the Operating Partnership and was formed for the sole purpose of being a co-issuer of some of the Operating Partnership's indebtedness. MPT Finance Corporation has no substantive assets or operations. Our primary business strategy is to acquire and develop real estate and improvements, primarily for long term lease to providers of healthcare services such as operators of general acute care hospitals, inpatient physical rehabilitation hospitals, long-term acute care hospitals, surgery centers, centers for treatment of specific conditions such as cardiac, pulmonary, cancer, and neurological hospitals, and other healthcare-oriented facilities. We also make mortgage and other loans to operators of similar facilities. In addition, we may obtain profits interest in our tenants, from time to time, in order to enhance our overall return. We manage our business as a single business segment.

- Definition

The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 2-6
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Name Statement of Position (SOP)
-Publisher AICPA
-Number 94-6
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Name FASB Interpretation (FIN)
-Publisher FASB
-Number 46R
-Paragraph 4, 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6359553&loc=d3e288-107754

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6921930&loc=d3e5614-111684

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 915
-SubTopic 235
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6472506&loc=d3e38932-110933

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2209116

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 272
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6970148&loc=SL6228881-111685

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2122150

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 720
-SubTopic 15
-URI http://asc.fasb.org/subtopic&trid=2122524

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2134480

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS140-4/FIN46(R)-8
-Paragraph 8, C1, C7
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Summary Of Significant Accounting Policies

12 Months Ended

Dec. 31, 2010

Summary Of Significant Accounting Policies [Abstract]

Summary Of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Use of Estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Principles of Consolidation: Property holding entities and other subsidiaries of which we own 100% of the equity or have a controlling financial interest evidenced by ownership of a majority voting interest are consolidated. All inter-company balances and transactions are eliminated. For entities in which we own less than 100% of the equity interest, we consolidate the property if we have the direct or indirect ability to control the entities' activities based upon the terms of the respective entities' ownership agreements. For these entities, we record a non-controlling interest representing equity held by non-controlling interests.

We continually evaluate all of our transactions and investments to determine if they represent variable interests in a variable interest entity. If we determine that we have a variable interest in a variable interest entity, we then evaluate if we are the primary beneficiary of the variable interest entity. The evaluation is a qualitative assessment as to whether we have the ability to direct the activities of a variable interest entity that most significantly impact the entity's economic performance. We consolidate each variable interest entity in which we, by virtue of or transactions with our investments in the entity, are considered to be the primary beneficiary. We have determined that Vibra, Monroe Hospital and two other smaller tenants are variable interest entities that we have investments in and/or outstanding loans and other receivables due to us of approximately 3%, 2% and 1% of our total assets, respectively. These investments in and/or outstanding loans and other receivables due from these entities represent our maximum exposure to loss. Through qualitative analysis, we have determined that we are not the primary beneficiary of these entities as we do not direct the activities that most significantly impact the economic performance of these entities (such as the day-to-day management of the tenant's hospital operations). Therefore, we have not consolidated these entities in our financial statements.

Cash and Cash Equivalents: Certificates of deposit, short-term investments with original maturities of three months or less and money-market mutual funds are considered cash equivalents. The majority of our cash and cash equivalents are held at major commercial banks which at times may exceed the Federal Deposit Insurance Corporation limit. We have not experienced any losses to date on our invested cash. Cash and cash equivalents which have been restricted as to its use are recorded in other assets.

Revenue

Recognition: We receive income from operating leases based on the fixed, minimum required rents (base rents) per the lease agreements. Rent revenue from base rents is recorded on the straight-line method over the terms of the related lease agreements for new leases and the remaining terms of existing leases for acquired properties. The straight-line method records the periodic average amount of base rent earned over the term of a lease, taking into account contractual rent increases over the lease term. The straight-line method typically has the effect of recording more rent revenue from a lease than a tenant is required to pay early in the term of the lease. During the later parts of a lease term, this effect reverses with less rent revenue recorded than a tenant is required to pay. Rent revenue as recorded on the straight-line method in the consolidated statements of income is presented as two amounts: billed rent revenue and straight-line revenue. Billed rent revenue is the amount of base rent actually billed to the customer each period as required by the lease. Straight-line rent revenue is the difference between rent revenue earned based on the straight-line method and the amount recorded as billed rent revenue. We record the difference between base rent revenues earned and amounts due per the respective lease agreements, as applicable, as an increase or decrease to straight-line rent receivable.

Certain leases provide for additional rents contingent upon a percentage of the tenant revenue in excess of specified base amounts/thresholds (percentage rents). Percentage rents are recognized in the period in which revenue thresholds are met. Rental payments received prior to their recognition as income are classified as deferred revenue. We may also receive additional rent (contingent rent) under some leases when the U.S. Department of Labor consumer price index exceeds the annual minimum percentage increase in the lease. Contingent rents are recorded as billed rent revenue in the period earned.

In instances where we have a profits interest in our tenant's operations, we record revenue equal to our percentage interest of the tenant's profits, as defined in the lease or tenant's operating agreements, once annual thresholds, if any, are met.

We begin recording base rent income from our development projects when the lessee takes physical possession of the facility, which may be different from the stated start date of the lease. Also, during construction of our development projects, we are generally entitled to accrue rent based on the cost paid during the construction period (construction period rent). We accrue construction period rent as a receivable and deferred revenue during the construction period. When the lessee takes physical possession of the facility, we begin recognizing the accrued construction period rent on the straight-line method over the remaining term of the lease.

We receive interest income from our tenants/borrowers on mortgage loans, working capital loans, and other long-term loans. Interest income from these loans is recognized as earned based upon the principal outstanding and terms of the loans.

Commitment fees received from development and leasing services for lessees are initially recorded as deferred revenue and recognized as income over the initial term of an operating lease to produce a constant effective yield on the lease (interest method). Commitment and origination fees from lending services are recorded as deferred revenue and recognized as income over the life of the loan using the interest method.

Acquired Real Estate Purchase Price Allocation: We allocate the purchase price of acquired properties to net tangible and identified intangible assets acquired based on their fair values. In making estimates of fair values for purposes of allocating purchase prices of acquired real estate, we utilize a number of sources, from time to time, including independent appraisals that may be obtained in connection with the acquisition or financing of the respective property and other market data. We also consider information obtained about each property as a result of our pre-acquisition due diligence, marketing and leasing activities in estimating the fair value of the tangible and intangible assets acquired.

We record above-market and below-market in-place lease values, if any, for our facilities, which are based on the present value (using an interest rate which reflects the risks associated with the leases acquired) of the difference between (i) the contractual amounts to be paid pursuant to the in-place leases and (ii) management's estimate of fair market lease rates for the corresponding in-place leases, measured over a period equal to the remaining non-cancelable term of the lease. We amortize any resulting capitalized above-market lease values as a reduction of rental income over the remaining non-cancelable terms of the respective leases. We amortize any resulting capitalized below-market lease values as an increase to rental income over the initial term and any fixed-rate renewal periods in the respective leases.

We measure the aggregate value of other lease intangible assets acquired based on the difference between (i) the property valued with new or in-place leases adjusted to market rental rates and (ii) the property valued as if vacant. Management's estimates of value are made using methods similar to those used by independent appraisers (e.g., discounted cash flow analysis). Factors considered by management in our analysis include an estimate of carrying costs during hypothetical expected lease-up periods considering current market conditions, and costs to execute similar leases. We also consider information obtained about each targeted facility as a result of our pre-acquisition due diligence, marketing, and leasing activities in estimating the fair value of the tangible and intangible assets acquired. In estimating carrying costs, management includes real estate taxes, insurance and other operating expenses and estimates of lost rentals at market rates during the expected lease-up periods, which we expect to be about six months. depending on specific local market conditions. Management also estimates costs to execute similar leases including leasing commissions, legal costs, and other related expenses to the extent that such costs are not already incurred in connection with a new lease origination as part of the transaction.

Other intangible assets acquired, may include customer relationship intangible values which are based on management's evaluation of the specific characteristics of each prospective tenant's lease and our overall relationship with that tenant. Characteristics to be considered by management in allocating these values include the nature and extent of our existing business relationships with the tenant, growth prospects for developing new business with the tenant, the tenant's credit quality and expectations of lease renewals, including those existing under the terms of the lease agreement, among other factors.

We amortize the value of in-place leases, if any, to expense over the initial term of the respective leases. The value of customer relationship intangibles is amortized to expense over the initial term and any renewal periods in the respective leases, but in no event will the amortization period for intangible assets exceed the remaining depreciable life of the building. If a lease is terminated, the unamortized portion of the in-place lease value and customer relationship intangibles are charged to expense.

Real Estate and Depreciation: Real estate, consisting of land, buildings and improvements, are recorded at cost. Although typically paid by our tenants, any expenditures for ordinary maintenance and repairs that we pay are expensed to operations as incurred. Significant renovations and improvements which improve and/or extend the useful life of the asset are capitalized and depreciated over their estimated useful lives. We record impairment losses on long-lived assets used in operations when events and circumstances indicate that the assets might be impaired and the undiscounted cash flows estimated to be generated by those assets, including an estimated liquidation amount, during the expected holding periods are less than the carrying amounts of those assets. Impairment losses are measured as the difference between carrying value and fair value of assets. For assets held for sale, we cease recording depreciation expense and adjust the assets' value to the lower of its carrying value or fair value, less cost of disposal. Fair value is based on estimated cash flows discounted at a risk-adjusted rate of interest. We classify real estate assets as held for sale when we have commenced an active program to sell the assets, and in the opinion of management, it is probable the asset will be sold within the next 12 months. We record the results of operations from material property sales or planned sales (which include real property, loans and any receivables) as discontinued operations in the consolidated statements of income for all periods presented if we do not have any continuing involvement with the property subsequent to its sale. Results of discontinued operations include interest expense from debt which specifically collateralizes the property sold or held for sale.

Construction in progress includes the cost of land, the cost of construction of buildings, improvements and fixed equipment, and costs for design and engineering. Other costs, such as interest, legal, property taxes and corporate project supervision, which can be directly associated with the project during construction, are also included in construction in progress.

Depreciation is calculated on the straight-line method over the weighted average useful lives of the related real estate and other assets, as follows:


Buildings and improvements			37.8 years
Tenant lease intangibles			14.3 years
Tenant improvements			5.4 years
Furniture, equipment and other			9.5 years

Losses from Rent Receivables: We continuously monitor the performance of our existing tenants including, but not limited to,: admission levels and surgery/procedure volumes by type; current operating margins; ratio of our tenant's operating margins both to facility rent and to facility rent plus other fixed costs; trends in revenue and patient mix; and the effect of evolving healthcare regulations on tenant's profitability and liquidity. We utilize this information along with the tenant's payment and default history in evaluating (on a property-by-property basis) whether or not a provision for losses on outstanding rent receivables is needed. A provision for losses on rent receivables (including straight-line rent receivables) is ultimately recorded when it becomes probable that the receivable will not be collected in full. The provision is an amount which reduces the receivable to its estimated net realizable value based on a determination of the eventual amounts to be collected either from the debtor or from the collateral, if any.

Loans: Loans consist of mortgage loans, working capital loans and other long-term loans. Mortgage loans are collateralized by interests in real property. Working capital and other long-term loans are generally collateralized by interests in receivables and corporate and individual guarantees. We record loans at cost. We evaluate the collectability of both interest and principal on a loan-by-loan basis (using the same process as we do for assessing the collectability of rents) to determine whether they are impaired. A loan is considered impaired when, based on current information and events, it is probable that we will be unable to collect all amounts due according to the existing contractual terms. When a loan is considered to be impaired, the amount of the allowance is calculated by comparing the recorded investment to either the value determined by discounting the expected future cash flows using the loan's effective interest rate or to the fair value of the collateral if the loan is collateral dependent. When a loan is deemed to be impaired, we generally place the loan on non-accrual status and record interest income only upon receipt of cash.

Earnings Per Share/Unit: Basic earnings per common share/unit is computed by dividing net income applicable to common shares/units by the weighted number of shares of common stock/units outstanding during the period. Diluted earnings per common share/unit is calculated by including the effect of dilutive securities.

Certain of our unvested restricted and performance stock/unit awards contain non-forfeitable rights to dividends, and accordingly, these awards are deemed to be participating securities. These participating securities are included in the earnings allocation in computing both basic and diluted earnings per common share.

Income Taxes: We conduct our business as a real estate investment trust ("REIT") under Sections 856 through 860 of the Internal Revenue Code. To qualify as a REIT, we must meet certain organizational and operational requirements, including a requirement to distribute to stockholders at least 90% of our ordinary taxable income. As a REIT, we generally are not subject to federal income tax on taxable income that we distribute to our stockholders. If we fail to qualify as a REIT in any taxable year, we will then be subject to federal income taxes on our taxable income at regular corporate rates and will not be permitted to qualify for treatment as a REIT for federal income tax purposes for four years following the year during which qualification is lost, unless the Internal Revenue Service grants us relief under certain statutory provisions. Such an event could materially adversely affect our net income and net cash available for distribution to stockholders. However, we intend to operate in such a manner so that we will remain qualified as a REIT for federal income tax purposes.

Our financial statements include the operations of two taxable REIT subsidiaries, MPT Development Services, Inc. ("MDS") and MPT Covington TRS, Inc. (CVT") that are not entitled to a dividends paid deduction and are subject to federal, state and local income taxes. MDS and CVT are authorized to provide property development, leasing and management services for third-party owned properties and make loans to lessees and operators.

Stock-Based Compensation: We currently sponsor the Second Amended and Restated Medical Properties Trust, Inc. 2004 Equity Incentive Plan (the "Equity Incentive Plan") that was established in 2004. Awards of restricted stock, stock options and other equity-based awards with service conditions are amortized to compensation expense over the vesting periods which generally range from three to seven years, using the straight-line method. Awards of deferred stock units vest when granted and are charged to expense at the date of grant. Awards that contain market conditions are amortized to compensation expense over the derived vesting periods, which correspond to the periods over which we estimate the awards will be earned, which generally range from three to seven years, using the straight-line method. Awards with performance conditions are amortized using the straight-line method over the service period in which the performance conditions are measured, adjusted for the probability of achieving the performance conditions.For each share of common stock issued by Medical Properties Trust, Inc. pursuant to its equity compensation plans, the Operating Partnership issues a corresponding number of operating partnership units.

Deferred Costs: Costs incurred prior to the completion of offerings of stock or other capital instruments (along with their corresponding units in the Operating Partnership) that directly relate to the offering are deferred and netted against proceeds received from the offering. External costs incurred in connection with anticipated financings and refinancing of debt are generally capitalized as deferred financing costs in other assets and amortized over the lives of the related loans as an addition to interest expense. For debt with defined principal re-payment terms, the deferred costs are amortized to produce a constant effective yield on the loan (interest method). For debt without defined principal repayment terms, such as revolving credit agreements, the deferred costs are amortized on the straight-line method over the term of the debt. Leasing commissions and other leasing costs directly attributable to tenant leases are capitalized as deferred leasing costs and amortized on the straight-line method over the terms of the related lease agreements. Costs identifiable with loans made to borrowers are recognized as a reduction in interest income over the life of the loan.

Derivative Financial Investments and Hedging Activities. During our normal course of business, we may use certain types of derivative instruments for the purpose of managing interest rate risk. We record our derivative and hedging instruments at fair value on the balance sheet. Changes in the estimated fair value of derivative instruments that are not designated as hedges or that do not meet the criteria for hedge accounting are recognized in earnings. For derivatives designated as cash flow hedges, the change in the estimated fair value of the effective portion of the derivative is recognized in accumulated other comprehensive income (loss), whereas the change in the estimated fair value of the ineffective portion is recognized in earnings. For derivates designated as fair value hedges, the change in the estimated fair value of the effective portion of the derivates offsets the change in the estimated fair value of the hedged item, whereas the change in the estimated fair value of the ineffective portion is recognized in earnings.

To qualify for hedge accounting, we formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking the hedge prior to entering into a derivative transaction. This process includes specific identification of the hedging instrument and the hedge transaction, the nature of the risk being hedged and how the hedging instrument's effectiveness in hedging the exposure to the hedged transaction's variability in cash flows attributable to the hedged risk will be assessed. Both at the inception of the hedge and on an ongoing basis, we assess whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in cash flows or fair values of hedged items. In addition, for cash flow hedges, we assess whether the underlying forecasted transaction will occur. We discontinue hedge accounting if a derivative is not determined to be highly effective as a hedge or that is probable that the underlying forecasted transaction will not occur.

Fair Value Measurement

We measure and disclose the estimated fair value of financial assets and liabilities utilizing a hierarchy of valuation techniques based on whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy:

•

Level 1 — quoted prices for identical instruments in active markets;

•

Level 2 — quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and

•

Level 3 — fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

We measure fair value using a set of standardized procedures that are outlined herein for all assets and liabilities which are required to be measured at their estimated fair value on either a recurring or non-recurring basis. When available, we utilize quoted market prices from an independent third party source to determine fair value and classifies such items in Level 1. In some instances where a market price is available, but the instrument is in an inactive or over-the-counter market, we consistently apply the dealer (market maker) pricing estimate and classify the asset or liability in Level 2.

If quoted market prices or inputs are not available, fair value measurements are based upon valuation models that utilize current market or independently sourced market inputs, such as interest rates, option volatilities, credit spreads, market capitalization rates, etc. Items valued using such internally-generated valuation techniques are classified according to the lowest level input that is significant to the fair value measurement. As a result, the asset or liability could be classified in either Level 2 or 3 even though there may be some significant inputs that are readily observable. Internal fair value models and techniques used by us include discounted cash flow and Black Scholes valuation models. We also consider our counterparty's and own credit risk on derivatives and other liabilities measured at their estimated fair value.

Reclassifications: Certain reclassifications have been made to the consolidated financial statements to conform to the 2010 consolidated financial statement presentation. Assets sold or held for sale have been reclassified on the consolidated balance sheets and related operating results have been reclassified from continuing operations to discontinued operations (see Note 11).

Real Estate And Loans Receivable

12 Months Ended

Dec. 31, 2010

Real Estate And Loans Receivable [Abstract]

Real Estate And Loans Receivable

3. Real Estate and Loans Receivable

Acquisitions

We acquired the following assets:


	2010		2009		2008
	(Amounts in thousands)
Land	$	8,227	$	421	$	45,293
Buildings		119,626		—		373,472
Intangible lease assets-subject to amortization (weighted-average useful life 19.4 years in 2010 and 10.7 years in 2008)		9,955		—		11,945

	$	137,808	$	421	$	430,710

In the fourth quarter of 2010, we acquired two long-term acute care hospital facilities in Texas for an aggregate purchase price of $64 million. The properties acquired had existing leases in place which we assumed. The Triumph Hospital Clear Lake, a 110-bed facility that opened in 2005, is subject to a lease maturing in 2025 and can be renewed by the lessee for two five-year terms. Triumph Hospital Tomball, a 75-bed facility that opened in August 2006, is subject to a lease that matures in 2026 and can be renewed by the lessee for two five-year terms.

In the second quarter of 2010, we acquired three inpatient rehabilitation hospitals in Texas for an aggregate purchase price of $74 million. The properties acquired had existing leases in place which we assumed, that have initial terms expiring in 2033. Each lease may, subject to conditions, be renewed by the operator for two additional ten-year terms.

From the respective acquisition dates in 2010 through year-end, these 2010 acquisitions contributed $4.3 million of revenue and $3.4 million of income. In addition, we incurred approximately $2.0 million in acquisition related expenses in 2010, of which approximately $0.9 million related to acquisitions consummated as of December 31, 2010. These acquisition expenses are reflected in general and administrative expenses in the consolidated statements of income.

In the second and third quarters of 2008, we completed the acquisition of 20 properties from a single seller for $357.2 million. The properties acquired had existing leases in place, which we assumed, on six acute care hospitals, three long-term acute care hospitals, five rehabilitation hospitals, and six wellness centers.

In May 2008, we acquired a long-term acute care hospital at a cost of $10.8 million from an unrelated party and entered into an operating lease with Vibra Healthcare ("Vibra").

In June 2008, we entered into a $60 million loan with affiliates of Prime related to three southern California hospital campuses operated by Prime. We acquired one of the facilities in July 2008 from a Prime affiliate for approximately $15 million and the other two facilities (including two medical office buildings) in the 2008 fourth quarter for $45 million. We entered into a 10-year lease with the Prime affiliate concurrent with our acquisitions of each of these facilities.

The results of operations for each of the properties acquired are included in our consolidated results from the effective date of each acquisition. The following table sets forth certain unaudited pro forma consolidated financial data for 2010, 2009 and 2008, as if each significant acquisition was consummated on the same terms at the beginning of each year.


	2010		2009
	(Amounts in thousands
	except per share/ unit amounts)
Total revenues	$	130,470	$	129,454
Net income		18,026		37,884
Net income per share/unit diluted	$	0.17	$	0.47

Disposals

In the fourth quarter 2010, we sold the real estate of our Montclair Hospital, an acute care medical center to Prime for proceeds of $20.0 million. We realized a gain on the sale of $2.2 million. Due to this sale, operating results of our Montclair facility have been included in discontinued operations for the current period and all prior periods and, we have reclassified the asset of this property to Real Estate Held for Sale in our accompanying Consolidated Balance Sheet at December 31, 2009.

In October 2010, we sold the real estate of our Sharpstown facility in Houston, Texas to a third party for net proceeds of $2.7 million resulting in a gain of $0.7 million. At December 31, 2009, this facility was reclassified as held for sale and the related operating results have been included in discontinued operations for the current period and all prior periods.

In the second quarter 2010, we sold the real estate of our Inglewood Hospital, a 369-bed acute care medical center located in Inglewood, California, to Prime Healthcare, for $75 million resulting in a gain of approximately $6 million. Due to this sale, operating results of our Inglewood facility have been included in discontinued operations for the current period and all prior periods, and we have reclassified the asset of this property to Real Estate Held for Sale in our accompanying Consolidated Balance Sheet at December 31, 2009.

In the fourth quarter of 2009, we sold the real estate asset of one acute care facility to Prime for proceeds of $15.0 million. The sale was completed on December 28, 2009, and we realized a gain on the sale of $0.3 million.

In the second quarter of 2008, we sold the real estate assets of three inpatient rehabilitation facilities to Vibra for proceeds of approximately $105 million, including $7.0 million in early lease termination fees and $8.0 million of a loan pre-payment. The sale was completed on May 7, 2008, realizing a gain on the sale of $9.3 million. We also wrote off $9.5 million in related straight-line rent receivable upon completion of the sales.

Intangible Assets

At December 31, 2010 and 2009, our intangible lease assets were $35.0 million ($27.6 million, net of accumulated amortization) and $24.1 million ($19.0 million, net of accumulated amortization), respectively.

We recorded amortization expense related to intangible lease assets of $3.2 million, $4.5 million (including $0.5 million of accelerated amortization as described below) and $8.1 million (including $4.5 million of accelerated amortization as described below) in 2010, 2009, and 2008, respectively, and expect to recognize amortization expense from existing lease intangible assets as follows: (amounts in thousands)


For the Year Ended December 31:
2011	$	2,957
2012		2,592
2013		2,559
2014		2,494
2015		2,305

As of December 31, 2010, capitalized lease intangibles have a weighted average remaining life of 14.3 years.

Leasing Operations

Minimum rental payments due to us in future periods under operating leases which have non-cancelable terms extending beyond one year at December 31, 2010, are as follows: (amounts in thousands)


2011	$	93,799
2012		90,443
2013		90,980
2014		89,291
2015		86,392
Thereafter		653,621

	$	1,104,526

In September 2010, we exchanged properties with one of our tenants. In exchange for our acute care facility in Cleveland, Texas, we received a similar acute care facility in Hillsboro, Texas. The lease that was in place on our Cleveland facility was carried over to the new facility with no change in lease term or lease rate. This exchange was accounted for at fair value, resulting in a gain of $1.3 million (net of $0.2 million from the write-off of straight-line rent receivables).

In April 2009, we terminated leases on two of our facilities in Louisiana (Covington and Denham Springs) after the operator defaulted on the leases. As a result of the lease terminations, we recorded a $1.1 million charge in order to fully reserve and write off, respectively, the related straight-line rent receivables associated with the Covington and Denham Springs facilities. In addition, we accelerated the amortization of the related lease intangibles resulting in $0.5 million of expense in the 2009 second quarter. In June 2009, we re-leased the Denham Springs facility to a new operator under terms similar to the terminated lease. In March 2010, we re-leased our Covington facility. The lease has a fixed term of 15 years with an option, at the lessee's discretion, to extend the term for three additional periods of five years each. Rent during 2010 was based on an annual rate of $1.4 million and, commencing on January 1, 2011, increases annually by 2%. At the end of each term, the tenant has the right to purchase the facility at a price generally equivalent to the greater of our undepreciated cost and fair market value. Separately, we also obtained an interest in the operations of the tenant whereby we may receive additional consideration based on the profitability of such operations.

In January 2009, the then-operator of our Bucks County facility gave notice of its intentions to close the facility. The associated lease was terminated, which resulted in the write-off of $4.7 million in uncollectible rent and other receivables in December 2008. This write-off excluded $3.8 million of receivables that were guaranteed by the former tenant's parent company. In the 2010 fourth quarter, we agreed to settle our $3.8 million claim of unpaid rent for $1.4 million resulting in a $2.4 million charge to earnings.

In July 2009, we re-leased our Bucks County facility located in Bensalem, Pennsylvania. The lease has a fixed term of five years with an option, at the lessee's discretion, to extend 15 additional periods of one year each. Initial cash rent was $2.0 million per year with annual escalations of 2%. Separately, we also obtained a profits interest whereby we may receive up to an additional $1.0 million annually pursuant to an agreement that provides for our participation in certain cash flows, if any, as defined in the agreement. After the fixed term, the tenant has the right to purchase the facility at a price based on a formula set forth in the lease agreement.

In the third quarter of 2008, we terminated leases on two general acute care hospitals in Houston, Texas and one hospital in Redding, California due to certain tenant defaults. These facilities were previously leased to affiliates of HPA that filed for bankruptcy subsequent to the lease terminations. Pursuant to these lease terminations, we recorded $4.5 million in accelerated amortization in the 2008 third quarter related to lease intangibles. In addition, we recorded a $1.5 million charge for the write-off of straight-line rent.

On November 1, 2008, we entered into a new lease agreement for the Redding hospital. The new operator, an affiliate of Prime, agreed to increase the lease base from $60.0 million to $63.0 million and to pay up to $12.0 million in additional rent and a profits participation of up to $8.0 million based on the future profitability of the new lessee's operations. In the 2010 second quarter, Prime paid us $12 million in additional rent related to our Redding property, and we terminated our agreements with Prime concerning the additional rent and profits interest. Of this $12 million in additional rent, $2.6 million has been recognized in income from lease inception through December 31, 2010, (including $1.2 million in each of 2010 and 2009) and we expect to recognize the other $9.4 million into income over the remainder of the lease life.

As of December 31, 2010, we have advanced approximately $28 million to the operator/lessee of Monroe Hospital in Bloomington, Indiana pursuant to a working capital loan agreement, including additional advances of $1.3 million in 2010. In addition as of December 31, 2010, we have $11.5 million ($1.9 million accrued in 2010) of rent, interest and other charges outstanding, of which $5.4 million of interest receivables are significantly more than 90 days past due. Because the operator has not made all payments required by the working capital loan agreement and the related real estate lease agreement, we consider the loan to be impaired. During the first quarter of 2010, we evaluated alternative strategies for the recovery of our advances and accruals and at that time determined that the future cash flows of the current tenant or related collateral would, more likely than not, result in less than a full recovery of our loan advances. Accordingly, we recorded a $12 million charge in the 2010 first quarter to recognize the estimated impairment of the working capital loan. During the third quarter of 2010, we determined that it is reasonably likely that the existing tenant will be unable to make certain lease payments that become due in future years. Accordingly, we recorded a valuation allowance for unbilled straight-line rent in the amount of $2.5 million. At December 31, 2010, our net investment (exclusive of the related real estate) of $27.6 million is our maximum exposure to Monroe and the amount is deemed collectible/recoverable. In making this determination, we considered our first priority secured interest in approximately (i) $4 million in hospital patient receivables, (ii) cash balances of approximately $4 million, and (iii) 100% of the membership interests of the operator/lessee and our assessment of the realizable value of our other collateral.

We continue to evaluate possible operating strategies for the hospital. We have entered into a forbearance agreement with the operator whereby we have generally agreed, under certain conditions, not to fully exercise our rights and remedies under the lease and loan agreements during limited periods. We have not committed to the adoption of a plan to transition ownership or management of the hospital to any new operator, and there is no assurance that any such plan will be completed. Moreover, there is no assurance that any plan that we ultimately pursue will not result in additional charges for further impairment of our working capital loan. We have not recognized any interest income on the Monroe loan since it was considered impaired in the 2010 first quarter.

Loans

The following is a summary of our loans ($ amounts in thousands):


	As of December 31, 2010					As of December 31, 2009
	Balance		Weighted Average Interest Rate			Balance		Weighted Average Interest Rate
Mortgage loans	$	165,000		10.0	%	$	200,164		9.9	%
Other loans		50,985		10.8	%		110,842		10.6	%

	$	215,985				$	311,006

In 2010, we funded $2.8 million for an expansion loan on the Centinela property. This expansion loan and original mortgage loan were repaid in the amount of $43 million in the 2010 fourth quarter.

In December 2009, we committed to fund a mortgage loan totaling $20.0 million to an affiliate of Prime, $15 million of which was advanced in 2009 with the remainder advanced in 2010. This loan is collateralized by the Desert Valley facility and the purpose of the loan was to help fund an overall $35.0 million expansion and renovation.

Including our working capital loans to Monroe (discussed previously), our other loans primarily consist of loans to our tenants for acquisitions and working capital purposes. In 2008 and as part of the leasing of our Redding Hospital, we agreed to provide Prime a working capital loan up to $20 million. In April 2010, Prime repaid this loan and other working capital loans plus accrued interest in the amount of $40 million. In conjunction with our purchase of six healthcare facilities in July and August 2004, we also made loans aggregating $41.4 million to Vibra. As of December 31, 2010, Vibra has reduced the balance of the loans to $19.6 million.

Concentration of Credit Risks

For the years ended December 31, 2010, 2009, and 2008, affiliates of Prime (including rent and interest from mortgage and working capital loans) accounted for 32.7%, 33.7%, and 26.9%, respectively, of our total revenues , and Vibra (including rent and interest from working capital loans) accounted for 14.5%, 15.1%, and 17.4%, respectively, of our total revenues.

Debt

12 Months Ended

Dec. 31, 2010

Debt [Abstract]

Debt

4. Debt

The following is a summary of debt ($ amounts in thousands):


	As of December 31, 2010						As of December 31, 2009
	Balance			Interest Rate			Balance			Interest Rate
Revolving credit facilities	$	—			Variable		$	137,200			Variable
Senior unsecured notes — fixed rate through July and October 2011 due July and October 2016		125,000			7.333%- 7.871%			125,000			7.333%- 7.871%
Exchangeable senior notes
Principal amount		91,175			6.125 9.250	%- %		220,000			6.125 9.250	%- %
Unamortized discount		(2,585	)					(8,265	)

		88,590						211,735
Term loans Principal amount		157,683			Various			102,743			Various
Unamortized discount		(1,303	)					—

		156,380						102,743

	$	369,970					$	576,678

As of December 31, 2010, principal payments due on our debt (which exclude the effects of any discounts recorded) are as follows:


2011	$	25,608
2012		1,500
2013		83,500
2014		1,500
2015		1,500
Thereafter		260,250

Total	$	373,858

In May 2010, we closed on a new $450 million secured credit facility with a syndicate of banks and others, and the proceeds of such new credit facility along with cash proceeds from a secondary stock offering as more fully described in Note 9 were used to repay in full all outstanding obligations under the old $220 million credit facility, fund the purchase of 93% of our outstanding 6.125% exchangeable senior notes and payoff of a $30 million term loan. These refinancing activities resulted in a charge of approximately $6.7 million in 2010 related to the write-off of previously deferred financing costs and the premium we paid associated with the exchangeable notes buy back. The new credit facility includes a $150 million term loan facility ("2010 Term Loan") and a $300 million revolving loan facility ("2010 Revolving Facility"), which was increased to $330 million in September 2010. We may further increase the 2010 Revolving Facility up to $375 million via an accordion feature through November 2011.

Revolving Credit Facilities

The 2010 Revolving Facility has a 3-year term that matures on May 17, 2013 and has an interest rate option of (1) the higher of the "prime rate" or federal funds rate plus 0.5%, plus a spread initially set at 2.00%, but that is adjustable from 2.00% to 2.75% based on current total leverage, or (2) LIBOR plus a spread initially set at 3.00%, but that is adjustable from 3.00% to 3.75% based on current total leverage. In addition, we are required to pay a quarterly commitment fee on the undrawn portion of the 2010 Revolving Facility, ranging from 0.375% to 0.500% per year. The 2010 Revolving Facility is collateralized by (i) the equity interests of certain of our subsidiaries and (ii) mortgage loans payable to us. We may borrow up to the maximum of the facility so long as we do not permit the ratio of outstanding indebtedness under the facility to exceed 55% of the value of the borrowing base, as described in the revolving facility agreement. From inception of this new facility through December 31, 2010, we have not borrowed under this facility, and as of December 31, 2010, we had $322.4 million of availability.

In regards to the $220 million credit facility that we paid off in 2010, our outstanding borrowings under the revolving facility were $96 million at December 31, 2009. For 2009, our interest rate was primarily set of the 30-day LIBOR plus 1.75% (1.99% at December 31, 2009). In addition, the old credit facility provided for a quarterly commitment fee on the unused portion ranging from 0.20% to 0.35%. The weighted average interest rate on this facility was 2.21% for 2009.

In June 2007, we signed a collateralized revolving bank credit facility for up to $42 million. The terms are for five years with interest at the 30-day LIBOR plus 1.50% (1.77% at December 31, 2010 and 1.73% at December 31, 2009). The amount available under the facility decreases $0.8 million per year until maturity. The facility is collateralized by one real estate property with a net book value of $56.5 million and $57.9 million at December 31, 2010 and 2009, respectfully. This facility had an outstanding balance of $0 and $41.2 million at December 31, 2010 and December 31, 2009, respectively. At December 31, 2010, we had $40.4 million of availability under this revolving credit facility. The weighted-average interest rate on this revolving bank credit facility was 1.74% and 1.86% for 2010 and 2009, respectively.

Senior Unsecured Notes

During 2006, we issued $125.0 million of Senior Unsecured Notes (the "Senior Notes"). The Senior Notes were placed in private transactions exempt from registration under the Securities Act of 1933, as amended, (the "Securities Act"). One of the issuances of Senior Notes totaling $65.0 million pays interest quarterly at a fixed annual rate of 7.871% through July 30, 2011, thereafter, at a floating annual rate of three-month LIBOR plus 2.30% and may be called at par value by us at any time on or after July 30, 2011. This portion of the Senior Notes matures in July 2016. The remaining issuances of Senior Notes pay interest quarterly at fixed annual rates ranging from 7.333% to 7.715% through October 30, 2011, thereafter, at a floating annual rate of three-month LIBOR plus 2.30% and may be called at par value by us at any time on or after October 30, 2011. These remaining notes mature in October 2016.

During the second quarter 2010, we entered into an interest rate swap to fix $65 million of our $125 million Senior Notes, starting July 31, 2011 (date on which the interest rate is scheduled to turn variable) through maturity date (or July 2016), at a rate of 5.507%. We also entered into an interest rate swap to fix $60 million of our Senior Notes starting October 31, 2011 (date on which the related interest rate is scheduled to turn variable) through the maturity date (or October 2016) at a rate of 5.675%. At December 31, 2010, the fair value of the interest rate swaps is $3.6 million, which is reflected in accounts payable and accrued expenses on the condensed consolidated balance sheet.

We account for our interest rate swaps as cash flow hedges. Accordingly, the effective portion of changes in the fair value of our swaps is recorded as a component of accumulated other comprehensive income/loss on the balance sheet until the underlying debt matures while the ineffective portion is recorded through earnings. We did not have any hedge ineffectiveness from inception of our interest rate swaps through December 31, 2010 and therefore, there was no income statement effect recorded during the year ended December 31, 2010.

Exchangeable Senior Notes

In November 2006, our Operating Partnership issued and sold, in a private offering, $138.0 million of Exchangeable Senior Notes (the "2006 Exchangeable Notes"). The 2006 Exchangeable Notes pay interest semi-annually at a rate of 6.125% per annum and mature on November 15, 2011. The 2006 Exchangeable Notes have an initial exchange rate of 60.3346 of our common shares per $1,000 principal amount of the notes, representing an exchange price of $16.57 per common share. The initial exchange rate is subject to adjustment under certain circumstances. The 2006 Exchangeable Notes are exchangeable, prior to the close of business on the second business day immediately preceding the stated maturity date at any time beginning on August 15, 2011 and also upon the occurrence of specified events, for cash up to their principal amount and cash or our common shares for the remainder of the exchange value in excess of the principal amount. Net proceeds from the offering of the 2006 Exchangeable Notes were approximately $134 million, after deducting the initial purchasers' discount. The 2006 Exchangeable Notes are senior unsecured obligations of the Operating Partnership, guaranteed by us. During 2010, 93% of the outstanding 6.125% exchangeable senior notes due 2011 were repurchased at a price of 103% of the principal amount plus accrued and unpaid interest (or $136.3 million). The outstanding balance on the 2006 Exchangeable Notes is $9.2 million as of December 31, 2010.

Concurrent with the pricing of the 2006 exchangeable notes, the Operating Partnership entered into a "capped call" transaction with affiliates of the initial purchasers (the "option counterparties") in order to increase the effective exchange price of the Exchangeable Notes to $18.94 per common share. The capped call transaction is expected to reduce the potential dilution with respect to our common stock upon exchange of the 2006 Exchangeable Notes to the extent the then market value per share of our common stock does not exceed $18.94 during the observation period relating to an exchange. We have reserved 8.3 million shares, which may be issued in the future to settle the 2006 Exchangeable Notes. The premium of $6.3 million paid for the "capped call" transaction has been recorded as a permanent reduction to additional paid in capital in the consolidated statement of equity.

In March 2008, our Operating Partnership issued and sold, in a private offering, $75.0 million of Exchangeable Senior Notes (the "2008 Exchangeable Notes") and received proceeds of $72.8 million. In April 2008, the Operating Partnership sold an additional $7.0 million of the 2008 Exchangeable Notes (under the initial purchasers' overallotment option) and received proceeds of $6.8 million. The 2008 Exchangeable Notes pay interest semi-annually at a rate of 9.25% per annum and mature on April 1, 2013. The 2008 Exchangeable Notes have an initial exchange rate of 80.8898 shares of our common stock per $1,000 principal amount, representing an exchange price of $12.36 per common share. The initial exchange rate is subject to adjustment under certain circumstances. The 2008 Exchangeable Notes are exchangeable prior to the close of business on the second day immediately preceding the stated maturity date at any time beginning on January 1, 2013 and also upon the occurrence of specified events, for cash up to their principal amounts and cash or our common shares for the remainder of the exchange value in excess of the principal amount. The 2008 Exchangeable Notes are senior unsecured obligations of the Operating Partnership, guaranteed by us.

Term Loans

The 2010 Term Loan has a 6-year term that matures May 17, 2016 and has an interest rate option of (1) LIBOR plus a spread of 3.5% or (2) the higher of the "prime rate" or federal funds rate plus 0.5%, plus a spread of 2.50%. This 2010 Term Loan is subject to a LIBOR floor of 1.5% (5.00% at December 31, 2010). We make quarterly principal payments of $375,000 on the term loan. The 2010 Term Loan had an outstanding balance of $149.3 million at December 31, 2010.

Included in the $220 million credit facility that was paid off in 2010 was a term loan that had an outstanding balance of $64.5 million at December 31, 2009. This term loan's interest rate was based on the 30-day LIBOR plus a spread of 200 basis points (2.26% at December 31, 2009).

In June 2008, our Operating Partnership signed a term loan agreement for $30.0 million that was paid off during 2010. This facility had an outstanding balance of $29.6 million at December 31, 2009. The loan had a variable interest rate of 400 basis points in excess of LIBOR (4.23% at December 31, 2009).

In November 2008, we signed a collateralized term loan facility for $9 million with interest fixed at 5.66%. The term loan has a stated maturity date of November 2013; however, this could mature earlier if the lease of the collateralized property (that comes due in December 2011) is not extended. We make monthly principal and interest payments on this loan. The facility is collateralized by one real estate property with a book value of $18.2 million at December 31, 2010. This facility had an outstanding balance of $8.4 million at December 31, 2010.

Our debt facilities impose certain restrictions on us, including restrictions on our ability to: incur debts; grant liens; provide guarantees in respect of obligations of any other entity; make redemptions and repurchases of our capital stock; prepay, redeem or repurchase debt; engage in mergers or consolidations; enter into affiliated transactions; dispose of real estate; and change our business. In addition, these agreements limit the amount of dividends we can pay to 90% of normalized adjusted funds from operations, as defined in the agreements, on a rolling four quarter basis starting for the fiscal quarter ending March 31, 2012 and thereafter. Prior to March 31, 2012, a similar dividend restriction exists but at a higher percentage for transitional purposes. These agreements also contain provisions for the mandatory prepayment of outstanding borrowings under these facilities from the proceeds received from the sale of properties that serve as collateral, except a portion may be reinvested subject to certain limitations, as defined in the credit facility agreement.

In addition to these restrictions, the new credit facility contains customary financial and operating covenants, including covenants relating to our total leverage ratio, fixed charge coverage ratio, mortgage secured leverage ratio, recourse mortgage secured leverage ratio, consolidated adjusted net worth, facility leverage ratio, and borrowing base interest coverage ratio. This facility also contains customary events of default, including among others, nonpayment of principal or interest, material inaccuracy of representations and failure to comply with our covenants. If an event of default occurs and is continuing under the facility, the entire outstanding balance may become immediately due and payable. At December 31, 2010, we were in compliance with all such financial and operating covenants.

Income Taxes

12 Months Ended

Dec. 31, 2010

Income Taxes [Abstract]

Income Taxes

5. Income Taxes

Medical Properties Trust, Inc.

We have maintained and intend to maintain our election as a REIT under the Internal Revenue Code of 1986, as amended. To qualify as a REIT, we must meet a number of organizational and operational requirements, including a requirement to distribute at least 90% of our taxable income to our stockholders. As a REIT, we generally will not be subject to federal income tax if we distribute 100% of our taxable income to our stockholders and satisfy certain other requirements. Income tax is paid directly by our stockholders on the dividends distributed to them. If our taxable income exceeds our dividends in a tax year, REIT tax rules allow us to designate dividends from the subsequent tax year in order to avoid current taxation on undistributed income. If we fail to qualify as a REIT in any taxable year, we will be subject to federal income taxes at regular corporate rates, including any applicable alternative minimum tax. Taxable income from non-REIT activities managed through our taxable REIT subsidiaries is subject to applicable federal, state and local income taxes. For 2010 and 2009, we recorded tax expense of $1.6 million and $0.3 million, respectively, while we recorded a tax benefit of $1.1 million in 2008.

At December 31, 2010 and 2009, we had a net deferred tax asset (prior to valuation allowance) of $6.7 million and $1.8 million respectively. This increase is primarily related to the loss reserve recorded in 2010 on the Monroe loan and an increase in the federal and state net operating loss carry forwards ("NOLs"). NOLs are available to offset future earnings in one of our taxable REIT subsidiaries within the periods specified by law. At December 31, 2010, we had U.S. federal and state NOLs of $7.4 million and $7.9 million, respectively, that expire in 2020 through 2030.

With the early prepayment of working capital loans by Prime and the impairment of the Monroe loan as more fully described in Note 3, we did not believe that one of our taxable REIT subsidiaries would generate enough taxable income to use the federal and state net operating losses noted above within the carry forward period specified by law. Therefore, in the 2010 second quarter, we fully reserved for the net deferred tax asset. At December 31, 2010 and 2009 the valuation allowance was $6.8 million and $0.3 million, respectively. We will continue to monitor this valuation allowance and, if circumstances change (such as entering into new working capital loans or other transactions), we will adjust this valuation allowance accordingly.

Earnings and profits, which determine the taxability of distributions to stockholders, will differ from net income reported for financial reporting purposes due primarily to differences in cost bases, differences in the estimated useful lives used to compute depreciation, and differences between the allocation of our net income and loss for financial reporting purposes and for tax reporting purposes.

A schedule of per share distributions we paid and reported to our stockholders is set forth in the following:


	For the Years Ended December 31,
	2010		2009		2008
Common share distribution	$	0.800000	$	0.800000	$	1.080000
Ordinary income		0.388128		0.471792		0.677940
Capital gains(1)		0.027724		0.003708		0.145400
Unrecaptured Sec. 1250 gain		0.022784		0.003708		0.138168
Return of capital		0.384148		0.324500		0.256660
Allocable to next year		—		—		—

(1)	Capital gains include unrecaptured Sec. 1250 gains.

MPT Operating Partnership, L.P.

As a partnership, the allocated share of income of the Operating Partnership is included in the income tax returns of the general and limited partners. Accordingly, no accounting for income taxes is generally required for such income of the Operating Partnership. However, the Operating Partnership has formed taxable REIT subsidiaries on behalf of Medical Properties Trust, Inc., which are subject to federal, state and local income taxes at regular corporate rates. See discussion above under Medical Properties Trust, Inc. for more details of income taxes associated with our taxable REIT subsidiaries.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 136, 172
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 43, 44, 45, 46, 47, 48, 49
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

+ Details

Earnings Per Share/Unit

12 Months Ended

Dec. 31, 2010

Earnings Per Share/Unit [Abstract]

Earnings Per Share/Unit

6. Earnings Per Share/Unit

Medical Properties Trust, Inc.

Our earnings per share were calculated based on the following (amounts in thousands):


	For the Years Ended December 31,
	2010			2009			2008
Numerator:
Income from continuing operations	$	13,228		$	33,670		$	18,590
Non-controlling interests' share in continuing operations		(99	)		(36	)		(29	)
Participating securities' share in earnings		(1,254	)		(1,506	)		(1,745	)

Income from continuing operations, less participating securities' share in earnings		11,875			32,128			16,816
Income from discontinued operations		9,784			2,697			14,143
Non-controlling interests' share in discontinued operations		—			(1	)		(4	)

Income from discontinued operations attributable to MPT common stockholders		9,784			2,696			14,139

Net income, less participating securities' share in earnings	$	21,659		$	34,824		$	30,955

Denominator:
Basic weighted-average common shares		100,706			78,117			62,027
Dilutive stock options		2			—			8

Diluted weighted-average common shares		100,708			78,117			62,035

MPT Operating Partnership, L.P.

Our earnings per unit were calculated based on the following (amounts in thousands):


	For the Years Ended December 31,
	2010			2009			2008
Numerator:
Income from continuing operations	$	13,303		$	33,733		$	18,590
Non-controlling interests' share in continuing operations		(99	)		(36	)		(29	)
Participating securities' share in earnings		(1,254	)		(1,506	)		(1,745	)

Income from continuing operations, less participating securities' share in earnings		11,950			32,191			16,816


	For the Years Ended December 31,
	2010		2009			2008
Income from discontinued operations		9,784		2,697			14,143
Non-controlling interests' share in discontinued operations		—		(1	)		(4	)

Income from discontinued operations attributable to MPT Operating Partnership partners		9,784		2,696			14,139

Net income, less participating securities' share in earnings	$	21,734	$	34,887		$	30,955

Denominator:
Basic weighted-average units		100,706		78,117			62,027
Dilutive options		2		—			8

Diluted weighted-average units		100,708		78,117			62,035

For each of the years ended December 31, 2010, 2009, and 2008, 0.1 million of options were excluded from the diluted earnings per share/unit calculation as they were not determined to be dilutive. Shares/units that may be issued in the future in accordance with our exchangeable senior notes were excluded from the diluted earnings per share/unit calculation as they were not determined to be dilutive.

Stock Awards

12 Months Ended

Dec. 31, 2010

Stock Awards [Abstract]

Stock Awards

7. Stock Awards

We have adopted the Second Amended and Restated Medical Properties Trust, Inc. 2004 Equity Incentive Plan (the "Equity Incentive Plan"), which authorizes the issuance of common stock options, restricted stock, restricted stock units, deferred stock units, stock appreciation rights, performance units and awards of interests in our Operating Partnership. The Equity Incentive Plan is administered by the Compensation Committee of the Board of Directors. We have reserved 7,441,180 shares of common stock for awards under the Equity Incentive Plan for which 3,716,379 shares remain available for future stock awards as of December 31, 2010. The Equity Incentive Plan contains a limit of 1,000,000 shares as the maximum number of shares of common stock that may be awarded to an individual in any fiscal year. Awards under the Equity Incentive Plan are subject to forfeiture due to termination of employment prior to vesting. In the event of a change in control, outstanding and unvested options will immediately vest, unless otherwise provided in the participant's award or employment agreement, and restricted stock, restricted stock units, deferred stock units and other stock-based awards will vest if so provided in the participant's award agreement. The term of the awards is set by the Compensation Committee, though Incentive Stock Options may not have terms of more than ten years. Forfeited awards are returned to the Equity Incentive Plan and are then available to be re-issued as future awards. For each share of common stock issued by Medical Properties Trust, Inc. pursuant to its equity compensation plans, the Operating Partnership issues a corresponding number of operating partnership units.

We awarded 50,000 common stock options in 2007, with an exercise price and estimated grant date fair values of $12.09 and $1.36 per option, respectively. The options awarded in 2007 vest annually in equal amounts over three years from the date of award and expire in 2012. We use the Black-Scholes pricing model to calculate the fair values of the options awarded. In 2007, the following assumptions were used to derive the fair values: an option term of four years; expected volatility of 28.34%; a weighted average risk-free rate of return of 4.62%; and a dividend yield of 8.93%. The intrinsic value of options exercisable and outstanding at December 31, 2010, is $-0-. No options were granted, exercised, or forfeited in 2010, 2009, or 2008. At December 31, 2010, we had 130,000 options outstanding and exercisable, with a weighted-average exercise price of $10.80 per option. The weighted average remaining contractual term of options exercisable and outstanding is 3.0 years.

Other stock-based awards are in the form of service-based awards and performance-based awards. The service-based awards vest as the employee provides the required service over periods that generally range from three to seven years. Service based awards are valued at the average price per share of common stock on the date of grant. In 2006, 2007, and 2010, the Compensation Committee made awards which vest based on us achieving certain performance levels, stock price levels, total shareholder return or comparison to peer total return indices. The 2010 awards are based on us achieving a simple 9.5% annual total shareholder return over a three year period; however, the award contains both carry forward and carry back provisions through December 31, 2014. The 2006 awards are based on us achieving levels of total shareholder return compared to an industry index.

The 2007 awards were granted under our 2007 Multi-year Incentive Plan ("MIP") adopted by the Compensation Committee and consist of three components: service-based awards, core performance awards ("CPRE"), and superior performance awards ("SPRE"). The service-based awards vest annually and ratably over a seven-year period beginning December 31, 2007. The CPRE awards also vest annually and ratably over the same seven-year period contingent upon our achievement of a simple 9% annual total return to shareholders (pro-rated to 7.5% for the first vesting period ending December 31, 2007). In years in which the annual total return exceeds 9%, the excess return may be used to earn CPRE awards not earned in a prior or future year. SPRE awards were to be earned based on achievement of specified share price thresholds during the period beginning March 1, 2007 through December 31, 2010, and were to vest annually and ratably over the subsequent three-year period (2011-2013). At December 31, 2010, the share price thresholds were not met. However, in accordance with the SPRE award agreements, 33.334% of the SPRE awards were earned as we performed at or above the 50th percentile of all real estate investment trusts included in the Morgan Stanley REIT Index in terms of total return to shareholders over the same period. The other 66.666% of the SPRE awards were deemed forfeited. All unvested 2007 MIP awards provide for payment of dividends and other non-liquidating distributions, except that the SPRE awards, prior to the awards being earned, pay dividends at 20% of the per share dividend amount. The 2007 MIP awards were made in the form of restricted shares and a new class of partnership units in our Operating Partnership ("LTIP units") — see Note 14 for further details . The LTIP units that are earned may eventually be converted, at our election, into either shares of common stock on a one-for-one basis or their equivalent in cash. We have valued our LTIP awards at the same per unit value as a corresponding restricted stock award. We used an independent valuation consultant to assist us in determining the value of the 2007 MIP awards' CPRE and SPRE components using a Monte Carlo simulation. The following assumptions were used to derive the fair values for the SPRE and CPRE, respectively: term — 3.4 years and 6.4 years; expected (implied) volatility 27.00% and 26.00%; risk-free rate of return 4.55% and 4.65%; and, dividends — $1.08 in 2007, $1.10 in 2008, $1.13 in 2009, and 3% annual increase thereafter through 2013. In addition to the SPRE awards noted earlier, 79,287 shares/LTIP units were earned in 2010 under the CPRE award. For 2009, 79,287 shares/LTIP units were earned under the CPRE award, but no SPRE awards were earned.

The following summarizes restricted equity awards activity in 2010 and 2009, respectively:

For the Year Ended December 31, 2010:


	Vesting Based on Service					Vesting Based on Market/Performance Conditions
	Shares			Weighted Average Value at Award Date		Shares			Weighted Average Value at Award Date
Nonvested awards at beginning of the year		962,350		$	10.22		1,301,088		$	6.90
Awarded		277,680		$	10.39		182,600		$	9.25
Vested		(454,323	)	$	9.97		(175,279	)	$	10.64
Forfeited		(2,402	)	$	8.66		(480,000	)	$	3.31

Nonvested awards at end of year		783,305		$	10.43		828,409		$	8.70

For the Year Ended December 31, 2009:


	Vesting Based on Service					Vesting Based on Market/Performance Conditions
	Shares			Weighted Average Value at Award Date		Shares			Weighted Average Value at Award Date
Nonvested awards at beginning of the year		828,106		$	12.24		1,380,375		$	7.15
Awarded		441,134		$	6.30		—			—
Vested		(299,167	)	$	10.08		(79,287	)	$	11.29
Forfeited		(7,723	)	$	8.16		—			—

Nonvested awards at end of year		962,350		$	10.22		1,301,088		$	6.90

The value of stock-based awards is charged to compensation expense over the vesting periods. In the years ended December 31, 2010, 2009 and 2008, we recorded $6.6 million, $5.5 million, and $6.4 million respectively, of non-cash compensation expense. The remaining unrecognized cost from restricted equity awards at December 31, 2010, is $9.6 million and will be recognized over a weighted average period of 2.4 years. Restricted equity awards which vested in 2010 had a value of $6.1 million on the vesting dates.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 123R
-Paragraph 64, 65, A240
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Statement of Position (SOP)
-Number 93-6
-Paragraph 53
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 14

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 40
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

+ Details

Commitments And Contingencies

12 Months Ended

Dec. 31, 2010

Commitments And Contingencies [Abstract]

Commitments And Contingencies

8. Commitments and Contingencies

Our operating leases primarily consist of ground leases on which certain of our facilities or other related property reside along with corporate office and equipment leases. These ground leases are long-term leases and some contain escalation provisions. Properties subject to these ground leases are subleased to our tenants. Lease and rental expense for 2010, 2009 and 2008, respectively, were $989,170, $859,570, and $919,735, which was offset by sublease rental income of $520,090, $520,090, and $498,733 for 2010, 2009, and 2008, respectively.

Fixed minimum payments due under operating leases with non-cancelable terms of more than one year at December 31, 2010 are as follows: (amounts in thousands)


2011	$	2,128
2012		2,135
2013		2,021
2014		1,657
2015		1,657
Thereafter		38,971

	$	48,569

The total amount to be received in the future from non-cancellable subleases at December 31, 2010, is $31.1 million.

In November 2009, we reached an agreement to settle all of the claims asserted by Stealth, L.P. in previously disclosed litigation concerning the termination of leases of the Houston Town and Country Hospital and medical office building in October 2006, with the exception of a single contract claim for which Memorial Hermann Healthcare System had agreed to provide indemnification. Claims separately asserted against us by six of Stealth L.P.'s limited partners were not affected by the settlement. In January 2010, Memorial Hermann settled all claims asserted by Stealth including the single contract claim against us at no additional cost to us. The settlement with Stealth did not affect certain contract and tort claims asserted by six of Stealth's limited partners. As part of the settlement in November, however, Stealth indemnified us for any judgment amount and certain defense-related costs that we incurred. During the first quarter of 2010, these claims were tried in Harris County District Court in Houston, Texas, and the jury found against the plaintiffs on all claims. In the second quarter 2010, we settled the indemnification claim with Stealth resulting in $875,000 of proceeds to cover these defense costs, which we recorded as a reduction of legal expenses in June 2010.

We are a party to various legal proceedings incidental to our business. In the opinion of management, after consultation with legal counsel, the ultimate liability, if any, with respect to those proceedings is not presently expected to materially affect our financial position, results of operations or cash flows.

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 14
-Paragraph 3
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 9, 10, 11, 12
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

+ Details

Common Stock	12 Months Ended
Common Stock	Dec. 31, 2010
Common Stock [Abstract]
Common Stock	9. Common Stock In April 2010, we completed a public offering of 26 million shares of common stock at $9.75 per share. Including the underwriters' purchase of 3.9 million additional shares to cover over allotments, net proceeds from the offering, after underwriting discount and commissions, were $279.1 million. We used the net proceeds from the offering to fund our refinancing activities as discussed in Note 4 with any remaining proceeds to be used for general corporate purposes including funding acquisitions during 2010. During the first quarter of 2010, we sold 0.9 million shares of our common stock under our at-the-market equity offering program, at an average price of $10.77 per share, for total proceeds, net of a 2% sales commission, of $9.5 million. In November 2009, we put an at-the-market program in place, and we have the ability to sell up to $50 million of stock under that plan. During the fourth quarter of 2009, we sold 30,000 shares at an average price per share of $10.25 resulting in a proceeds, net of a 2% sales agent commission, of $0.3 million. On January 9, 2009, we filed Articles of Amendment to our charter with the Maryland State Department of Assessments and Taxation increasing the number of authorized shares of common stock, par value $0.001 per share available for issuance from 100,000,000 to 150,000,000. In January 2009, we completed a public offering of 12.0 million shares of our common stock at $5.40 per share. Including the underwriters' purchase of 1.3 million additional shares to cover over allotments, net proceeds from this offering, after underwriting discount and commissions, were $67.8 million. The net proceeds of this offering were generally used to repay borrowings outstanding under our revolving credit facilities. In March 2008, we sold 12,650,000 shares of common stock at a price of $10.75 per share. After deducting underwriters commissions and offering expenses, we realized proceeds of $128.3 million.

- Definition

The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 12
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 4
-Section 08
-Paragraph d

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 43
-Chapter 1
-Section B
-Paragraph 7, 11A
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 129
-Paragraph 2, 3, 4, 5, 6, 7, 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30, 31
-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section C

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 20: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

Reference 21: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 22: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 23: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187143-122770

+ Details

Partner's Capital	12 Months Ended
Partner's Capital	Dec. 31, 2010
Partners' Capital [Abstract]
Partner's Capital	10. Partner's Capital The Operating Partnership is made up of a general partner, Medical Properties Trust, LLC ("General Partner") and limited partners, including the Company (which owns 100% of the General Partner) and three other partners who are employees. By virtue of its ownership of the General Partner, the Company has a 99.9% ownership interest in Operating Partnership via its ownership of all the common units. The remaining ownership interest is held by the three employees via their ownership of LTIP units. These LTIP units were issued to the employees pursuant to the 2007 Multi-Year Incentive Plan, which is part of the Equity Incentive Plan discussed in Note 6 and once vested in accordance with their award agreement, may be converted to common units per the Second Amended and Restated Agreement of Limited Partnership of MPT Operating Partnership, L.P. ("Operating Partnership Agreement") In regards to distributions, the Operating Partnership shall distribute cash at such times and in such amounts as are determined by the General Partner in its sole and absolute discretion, to common unit holders who are common unit holders on the record date. However, per the Operating Partnership Agreement, the General Partner shall use its reasonable efforts to cause the Operating Partnership to distribute amounts sufficient to enable the Company to pay stockholder dividends that will allow the Company to (i) meet its distribution requirement for qualification as a REIT and (ii) avoid any federal income or excise tax liability imposed by the Internal Revenue Code, other than to the extent the Company elects to retain and pay income tax on its net capital gain. In accordance with the Operating Partnership Agreement, LTIP units are treated as common units for distribution purposes. The Operating Partnership's net income will generally be allocated first to the General Partner to the extent of any cumulative losses and then to the limited partners in accordance with their respective percentage interests in the common units issued by the Operating Partnership. Any losses of the Operating Partnership will generally be allocated first to the limited partners until their capital account is zero and then to the General Partner. In accordance with the Operating Partnership Agreement, LTIP units are treated as common units for purposes of income and loss allocations. Limited partners have the right to require the Operating Partnership to redeem part or all of their common units. It is at the Operating Partnership's discretion to redeem such common units for cash based on the fair market value of an equivalent number of shares of the Company's common stock at the time of redemption or, alternatively, redeem the common units for shares of the Company's common stock on a one-for-one basis, subject to adjustment in the event of stock splits, stock dividends, or similar events. In order for LTIP units to be redeemed, they must first be converted to common units and then must wait two years from the issuance of the LTIP units to be redeemed. For each share of common stock issued by Medical Properties Trust, Inc., the Operating Partnership issues a corresponding number of operating partnership units.

- Definition

The entire disclosure for the formation, structure, control and ownership of the partnership. Disclosures related to accounts comprising partners' capital. Includes balances of general partners' capital account, limited partners' capital account, preferred partners' capital account and total partners' capital account and units outstanding; accumulated other comprehensive income; amount and nature of changes to amount of partner's capital and units outstanding by class, rights and privileges for each class of units; distribution policies and distributions paid by unit class; impact of and correction of an error in previously issued financial statements; limitations of partners' liability; redemption, conversion and distribution policies; and deferred compensation related to the issuance of units.

+ References + Details

Fair Value Of Financial Instruments

12 Months Ended

Dec. 31, 2010

Fair Value Of Financial Instruments [Abstract]

Fair Value Of Financial Instruments

11. Fair Value of Financial Instruments

We have various assets and liabilities that are considered financial instruments. We estimate that the carrying value of cash and cash equivalents, and accounts payable and accrued expenses approximates their fair values. Included in accounts payable and accrued expenses are our interest rate swaps, which are recorded at fair value based on Level 2 observable market assumptions using standardized derivative pricing models. We estimate the fair value of our loans, interest, and other receivables by discounting the estimated future cash flows using the current rates at which similar receivables would be made to others with similar credit ratings and for the same remaining maturities. We determine the fair value of our exchangeable notes based on quotes from securities dealers and market makers. We estimate the fair value of our senior notes, revolving credit facilities, and term loans based on the present value of future payments, discounted at a rate which we consider appropriate for such debt.

The following table summarizes fair value information for our financial instruments: (amounts in thousands)


	December 31, 2010						December 31, 2009
Asset (Liability)	Book Value			Fair Value			Book Value			Fair Value
Interest and rent receivables	$	26,176		$	20,265		$	19,845		$	16,712
Loans		215,985			209,126			311,006			299,123
Debt, net		(369,970	)		(359,910	)		(576,678	)		(547,242	)

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 44A, 44B
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15C, 15D
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15A
-Subparagraph a-d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15B
-Subparagraph a, b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 3, 10, 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 157
-Paragraph 32, 33, 34
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 159
-Paragraph 17-22, 27, 28
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19207-110258

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13537-108611

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13433-108611

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13504-108611

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19296-110258

+ Details

Discontinued Operations

12 Months Ended

Dec. 31, 2010

Discontinued Operations [Abstract]

Discontinued Operations

12. Discontinued Operations

In the fourth quarter 2010, we sold the real estate of our Montclair Hospital, an acute care medical center to Prime for proceeds of $20.0 million. We realized a gain on the sale of $2.2 million. In October of 2010, we sold the real estate of our Sharpstown hospital in Houston, Texas to a third party for proceeds of $3.0 million resulting in a gain of $0.7 million. In the second quarter of 2010, we sold the real estate of our Inglewood Hospital, a 369-bed acute care medical center located in Inglewood, California, to Prime for $75 million resulting in a gain of approximately $6 million. Due to these sales, we have reclassified these assets to Real Estate Held for Sale in our accompanying Consolidated Balance Sheet at December 31, 2009 and reclassified the related operating results to discontinued operations for the current and prior periods.

In the fourth quarter of 2009, we sold the real estate of a general acute hospital to Prime for proceeds of approximately $15 million. The sale was completed on December 28, 2009, resulting in a gain on the sale of $0.3 million. Due to this sale, we have reclassified the assets of this property to Real Estate Held for Sale in the accompanying Consolidated Balance Sheet, which approximated $15.0 million at December 31, 2008.

In the second quarter of 2008, we sold the real estate assets of three inpatient rehabilitation facilities to Vibra for proceeds of approximately $105 million, including $7.0 million in early lease termination fees and $8.0 million of a loan pre-payment. The sale was completed on May 7, 2008, resulting in a gain on the sale of $9.3 million. We also wrote off $9.5 million in related straight-line rent receivables upon completion of the sales.

In 2006, we terminated leases for a hospital and medical office building ("MOB") complex and repossessed the real estate. In January 2007, we sold the hospital and MOB complex and recorded a gain on the sale of real estate of $4.1 million. During the period between termination of the lease and sale of the real estate, we substantially funded through loans the working capital requirements of the hospital's operator pending the operator's collection of patient receivables from Medicare and other sources. At December 31, 2007, we had $4.2 million in working capital loans included in assets of discontinued operations on the consolidated balance sheet. In July 2008, we received from Medicare the substantial remainder of amounts that we expect to collect and based thereon wrote off in the second quarter of 2008 $2.1 million (net of $1.2 million in tax benefits) of remaining uncollectible receivables from the operator. We were defendants in litigation related to this discontinued operation and it resulted in a significant amount of legal expenses in 2009 and 2008 including a settlement of $2.7 million reached in the 2009 fourth quarter.

We have classified current and prior year activity related to these transactions, along with the related operating results of the facilities prior to these transactions taking place, as discontinued operations.

The following table presents the results of discontinued operations for the years ended December 31, 2010, 2009 and 2008 (in thousands except per share/units amounts):


	For the Years Ended December 31,
	2010		2009		2008
Revenues	$	3,838	$	3,269	$	12,970
Gain on sale		9,072		278		9,305
Income from discontinued operations		9,784		2,697		14,143
Income from discontinued operations — diluted per share/units	$	0.10	$	0.04	$	0.23

- Definition

The entire disclosure for the facts and circumstances leading to the completed or expected disposal, manner and timing of disposal, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the segment in which the disposal group was reported, and the classification (whether sold or classified as held for sale) and carrying value of the assets and liabilities comprising the disposal group. Includes all disposal groups, including those classified as components of the entity (discontinued operations).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 43-48
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1510-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1020-107759

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1012-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1474-107760

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6390789&loc=d3e2443-110228

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1436-107760

+ Details

Quarterly Financial Data

12 Months Ended

Dec. 31, 2010

Quarterly Financial Data [Abstract]

Quarterly Financial Data

13. Quarterly Financial Data (unaudited)

Medical Properties Trust, Inc.

The following is a summary of the unaudited quarterly financial information for the years ended December 31, 2010 and 2009: (amounts in thousands, except for per share data)


	For the Three Month Periods in 2010 Ended
	March 31			June 30			September 30		December 31
Revenues	$	30,858		$	30,593		$	28,644	$	31,752
Income (loss) from continuing operations		(3,439	)		(305	)		8,663		8,309
Income from discontinued operations		625			6,537			301		2,321
Net income (loss)		(2,814	)		6,232			8,964		10,630
Net income (loss) attributable to MPT common stockholders		(2,822	)		6,223			8,919		10,593
Net income (loss) attributable to MPT common stockholders per share — basic	$	(0.04	)	$	0.06		$	0.08	$	0.09
Weighted average shares outstanding — basic		79,176			103,498			110,046		110,103
Net income (loss) attributable to MPT common stockholders per share — diluted	$	(0.04	)	$	0.06		$	0.08	$	0.09
Weighted average shares outstanding — diluted		79,176			103,498			110,046		110,108


	For the Three Month Periods in 2009 Ended
	March 31		June 30		September 30		December 31
Revenues	$	29,460	$	28,640	$	30,639	$	30,069
Income from continuing operations		8,207		6,608		9,525		9,330
Income (loss) from discontinued operations		2,511		1,251		859		(1,924	)
Net income		10,718		7,859		10,384		7,406
Net income attributable to MPT common stockholders		10,710		7,846		10,374		7,399
Net income attributable to MPT common stockholders per share — basic	$	0.14	$	0.09	$	0.13	$	0.09
Weighted average shares outstanding — basic		76,432		78,616		78,655		78,755
Net income attributable to MPT common stockholders per share — diluted	$	0.14	$	0.09	$	0.13	$	0.09
Weighted average shares outstanding — diluted		76,432		78,616		78,655		78,755

MPT Operating Partnership, L.P.

The following is a summary of the unaudited quarterly financial information for the years ended December 31, 2010 and 2009: (amounts in thousands, except for per share data)


	For the Three Month Periods in 2010 Ended
	March 31			June 30			September 30		December 31
Revenues	$	30,858		$	30,593		$	28,644	$	31,752
Income (loss) from continuing operations		(3,424	)		(236	)		8,654		8,309
Income from discontinued operations		625			6,537			301		2,321
Net income (loss)		(2,799	)		6,301			8,955		10,630
Net income (loss) attributable to MPT Operating Partnership partners		(2,807	)		6,292			8,910		10,593
Net income (loss) attributable to MPT Operating Partnership partners per unit — basic	$	(0.04	)	$	0.06		$	0.08	$	0.09
Weighted average units outstanding — basic		79,176			103,498			110,046		110,103
Net income (loss) attributable to MPT
Operating Partnership partners per unit — diluted	$	(0.04	)	$	0.06		$	0.08	$	0.09
Weighted average units outstanding — diluted		79,176			103,498			110,046		110,108


	For the Three Month Periods in 2009 Ended
	March 31		June 30		September 30		December 31
Revenues	$	29,460	$	28,640	$	30,639	$	30,069
Income from continuing operations		8,270		6,608		9,525		9,330
Income (loss) from discontinued operations		2,511		1,251		859		(1,924	)
Net income		10,781		7,859		10,384		7,406
Net income attributable to MPT Operating Partnership partners		10,773		7,846		10,374		7,399
Net income attributable to MPT Operating Partnership partners per unit — basic	$	0.14	$	0.09	$	0.13	$	0.09
Weighted average units outstanding — basic		76,432		78,616		78,655		78,755
Net income attributable to MPT Operating Partnership partners per unit — diluted	$	0.14	$	0.09	$	0.13	$	0.09
Weighted average units outstanding — diluted		76,432		78,616		78,655		78,755

- Definition

The entire disclosure for the quarterly financial data in the annual financial statements. The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.

+ References + Details

Subsequent Events	12 Months Ended
Subsequent Events	Dec. 31, 2010
Subsequent Events [Abstract]
Subsequent Events	14. Subsequent Events As of September 29, 2011, we invested approximately $210 million in health care real estate.

Condensed Consolidating Financial Information

12 Months Ended

Dec. 31, 2010

Condensed Consolidating Financial Information [Abstract]

Condensed Consolidating Financial Information

15. Condensed Consolidating Financial Information

The following tables present the condensed consolidating financial information for (a) Medical Properties Trust, Inc. ("Parent" and a guarantor to our 2011 unsecured senior notes), (b) MPT Operating Partnership, L.P. and MPT Finance Corporation ("Subsidiary Issuer"), (c) on a combined basis, the guarantors of our 2011 unsecured senior notes ("Subsidiary Guarantors"), and (d) on a combined basis, the non-guarantor subsidiaries ("Non-Guarantor Subsidiaries"). The condensed consolidating information is presented for the parent and presents investments in subsidiaries based upon their proportionate share of the subsidiary's net assets. Separate financial statements of the Subsidiary Guarantors are not presented because the guarantee by each 100% owned Subsidiary Guarantor is full and unconditional, joint and several, and we believe separate financial statements and other disclosures regarding the Subsidiary Guarantors are not material to investors. Furthermore, there are no significant legal restrictions on the Parent's ability to obtain funds from its subsidiaries by dividend or loan.

Condensed Consolidated Balance Sheet

December 31, 2010

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	297	$	903,630		$	128,442		$	—		$	1,032,369
Mortgage loans		—		—		165,000			—			—			165,000

Gross investment in real estate assets		—		297		1,068,630			128,442			—			1,197,369
Accumulated depreciation and amortization		—		—		(65,767	)		(10,327	)		—			(76,094	)

Net investment in real estate assets		—		297		1,002,863			118,115			—			1,121,275
Cash & cash equivalents		—		96,822		—			1,586			—			98,408
Interest and rent receivable		—		157		20,727			5,292			—			26,176
Straight-line rent receivable		—		—		21,180			7,732			—			28,912
Other loans		—		178		—			50,807			—			50,985
Net intercompany receivable (payable)		21,944		774,771		(767,395	)		(29,320	)		—			—
Investment in subsidiaries		899,949		390,232		42,970			—			(1,333,151	)		—
Other assets		—		10,289		1,215			11,554			—			23,058

Total Assets	$	921,893	$	1,272,746	$	321,560		$	165,766		$	(1,333,151	)	$	1,348,814

Liabilities and Equity
Liabilities Debt, net	$	—	$	361,537	$	—		$	8,433		$	—		$	369,970
Accounts payable and accrued expenses		22,317		10,824		2,430			403			—			35,974
Deferred revenue		—		436		17,826			4,875			—			23,137
Lease deposits and other obligations to tenants		—		—		18,539			1,618			—			20,157

Total liabilities		22,317		372,797		38,795			15,329			—			449,238
Total Medical Properties Trust Inc. stockholder's equity		899,462		899,835		282,765			150,437			(1,333,037	)		899,462

Non-controlling interests		114		114		—			—			(114	)		114

Total equity		899,576		899,949		282,765			150,437			(1,333,151	)		899,576

Total Liabilities and Equity	$	921,893	$	1,272,746	$	321,560		$	165,766		$	(1,333,151	)	$	1,348,814

Condensed Consolidated Statements of Income

For the Year Ended December 31, 2010

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	79,388	$	14,427		$	(1,030	)	$	92,785
Straight-line rent		—			—			186		1,888			—			2,074
Interest and fee income		—			6,964			16,772		10,766			(7,514	)		26,988

Total revenues		—			6,964			96,346		27,081			(8,544	)		121,847
Expenses
Real estate depreciation and amortization		—			—			21,339		3,147			—			24,486
Impairment charge		—			—			—		12,000			—			12,000
Property-related		—			(4	)		4,376		1,065			(1,030	)		4,407
General and administrative		75			27,867			—		593			—			28,535

Total operating expenses		75			27,863			25,715		16,805			(1,030	)		69,428

Operating income		(75	)		(20,899	)		70,631		10,276			(7,514	)		52,419
Other income (expense)
Interest income and other		—			(13	)		1,493		38			—			1,518
Debt refinancing costs		—			(6,716	)		—		—			—			(6,716	)
Interest expense		—			(33,623	)		26		(7,910	)		7,514			(33,993	)

Net other expense		—			(40,352	)		1,519		(7,872	)		7,514			(39,191	)

Income (loss) from continuing operations		(75	)		(61,251	)		72,150		2,404			—			13,228
Income (loss) from discontinued operations		—			—			122		9,662			—			9,784

Equity in earnings of consolidated subsidiaries net of income taxes		23,087			84,338			4,273		—			(111,698	)		—

Net income		23,012			23,087			76,545		12,066			(111,698	)		23,012
Net income attributable to non-controlling interests		(99	)		(99	)		—		—			99			(99	)

Net income attributable to MPT common stockholders	$	22,913		$	22,988		$	76,545	$	12,066		$	(111,599	)	$	22,913

Condensed Consolidated Statements of Cash Flows

For the Year Ended December 31, 2010

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(29	)	$	(54,909	)	$	95,203		$	20,372		$	—		$	60,637
Investing Activities
Real estate acquired		—			—			(137,808	)		—			—			(137,808	)
Principal received on loans receivable		—			—			—			90,486			—			90,486
Proceeds from sales of real estate		—			—			2,669			95,000			—			97,669
Investments in and advances to subsidiaries		(211,181	)		99,564			48,986			(148,579	)		211,210			—
Investments in loans receivable and other investments		—			—			(5,000	)		(6,637	)		—			(11,637	)
Construction in progress and other		—			(108	)		(8,267	)		(7,554	)		—			(15,929	)

Net cash provided by (used in) investing activities		(211,181	)		99,456			(99,420	)		22,716			211,210			22,781
Financing Activities
Revolving credit facilities, net		—			(96,000	)		—			(41,200	)		—			(137,200	)
Proceeds from term debt, net of discount		—			148,500			—			—			—			148,500
Payments of term debt		—			(216,520	)		—			(245	)		—			(216,765	)
Distributions paid		(76,856	)		(77,087	)		—			—			76,856			(77,087	)
Proceeds from sale of common shares/units, net of offering costs		288,066			288,066			—			—			(288,066	)		288,066
Lease deposits and other obligations to tenants		—			—			4,217			(550	)		—			3,667
Debt issuance costs paid and other financing activities		—			(9,498	)		—			—			—			(9,498	)

Net cash provided by (used in) financing activities		211,210			37,461			4,217			(41,995	)		(211,210	)		(317	)

Increase in cash and cash equivalents for period		—			82,008			—			1,093			—			83,101
Cash and cash equivalents at beginning of period		—			14,814			—			493			—			15,307

Cash and cash equivalents at end of period	$	—		$	96,822		$	—		$	1,586		$	—		$	98,408

Condensed Consolidated Balance Sheet

December 31, 2009

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	2	$	760,711		$	215,558		$	—		$	976,271
Mortgage loans		—		—		160,000			40,164			—			200,164

Gross investment in real estate assets		—		2		920,711			255,722			—			1,176,435
Accumulated depreciation and amortization		—		—		(45,918	)		(7,180	)		—			(53,098	)

Net investment in real estate assets		—		2		874,793			248,542			—			1,123,337
Cash & cash equivalents		—		14,813		—			494			—			15,307
Interest and rent receivable		—		185		15,512			4,148			—			19,845
Straight-line rent receivable		—		—		20,859			6,680			—			27,539
Other loans		—		178		1,000			109,664			—			110,842
Net intercompany receivable (payable)		15,740		872,702		(718,409	)		(170,033	)		—			—
Investment in subsidiaries		671,872		313,877		44,908			—			(1,030,657	)		—
Other assets		—		6,986		1,315			4,727			—			13,028

Total Assets	$	687,612	$	1,208,743	$	239,978		$	204,222		$	(1,030,657	)	$	1,309,898

Liabilities and Equity
Liabilities
Debt, net	$	—	$	526,800	$	—		$	49,878		$	—		$	576,678
Accounts payable and accrued expenses		16,037		9,596		3,044			570			—			29,247
Deferred revenue		—		475		9,623			5,252			—			15,350
Lease deposits and other obligations to tenants		—		—		14,880			2,168			—			17,048

Total liabilities		16,037		536,871		27,547			57,868			—			638,323
Total Medical Properties Trust Inc. stockholder's equity		671,445		671,742		212,431			146,354			(1,030,527	)		671,445

Non-controlling interests		130		130		—			—			(130	)		130

Total equity		671,575		671,872		212,431			146,354			(1,030,657	)		671,575

Total Liabilities and Equity	$	687,612	$	1,208,743	$	239,978		$	204,222		$	(1,030,657	)	$	1,309,898

Condensed Consolidated Statements of Income

For the Year Ended December 31, 2009

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	69,327		$	12,538		$	—		$	81,865
Straight-line rent		—			—			6,244			1,977			—			8,221
Interest and fee income		—			10,010			14,400			14,732			(10,419	)		28,723

Total revenues		—			10,010			89,971			29,247			(10,419	)		118,809
Expenses
Real estate depreciation and amortization		—			—			19,571			3,057			—			22,628
Impairment charge		—			—			—			—			—			—
Property-related		—			(20	)		3,780			42			—			3,802
General and administrative		63			20,631			—			402			—			21,096

Total operating expenses		63			20,611			23,351			3,501			—			47,526

Operating income		(63	)		(10,601	)		66,620			25,746			(10,419	)		71,283
Other income (expense)
Interest income and other		—			51			—			(8	)		—			43
Debt refinancing costs		—			—			—			—			—			—
Interest expense		—			(36,761	)		(4	)		(11,310	)		10,419			(37,656	)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Net other income (expense)		—			(36,710	)		(4	)		(11,318	)		10,419			(37,613	)

Income (loss) from continuing operations		(63	)		(47,311	)		66,616			14,428			—			33,670
Income (loss) from discontinued operations		—			—			(1,254	)		3,951			—			2,697

Equity in earnings of consolidated subsidiaries net of income taxes		36,430			83,741			3,918			—			(124,089	)		—

Net income		36,367			36,430			69,280			18,379			(124,089	)		36,367
Net income attributable to non-controlling interests		(37	)		(37	)		—			—			37			(37	)

Net income attributable to MPT common stockholders	$	36,330		$	36,393		$	69,280		$	18,379		$	(124,052	)	$	36,330

Condensed Consolidated Statements of Cash Flows

For the Year Ended December 31, 2009

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(268	)	$	(35,554	)	$	76,583		$	21,990		$	—		$	62,751

Investing Activities
Real estate acquired		—			—			(421	)		—			—			(421	)
Principal received on loans receivable		—			—			—			4,305			—			4,305
Proceeds from sales of real estate		—			—			—			15,000			—			15,000
Investments in and advances to subsidiaries		(6,699	)		89,642			(60,656	)		(28,871	)		6,584			—
Investments in loans receivable and other investments		—			—			(15,000	)		(8,243	)		—			(23,243	)
Construction in progress and other		—			—			(3,067	)		(4,710	)		—			(7,777	)

Net cash provided by (used in) investing activities		(6,699	)		89,642			(79,144	)		(22,519	)		6,584			(12,136	)

Financing Activities
Revolving credit facilities, net		—			(55,000	)		—			(800	)		—			(55,800	)
Proceeds from term debt, net of discount		—			—			—			—			—			—
Payments of term debt		—			(960	)		—			(272	)					(1,232	)
Distributions paid		(61,419	)		(61,649	)		—			—			61,419			(61,649	)
Proceeds from sale of common shares/units, net of offering costs		68,003			68,003			—			—			(68,003	)		68,003
Lease deposits and other obligations to tenants		—			—			2,561			829			—			3,390
Debt issuance costs paid and other financing activities		378			(149	)		—			3			—			232

Net cash provided by (used in) financing activities		6,962			(49,755	)		2,561			(240	)		(6,584	)		(47,056	)

Increase in cash and cash equivalents for period		(5	)		4,333			—			(769	)		—			3,559
Cash and cash equivalents at beginning of period		5			10,481			—			1,262			—			11,748

Cash and cash equivalents at end of period	$	—		$	14,814		$	—		$	493		$	—		$	15,307

Condensed Consolidated Statements of Income

For the Year Ended December 31, 2008

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	63,399		$	10,747		$	—		$	74,146
Straight-line rent		—			(543	)		2,323			1,962			—			3,742
Interest and fee income		—			8,627			15,879			12,387			(7,711	)		29,182

Total revenues		—			8,084			81,601			25,096			(7,711	)		107,070
Expenses
Real estate depreciation and amortization		—			—			19,741			2,644			—			22,385
Impairment charge		—			—			—			—			—			—
Property-related		—			69			4,183			(10	)		—			4,242
General and administrative		—			19,357			8			150			—			19,515

Total operating expenses		—			19,426			23,932			2,784			—			46,142

Operating income		—			(11,342	)		57,669			22,312			(7,711	)		60,928
Other income (expense)
Interest income and other		—			85			2			(1	)		—			86
Debt refinancing costs		—			—			—			—			—			—
Interest expense		—			(40,671	)		(167	)		(9,297	)		7,711			(42,424	)

Net other expense		—			(40,586	)		(165	)		(9,298	)		7,711			(42,338	)

Income (loss) from continuing operations		—			(51,928	)		57,504			13,014			—			18,590
Income (loss) from discontinued operations		—			—			(437	)		14,580			—			14,143

Equity in earnings of consolidated subsidiaries net of income taxes		32,733			84,661			2,861			—			(120,255	)		—

Net income		32,733			32,733			59,928			27,594			(120,255	)		32,733
Net income attributable to non-controlling interests		(33	)		(33	)		—			—			33			(33	)

Net income attributable to MPT common stockholders	$	32,700		$	32,700		$	59,928		$	27,594		$	(120,222	)	$	32,700

Condensed Consolidated Statements of Cash Flows

For the Year Ended December 31, 2008

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	363		$	(28,412	)	$	72,841		$	25,125		$	—		$	69,917

Investing Activities
Real estate acquired		—			—			(354,392	)		(76,318	)		—			(430,710	)
Principal received on loans receivable		—			—			45,000			26,941			—			71,941
Proceeds from sales of real estate		—			—			—			89,959			—			89,959
Investments in and advances to subsidiaries		(63,549	)		(251,773	)		282,544			(30,765	)		63,543			—
Investments in loans receivable and other investments		—			—			(45,000	)		(50,567	)		—			(95,567	)
Construction in progress and other		—			(605	)		(3,179	)		(502	)		—			(4,286	)

Net cash provided by (used in) investing activities		(63,549	)		(252,378	)		(75,027	)		(41,252	)		63,543			(368,663	)

Financing Activities
Revolving credit facilities, net		—			31,014			—			7,000			—			38,014
Proceeds from term debt, net of discount		—			110,093			—			8,908			—			119,001
Payments of term debt		—			(810	)		—			(50	)		—			(860	)
Distributions paid		(64,788	)		(65,098	)		—			—			64,788			(65,098	)
Proceeds from sale of common shares/units, net of offering costs		128,331			128,331			—			—			(128,331	)		128,331
Lease deposits and other obligations to tenants		—			—			2,186			777			—			2,963
Debt issuance costs paid and other financing activities		(378	)		(5,674	)		—			(20	)		—			(6,072	)

Net cash provided by financing activities		63,165			197,856			2,186			16,615			(63,543	)		216,279

Increase in cash and cash equivalents for period		(21	)		(82,934	)		—			488			—			(82,467	)
Cash and cash equivalents at beginning of period		26			93,415			—			774			—			94,215

Cash and cash equivalents at end of period	$	5		$	10,481		$	—		$	1,262		$	—		$	11,748

- Definition

The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.

+ References + Details

Valuation And Qualifying Accounts

12 Months Ended

Dec. 31, 2010

Valuation and Qualifying Accounts [Abstract]

Valuation And Qualifying Accounts

Medical Properties Trust, Inc. and MPT Operating Partnership, L.P.

Schedule II: Valuation and Qualifying Accounts

December 31, 2010


	Balance at Beginning of Year(1)		Additions Charged Against Operations(1)			Net Recoveries(1)			Balance at End of Year(1)
Year Ended December 31,	(In thousands)
2010	$	4,339	$	22,245	(3)	$	2,658		$	23,926

2009	$	397	$	5,107		$	1,165		$	4,339

2008	$	4,202	$	397		$	4,202	(2)	$	397

(1)	Includes allowance for doubtful accounts, straight-line rent reserves, allowance for loan losses, tax valuation allowances and other reserves.

(2)	Includes $3.2 million of write offs associated with our West Houston property that was sold in 2007.

(3)	Includes $12 million loan loss reserve related to our Monroe property and a $6.5 million increase in valuation allowances to fully reserve for the net deferred tax asset of one of our taxable REIT subsidiaries.

Real Estate Investments And Accumulated Depreciation

12 Months Ended

Dec. 31, 2010

Real Estate Investments And Accumulated Depreciation [Abstract]

Real Estate Investments And Accumulated Depreciation

SCHEDULE III — REAL ESTATE INVESTMENTS AND ACCUMULATED DEPRECIATION

December 31, 2010


						Additions Subsequent to Acquisition																Life on which depreciation in latest income statements is
	Type of	Initial Costs						Carrying			Cost at December 31, 2010						Accumulated		Date of		Date	computed
Location	Property	Land		Buildings		Improvements		Costs			Land		Buildings		Total		Depreciation		Construction		Acquired	(Years)
(Dollar amounts in thousands)
Thornton, CO	Long term acute care hospital	$	2,130	$	6,013	$	2,237	$	—		$	2,130	$	8,250	$	10,380	$	1,068		1962	August 17, 2004		40
New Bedford, MA	Long term acute care hospital		1,400		19,772		256		—			1,400		20,028		21,428		3,159		1942	August 17, 2004		40
Covington, LA	Long term acute care hospital		821		10,238		—		14			821		10,252		11,073		1,431		1984	June 9, 2005		40
Denham Springs, LA	Long term acute care hospital		429		5,340		—		49			429		5,389		5,818		686		1960	June 9, 2005		40
Redding, CA	Long term acute care hospital		—		19,952		—		4,361			1,629		22,684		24,313		2,919		1991	June 30, 2005		40
Sherman Oaks, CA	Acute care general hospital		5,290		13,587		—		31			5,290		13,618		18,908		1,706		1956	December 30, 2005		40
Bloomington, IN	Acute care general hospital		2,457		31,209		—		408			2,576		31,498		34,074		3,435		2006	August 8, 2006		40
Dallas, TX	Long term acute care hospital		1,000		13,589		—		368			1,421		13,536		14,957		1,466		2006	September 5, 2006		40
Huntington Beach, CA	Acute care general hospital		937		10,907		—		3			937		10,910		11,847		1,136		1965	November 8, 2006		40
La Palma, CA	Acute care general hospital		937		10,907		—		3			937		10,910		11,847		1,136		1971	November 8, 2006		40
Anaheim, CA	Acute care general hospital		1,875		21,814		—		10			1,875		21,824		23,699		2,273		1964	November 8, 2006		40
Luling, TX	Long term acute care hospital		811		9,345		—		—			811		9,345		10,156		954		2002	December 1, 2006		40
San Antonio, TX	Rehabilitation hospital		—		10,198		—		—			—		10,198		10,198		1,041		1987	December 1, 2006		40
Victoria, TX	Long term acute care hospital		625		7,197		—		—			625		7,197		7,822		735		1998	December 1, 2006		40
Houston, TX	Acute care general hospital		4,757		56,238		—		1,259			5,464		56,790		62,254		5,742		2006	December 1, 2006		40
Bensalem, PA	Acute care general hospital		6,911		38,185		—		(352	)		6,912		37,832		44,744		3,670		2006	March 19, 2007		40
Portland, OR	Long term acute care hospital		3,085		17,859		—		2,559			3,071		20,432		23,503		1,815		1964	April 18, 2007		40
San Diego, CA	Acute care general hospital		6,550		15,653		—		77			6,550		15,730		22,280		1,439		1964	May 9, 2007		40
Redding, CA	Acute care general hospital		1,555		53,863		—		13			1,555		53,876		55,431		4,613		1974	August 10, 2007		40
Houston, TX	Acute care general hospital		3,501		34,530		—		(7,319	)		3,274		27,438		30,712		2,312		1960	August 10, 2007		40
Bennettsville, SC	Acute care general hospital		794		15,772		—		—			794		15,772		16,566		1,085		1984	April 1, 2008		40
Bossier City, LA	Long term acute care hospital		900		17,818		—		—			900		17,818		18,718		1,222		1982	April 1, 2008		40
Bristol, CT	Wellness Center		485		2,267		—		—			485		2,267		2,752		429		1975	April 22, 2008		10
Cheraw, SC	Acute care general hospital		657		19,576		—		—			657		19,576		20,233		1,345		1982	April 1, 2008		40
Detroit, MI	Long term acute care hospital		1,220		8,687		—		(365	)		1,220		8,322		9,542		624		1956	May 22, 2008		40
Enfield, CT	Wellness Center		384		2,257		—		—			384		2,257		2,641		427		1974	April 22, 2008		10
Fayetteville, AR	Rehabilitation hospital		909		18,332		—		—			909		18,332		19,241		1,146		1991	July 14, 2008		40
Fort Lauderdale, FL	Rehabilitation hospital		3,499		21,939		—		—			3,499		21,940		25,439		1,465		1985	April 22, 2008		40
Garden Grove, CA	Acute care general hospital		5,502		10,748		—		52			5,502		10,799		16,301		574		1982	November 25, 2008		40
Garden Grove, CA	Medical Office Building		862		7,888		—		28			862		7,916		8,778		413		1982	November 25, 2008		40


						Additions Subsequent to Acquisition															Life on which depreciation in latest income statements is
	Type of	Initial Costs						Carrying		Cost at December 31, 2010						Accumulated		Date of		Date	computed
Location	Property	Land		Buildings		Improvements		Costs		Land		Buildings		Total		Depreciation		Construction		Acquired	(Years)
(Dollar amounts in thousands)
Idaho Falls, ID	Acute care general hospital		1,822		37,467		—		4,665		1,822		42,132		43,954		2,741		2002	April 1, 2008		40
Morgantown, WV	Rehabilitation hospital		—		21,552		—		—		—		21,552		21,552		2,010		1989	May 19, 2008		40
Newington, CT	Wellness Center		270		1,615		—		—		270		1,615		1,885		308		1979	April 22, 2008		10
Petersburg, VA	Rehabilitation hospital		1,302		9,121		—		—		1,302		9,121		10,423		570		2006	July 1, 2008		40
West Valley City, UT	Acute care general hospital		5,516		58,314		—		—		5,516		58,314		63,830		3,895		1980	April 22, 2008		40
Poplar Bluff, MO	Acute care general hospital		2,659		38,694		—		—		2,659		38,694		41,353		2,584		1980	April 22, 2008		40
East Providence, RI	Wellness Center		209		1,265		—		—		209		1,265		1,474		241		1979	April 22, 2008		10
San Dimas, CA	Acute care general hospital		6,160		6,839		—		34		6,160		6,873		13,033		358		1972	November 25, 2008		40
San Dimas, CA	Medical Office Building		1,915		5,085		—		18		1,915		5,103		7,018		266		1979	November 25, 2008		40
West Springfield, MA	Wellness Center		583		3,185		—		—		583		3,185		3,768		608		1976	April 22, 2008		10
Tucson, AZ	Long term acute care hospital		920		6,078		—		—		920		6,078		6,998		418		1987	April 1, 2008		40
Warwick, RI	Wellness Center		1,265		759		—		—		1,265		759		2,024		144		1979	April 22, 2008		10
Webster, TX	Long term acute care hospital		988		10,432		—		1		988		10,433		11,421		717		1986	April 1, 2008		40
Wichita, KS	Rehabilitation hospital		1,019		18,373		—		1		1,019		18,374		19,393		1,262		1992	April 4, 2008		40
Addison, TX	Rehabilitation hospital		2,013		22,531		—		—		2,013		22,531		24,544		282		2008	June 17, 2010		40
Shenandoah, TX	Rehabilitation hospital		2,033		21,943		—		—		2,033		21,943		23,976		274		2008	June 17, 2010		40
Richardson, TX	Rehabilitation hospital		2,219		17,419		—		—		2,219		17,419		19,638		218		2008	June 17, 2010		40
Hill County, TX	Acute care general hospital		1,120		17,882		—		—		1,120		17,882		19,002		300		1980	September 17, 2010		15
Webster, TX	Long term acute care hospital		664		33,751		—		—		664		33,751		34,414		—		2004	December 21, 2010		40
Tomball, TX	Long term acute care hospital		1,298		23,982		—		—		1,298		23,982		25,280		—		2005	December 21, 2010		40

		$	94,258	$	887,967	$	2,493	$	5,918	$	96,894	$	893,741	$	990,635	$	68,662

The changes in total real estate assets including real estate held for sale but excluding construction in progress, intangible lease asset and mortgage loans, for the years ended:


	December 31, 2010			December 31, 2009			December 31, 2008
COST
Balance at beginning of period	$	934,601		$	943,700		$	614,088
Acquisitions		146,854			421			418,766
Transfers from construction in progress		—			—			2,475
Additions		1,709			5,550			308
Dispositions		(92,529	)		(15,070	)		(85,648	)
Other		—			—			(6,289	)

Balance at end of period	$	990,635		$	934,601	(1)	$	943,700	(1)

The changes in accumulated depreciation including real estate assets held for sale for the years ended:


	December 31, 2010			December 31, 2009			December 31, 2008
ACCUMULATED DEPRECIATION
Balance at beginning of period	$	51,638		$	30,581		$	20,214
Depreciation		22,664			21,389			18,118
Depreciation on disposed property		(5,640	)		(332	)		(7,751	)

Balance at end of period	$	68,662		$	51,638	(2)	$	30,581	(2)

(1)	Includes real estate cost included in real estate held for sale of $72,691 and $87,807 for 2009 and 2008, respectively. Excludes intangible lease assets that are included in real estate held for sale of $24,487 and $24,615 for 2009 and 2008, respectively.

(2)	Includes accumulated depreciation in real estate held for sale of $3,673 and $2,396 for 2009 and 2008 respectively. Excludes accumulated amortization related to intangible lease assets that are included in real estate held for sale of $3,532 and $2,020 for 2009 and 2008, respectively.

- Definition

The entire disclosure for real estate and accumulated depreciation. This may include a schedule that describes the property and lists the initial cost of land, buildings and improvements, improvements and carrying costs capitalized after acquisition, and the total carrying cost for land, buildings and improvements for each property and in aggregate. The schedule also lists the accumulated depreciation for each property and in aggregate, the date each property was constructed and acquired, the useful life used to calculate depreciation and any encumbrances on the properties. The entity provides a reconciliation of the carrying amount of real estate from the beginning of the period to the end of the period. Any real estate investments that have been written down or reserved against are described, including the basis of the write-down. A material amount of intercompany profit in the total carrying amount of real estate is disclosed. The aggregate cost of all real estate investments for federal income tax purposes is also disclosed.

+ References + Details

Mortgage Loan On Real Estate

12 Months Ended

Dec. 31, 2010

Mortgage Loan On Real Estate [Abstract]

Mortgage Loan On Real Estate

SCHEDULE IV — MORTGAGE LOAN ON REAL ESTATE

MEDICAL PROPERTIES TRUST, INC. AND MPT OPERATING PARTNERSHIP, L.P.


Column A	Column B			Column C		Column D	Column E			Column F		Column G(3)		Column H
Description	Interest Rate			Final Maturity Date		Periodic Payment Terms	Prior Liens			Face Amount of Mortgages		Carrying Amount of Mortgages		Principal Amount of Loans Subject to Delinquent Principal or Interest
	(Dollar amounts in thousands)
Long-term first mortgage loan:						Payable in monthly installments of interest plus principal payable in full at maturity
Desert Valley Hospital		9.9	%		2022			(1	)		70,000		70,000		(2	)
Desert Valley Hospital		10.7	%		2022			(1	)		20,000		20,000		(2	)
Chino Valley Medical Center		9.9	%		2022			(1	)		50,000		50,000		(2	)
Paradise Valley Hospital		9.6	%		2022			(1	)		25,000		25,000		(2	)

										$	165,000	$	165,000

(1)	There were no prior liens on loans as of December 31, 2010.

(2)	The mortgage loan was not delinquent with respect to principal or interest.

(3)	The aggregate cost for Federal income tax purposes is $165,000.

Changes in mortgage loans for the years ended December 31, 2010, 2009, and 2008 are summarized as follows:


	Year Ended December 31,
	2010			2009		2008
	(Dollar amounts in thousands)
Balance at beginning of year	$	200,164		$	185,000	$	185,000
Additions during year:
New mortgage loans and additional advances on existing loans		7,836			15,164		—

		208,000			200,164		185,000

Deductions during year:
Collection of principal		(43,000	)		—		—

		(43,000	)		—		—

Balance at end of year	$	165,000		$	200,164	$	185,000

Summary Of Significant Accounting Policies (Policy) - Parent [Member]

12 Months Ended

Dec. 31, 2010

Use Of Estimates

Principles Of Consolidation

Cash And Cash Equivalents

Revenue Recognition

Acquired Real Estate Purchase Price Allocation

Real Estate And Depreciation

Depreciation is calculated on the straight-line method over the weighted average useful lives of the related real estate and other assets, as follows:


Buildings and improvements			37.8 years
Tenant lease intangibles			14.3 years
Tenant improvements			5.4 years
Furniture, equipment and other			9.5 years

Losses From Rent Receivables

Loans

Earnings Per Share

Income Taxes

Stock-Based Compensation

Deferred Costs

Derivative Financial Investments And Hedging Activities

Fair Value Measurement

Fair Value Measurement

•

Level 1 — quoted prices for identical instruments in active markets;

•

Level 3 — fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

Reclassifications

Summary Of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2010

Summary Of Significant Accounting Policies [Abstract]

Useful Lives Of Related Real Estate And Other Assets


Buildings and improvements			37.8 years
Tenant lease intangibles			14.3 years
Tenant improvements			5.4 years
Furniture, equipment and other			9.5 years

Real Estate And Loans Receivable (Tables)

12 Months Ended

Dec. 31, 2010

Real Estate And Lending Activities [Line Items]

Pro Forma Consolidated Financial Data


	2010		2009
	(Amounts in thousands
	except per share/ unit amounts)
Total revenues	$	130,470	$	129,454
Net income		18,026		37,884
Net income per share/unit diluted	$	0.17	$	0.47

Summary Of Amortization Expense From Lease Intangible Assets


For the Year Ended December 31:
2011	$	2,957
2012		2,592
2013		2,559
2014		2,494
2015		2,305

Summary Of Minimum Rental Payments


2011	$	2,128
2012		2,135
2013		2,021
2014		1,657
2015		1,657
Thereafter		38,971

	$	48,569

Summary Of Loans


	As of December 31, 2010					As of December 31, 2009
	Balance		Weighted Average Interest Rate			Balance		Weighted Average Interest Rate
Mortgage loans	$	165,000		10.0	%	$	200,164		9.9	%
Other loans		50,985		10.8	%		110,842		10.6	%

	$	215,985				$	311,006

Minimum Rental Payments [Member]

Real Estate And Lending Activities [Line Items]

Summary Of Minimum Rental Payments


2011	$	93,799
2012		90,443
2013		90,980
2014		89,291
2015		86,392
Thereafter		653,621

	$	1,104,526

- Definition

Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.

+ References + Details

- Definition

The entire disclosure for claims held for amounts due a company. Examples include trade accounts receivables, notes receivables, loans receivables.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 3, 4
-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 7
-Article 9

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Statement of Position (SOP)
-Number 01-6
-Paragraph 13
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 4
-Section 08
-Paragraph k

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.3,4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6965416&loc=d3e5074-111524

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6965416&loc=d3e5066-111524

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6965416&loc=d3e5162-111524

+ Details

Debt (Tables)

12 Months Ended

Dec. 31, 2010

Debt [Abstract]

Principal Payments Due For Debt


2011	$	25,608
2012		1,500
2013		83,500
2014		1,500
2015		1,500
Thereafter		260,250

Total	$	373,858

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2010

Income Taxes [Abstract]

Schedule Of Per Share Distributions To Stockholders


	For the Years Ended December 31,
	2010		2009		2008
Common share distribution	$	0.800000	$	0.800000	$	1.080000
Ordinary income		0.388128		0.471792		0.677940
Capital gains(1)		0.027724		0.003708		0.145400
Unrecaptured Sec. 1250 gain		0.022784		0.003708		0.138168
Return of capital		0.384148		0.324500		0.256660
Allocable to next year		—		—		—

(1)	Capital gains include unrecaptured Sec. 1250 gains.

Earnings Per Share/Unit (Tables)

12 Months Ended

Dec. 31, 2010

Calculation Of Earnings Per Share


	For the Years Ended December 31,
	2010			2009			2008
Numerator:
Income from continuing operations	$	13,228		$	33,670		$	18,590
Non-controlling interests' share in continuing operations		(99	)		(36	)		(29	)
Participating securities' share in earnings		(1,254	)		(1,506	)		(1,745	)

Income from continuing operations, less participating securities' share in earnings		11,875			32,128			16,816
Income from discontinued operations		9,784			2,697			14,143
Non-controlling interests' share in discontinued operations		—			(1	)		(4	)

Income from discontinued operations attributable to MPT common stockholders		9,784			2,696			14,139

Net income, less participating securities' share in earnings	$	21,659		$	34,824		$	30,955

Denominator:
Basic weighted-average common shares		100,706			78,117			62,027
Dilutive stock options		2			—			8

Diluted weighted-average common shares		100,708			78,117			62,035

MPT Operating Partnership, L.P. [Member]

Calculation Of Earnings Per Share


	For the Years Ended December 31,
	2010			2009			2008
Numerator:
Income from continuing operations	$	13,303		$	33,733		$	18,590
Non-controlling interests' share in continuing operations		(99	)		(36	)		(29	)
Participating securities' share in earnings		(1,254	)		(1,506	)		(1,745	)

Income from continuing operations, less participating securities' share in earnings		11,950			32,191			16,816


	For the Years Ended December 31,
	2010		2009			2008
Income from discontinued operations		9,784		2,697			14,143
Non-controlling interests' share in discontinued operations		—		(1	)		(4	)

Income from discontinued operations attributable to MPT Operating Partnership partners		9,784		2,696			14,139

Net income, less participating securities' share in earnings	$	21,734	$	34,887		$	30,955

Denominator:
Basic weighted-average units		100,706		78,117			62,027
Dilutive options		2		—			8

Diluted weighted-average units		100,708		78,117			62,035

Stock Awards (Tables)

12 Months Ended

Dec. 31, 2010

Stock Awards [Abstract]

Restricted Equity Awards Activity

For the Year Ended December 31, 2010:


	Vesting Based on Service					Vesting Based on Market/Performance Conditions
	Shares			Weighted Average Value at Award Date		Shares			Weighted Average Value at Award Date
Nonvested awards at beginning of the year		962,350		$	10.22		1,301,088		$	6.90
Awarded		277,680		$	10.39		182,600		$	9.25
Vested		(454,323	)	$	9.97		(175,279	)	$	10.64
Forfeited		(2,402	)	$	8.66		(480,000	)	$	3.31

Nonvested awards at end of year		783,305		$	10.43		828,409		$	8.70

For the Year Ended December 31, 2009:


	Vesting Based on Service					Vesting Based on Market/Performance Conditions
	Shares			Weighted Average Value at Award Date		Shares			Weighted Average Value at Award Date
Nonvested awards at beginning of the year		828,106		$	12.24		1,380,375		$	7.15
Awarded		441,134		$	6.30		—			—
Vested		(299,167	)	$	10.08		(79,287	)	$	11.29
Forfeited		(7,723	)	$	8.16		—			—

Nonvested awards at end of year		962,350		$	10.22		1,301,088		$	6.90

Commitments And Contingencies (Tables)

12 Months Ended

Dec. 31, 2010

Commitments And Contingencies [Abstract]

Summary Of Minimum Rental Payments


2011	$	2,128
2012		2,135
2013		2,021
2014		1,657
2015		1,657
Thereafter		38,971

	$	48,569

Fair Value Of Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2010

Fair Value Of Financial Instruments [Abstract]

Summary Of Fair Value Information Of Financial Instruments


	December 31, 2010						December 31, 2009
Asset (Liability)	Book Value			Fair Value			Book Value			Fair Value
Interest and rent receivables	$	26,176		$	20,265		$	19,845		$	16,712
Loans		215,985			209,126			311,006			299,123
Debt, net		(369,970	)		(359,910	)		(576,678	)		(547,242	)

- Definition

Tabular disclosure of the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments, assets, and liabilities. Such certain disclosures about the financial instruments, assets, and liabilities include: (1) the fair value of the required items together with their carrying amounts (as appropriate) and (2) the methodology and assumptions used in developing such estimates of fair value.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 14
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15
-Subparagraph b-d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 157
-Paragraph 32
-Subparagraph a, c(1), c(2), c(3), d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 159
-Paragraph 18
-Subparagraph c(2), d, e, f
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 159
-Paragraph 19
-Subparagraph a, b, c(1), d(1)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13433-108611

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13467-108611

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13476-108611

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19207-110258

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6447952&loc=d3e13220-108610

+ Details

Discontinued Operations (Tables)

12 Months Ended

Dec. 31, 2010

Discontinued Operations [Abstract]

Schedule Of Discontinued Operations


	For the Years Ended December 31,
	2010		2009		2008
Revenues	$	3,838	$	3,269	$	12,970
Gain on sale		9,072		278		9,305
Income from discontinued operations		9,784		2,697		14,143
Income from discontinued operations — diluted per share/units	$	0.10	$	0.04	$	0.23

- Definition

Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the classification and carrying value of the assets and liabilities comprising the disposal group, and the segment in which the disposal group was reported. Also may include the amount of adjustments to amounts previously reported in discontinued operations such as resolution of contingencies arising from the disposal transaction or the operations of the component prior to disposal.

+ References + Details

Quarterly Financial Data (Tables)

12 Months Ended

Dec. 31, 2010

Summary Of The Unaudited Quarterly Financial Information


	For the Three Month Periods in 2010 Ended
	March 31			June 30			September 30		December 31
Revenues	$	30,858		$	30,593		$	28,644	$	31,752
Income (loss) from continuing operations		(3,424	)		(236	)		8,654		8,309
Income from discontinued operations		625			6,537			301		2,321
Net income (loss)		(2,799	)		6,301			8,955		10,630
Net income (loss) attributable to MPT Operating Partnership partners		(2,807	)		6,292			8,910		10,593
Net income (loss) attributable to MPT Operating Partnership partners per unit — basic	$	(0.04	)	$	0.06		$	0.08	$	0.09
Weighted average units outstanding — basic		79,176			103,498			110,046		110,103
Net income (loss) attributable to MPT
Operating Partnership partners per unit — diluted	$	(0.04	)	$	0.06		$	0.08	$	0.09
Weighted average units outstanding — diluted		79,176			103,498			110,046		110,108


	For the Three Month Periods in 2009 Ended
	March 31		June 30		September 30		December 31
Revenues	$	29,460	$	28,640	$	30,639	$	30,069
Income from continuing operations		8,270		6,608		9,525		9,330
Income (loss) from discontinued operations		2,511		1,251		859		(1,924	)
Net income		10,781		7,859		10,384		7,406
Net income attributable to MPT Operating Partnership partners		10,773		7,846		10,374		7,399
Net income attributable to MPT Operating Partnership partners per unit — basic	$	0.14	$	0.09	$	0.13	$	0.09
Weighted average units outstanding — basic		76,432		78,616		78,655		78,755
Net income attributable to MPT Operating Partnership partners per unit — diluted	$	0.14	$	0.09	$	0.13	$	0.09
Weighted average units outstanding — diluted		76,432		78,616		78,655		78,755

Parent [Member]

Summary Of The Unaudited Quarterly Financial Information


	For the Three Month Periods in 2010 Ended
	March 31			June 30			September 30		December 31
Revenues	$	30,858		$	30,593		$	28,644	$	31,752
Income (loss) from continuing operations		(3,439	)		(305	)		8,663		8,309
Income from discontinued operations		625			6,537			301		2,321
Net income (loss)		(2,814	)		6,232			8,964		10,630
Net income (loss) attributable to MPT common stockholders		(2,822	)		6,223			8,919		10,593
Net income (loss) attributable to MPT common stockholders per share — basic	$	(0.04	)	$	0.06		$	0.08	$	0.09
Weighted average shares outstanding — basic		79,176			103,498			110,046		110,103
Net income (loss) attributable to MPT common stockholders per share — diluted	$	(0.04	)	$	0.06		$	0.08	$	0.09
Weighted average shares outstanding — diluted		79,176			103,498			110,046		110,108


	For the Three Month Periods in 2009 Ended
	March 31		June 30		September 30		December 31
Revenues	$	29,460	$	28,640	$	30,639	$	30,069
Income from continuing operations		8,207		6,608		9,525		9,330
Income (loss) from discontinued operations		2,511		1,251		859		(1,924	)
Net income		10,718		7,859		10,384		7,406
Net income attributable to MPT common stockholders		10,710		7,846		10,374		7,399
Net income attributable to MPT common stockholders per share — basic	$	0.14	$	0.09	$	0.13	$	0.09
Weighted average shares outstanding — basic		76,432		78,616		78,655		78,755
Net income attributable to MPT common stockholders per share — diluted	$	0.14	$	0.09	$	0.13	$	0.09
Weighted average shares outstanding — diluted		76,432		78,616		78,655		78,755

Condensed Consolidating Financial Information (Tables)

12 Months Ended

Dec. 31, 2010

Condensed Consolidating Financial Information [Abstract]

Consolidated Balance Sheet

Condensed Consolidated Balance Sheet

December 31, 2010

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	297	$	903,630		$	128,442		$	—		$	1,032,369
Mortgage loans		—		—		165,000			—			—			165,000

Gross investment in real estate assets		—		297		1,068,630			128,442			—			1,197,369
Accumulated depreciation and amortization		—		—		(65,767	)		(10,327	)		—			(76,094	)

Net investment in real estate assets		—		297		1,002,863			118,115			—			1,121,275
Cash & cash equivalents		—		96,822		—			1,586			—			98,408
Interest and rent receivable		—		157		20,727			5,292			—			26,176
Straight-line rent receivable		—		—		21,180			7,732			—			28,912
Other loans		—		178		—			50,807			—			50,985
Net intercompany receivable (payable)		21,944		774,771		(767,395	)		(29,320	)		—			—
Investment in subsidiaries		899,949		390,232		42,970			—			(1,333,151	)		—
Other assets		—		10,289		1,215			11,554			—			23,058

Total Assets	$	921,893	$	1,272,746	$	321,560		$	165,766		$	(1,333,151	)	$	1,348,814

Liabilities and Equity
Liabilities Debt, net	$	—	$	361,537	$	—		$	8,433		$	—		$	369,970
Accounts payable and accrued expenses		22,317		10,824		2,430			403			—			35,974
Deferred revenue		—		436		17,826			4,875			—			23,137
Lease deposits and other obligations to tenants		—		—		18,539			1,618			—			20,157

Total liabilities		22,317		372,797		38,795			15,329			—			449,238
Total Medical Properties Trust Inc. stockholder's equity		899,462		899,835		282,765			150,437			(1,333,037	)		899,462

Non-controlling interests		114		114		—			—			(114	)		114

Total equity		899,576		899,949		282,765			150,437			(1,333,151	)		899,576

Total Liabilities and Equity	$	921,893	$	1,272,746	$	321,560		$	165,766		$	(1,333,151	)	$	1,348,814

Condensed Consolidated Balance Sheet

December 31, 2009

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	2	$	760,711		$	215,558		$	—		$	976,271
Mortgage loans		—		—		160,000			40,164			—			200,164

Gross investment in real estate assets		—		2		920,711			255,722			—			1,176,435
Accumulated depreciation and amortization		—		—		(45,918	)		(7,180	)		—			(53,098	)

Net investment in real estate assets		—		2		874,793			248,542			—			1,123,337
Cash & cash equivalents		—		14,813		—			494			—			15,307
Interest and rent receivable		—		185		15,512			4,148			—			19,845
Straight-line rent receivable		—		—		20,859			6,680			—			27,539
Other loans		—		178		1,000			109,664			—			110,842
Net intercompany receivable (payable)		15,740		872,702		(718,409	)		(170,033	)		—			—
Investment in subsidiaries		671,872		313,877		44,908			—			(1,030,657	)		—
Other assets		—		6,986		1,315			4,727			—			13,028

Total Assets	$	687,612	$	1,208,743	$	239,978		$	204,222		$	(1,030,657	)	$	1,309,898

Liabilities and Equity
Liabilities
Debt, net	$	—	$	526,800	$	—		$	49,878		$	—		$	576,678
Accounts payable and accrued expenses		16,037		9,596		3,044			570			—			29,247
Deferred revenue		—		475		9,623			5,252			—			15,350
Lease deposits and other obligations to tenants		—		—		14,880			2,168			—			17,048

Total liabilities		16,037		536,871		27,547			57,868			—			638,323
Total Medical Properties Trust Inc. stockholder's equity		671,445		671,742		212,431			146,354			(1,030,527	)		671,445

Non-controlling interests		130		130		—			—			(130	)		130

Total equity		671,575		671,872		212,431			146,354			(1,030,657	)		671,575

Total Liabilities and Equity	$	687,612	$	1,208,743	$	239,978		$	204,222		$	(1,030,657	)	$	1,309,898

Consolidated Statements Of Income

Condensed Consolidated Statements of Income

For the Year Ended December 31, 2010

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	79,388	$	14,427		$	(1,030	)	$	92,785
Straight-line rent		—			—			186		1,888			—			2,074
Interest and fee income		—			6,964			16,772		10,766			(7,514	)		26,988

Total revenues		—			6,964			96,346		27,081			(8,544	)		121,847
Expenses
Real estate depreciation and amortization		—			—			21,339		3,147			—			24,486
Impairment charge		—			—			—		12,000			—			12,000
Property-related		—			(4	)		4,376		1,065			(1,030	)		4,407
General and administrative		75			27,867			—		593			—			28,535

Total operating expenses		75			27,863			25,715		16,805			(1,030	)		69,428

Operating income		(75	)		(20,899	)		70,631		10,276			(7,514	)		52,419
Other income (expense)
Interest income and other		—			(13	)		1,493		38			—			1,518
Debt refinancing costs		—			(6,716	)		—		—			—			(6,716	)
Interest expense		—			(33,623	)		26		(7,910	)		7,514			(33,993	)

Net other expense		—			(40,352	)		1,519		(7,872	)		7,514			(39,191	)

Income (loss) from continuing operations		(75	)		(61,251	)		72,150		2,404			—			13,228
Income (loss) from discontinued operations		—			—			122		9,662			—			9,784

Equity in earnings of consolidated subsidiaries net of income taxes		23,087			84,338			4,273		—			(111,698	)		—

Net income		23,012			23,087			76,545		12,066			(111,698	)		23,012
Net income attributable to non-controlling interests		(99	)		(99	)		—		—			99			(99	)

Net income attributable to MPT common stockholders	$	22,913		$	22,988		$	76,545	$	12,066		$	(111,599	)	$	22,913

Condensed Consolidated Statements of Income

For the Year Ended December 31, 2009

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	69,327		$	12,538		$	—		$	81,865
Straight-line rent		—			—			6,244			1,977			—			8,221
Interest and fee income		—			10,010			14,400			14,732			(10,419	)		28,723

Total revenues		—			10,010			89,971			29,247			(10,419	)		118,809
Expenses
Real estate depreciation and amortization		—			—			19,571			3,057			—			22,628
Impairment charge		—			—			—			—			—			—
Property-related		—			(20	)		3,780			42			—			3,802
General and administrative		63			20,631			—			402			—			21,096

Total operating expenses		63			20,611			23,351			3,501			—			47,526

Operating income		(63	)		(10,601	)		66,620			25,746			(10,419	)		71,283
Other income (expense)
Interest income and other		—			51			—			(8	)		—			43
Debt refinancing costs		—			—			—			—			—			—
Interest expense		—			(36,761	)		(4	)		(11,310	)		10,419			(37,656	)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Net other income (expense)		—			(36,710	)		(4	)		(11,318	)		10,419			(37,613	)

Income (loss) from continuing operations		(63	)		(47,311	)		66,616			14,428			—			33,670
Income (loss) from discontinued operations		—			—			(1,254	)		3,951			—			2,697

Equity in earnings of consolidated subsidiaries net of income taxes		36,430			83,741			3,918			—			(124,089	)		—

Net income		36,367			36,430			69,280			18,379			(124,089	)		36,367
Net income attributable to non-controlling interests		(37	)		(37	)		—			—			37			(37	)

Net income attributable to MPT common stockholders	$	36,330		$	36,393		$	69,280		$	18,379		$	(124,052	)	$	36,330

Condensed Consolidated Statements of Income

For the Year Ended December 31, 2008

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	63,399		$	10,747		$	—		$	74,146
Straight-line rent		—			(543	)		2,323			1,962			—			3,742
Interest and fee income		—			8,627			15,879			12,387			(7,711	)		29,182

Total revenues		—			8,084			81,601			25,096			(7,711	)		107,070
Expenses
Real estate depreciation and amortization		—			—			19,741			2,644			—			22,385
Impairment charge		—			—			—			—			—			—
Property-related		—			69			4,183			(10	)		—			4,242
General and administrative		—			19,357			8			150			—			19,515

Total operating expenses		—			19,426			23,932			2,784			—			46,142

Operating income		—			(11,342	)		57,669			22,312			(7,711	)		60,928
Other income (expense)
Interest income and other		—			85			2			(1	)		—			86
Debt refinancing costs		—			—			—			—			—			—
Interest expense		—			(40,671	)		(167	)		(9,297	)		7,711			(42,424	)

Net other expense		—			(40,586	)		(165	)		(9,298	)		7,711			(42,338	)

Income (loss) from continuing operations		—			(51,928	)		57,504			13,014			—			18,590
Income (loss) from discontinued operations		—			—			(437	)		14,580			—			14,143

Equity in earnings of consolidated subsidiaries net of income taxes		32,733			84,661			2,861			—			(120,255	)		—

Net income		32,733			32,733			59,928			27,594			(120,255	)		32,733
Net income attributable to non-controlling interests		(33	)		(33	)		—			—			33			(33	)

Net income attributable to MPT common stockholders	$	32,700		$	32,700		$	59,928		$	27,594		$	(120,222	)	$	32,700

Condensed Consolidated Statements Of Cash Flows

Condensed Consolidated Statements of Cash Flows

For the Year Ended December 31, 2010

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(29	)	$	(54,909	)	$	95,203		$	20,372		$	—		$	60,637
Investing Activities
Real estate acquired		—			—			(137,808	)		—			—			(137,808	)
Principal received on loans receivable		—			—			—			90,486			—			90,486
Proceeds from sales of real estate		—			—			2,669			95,000			—			97,669
Investments in and advances to subsidiaries		(211,181	)		99,564			48,986			(148,579	)		211,210			—
Investments in loans receivable and other investments		—			—			(5,000	)		(6,637	)		—			(11,637	)
Construction in progress and other		—			(108	)		(8,267	)		(7,554	)		—			(15,929	)

Net cash provided by (used in) investing activities		(211,181	)		99,456			(99,420	)		22,716			211,210			22,781
Financing Activities
Revolving credit facilities, net		—			(96,000	)		—			(41,200	)		—			(137,200	)
Proceeds from term debt, net of discount		—			148,500			—			—			—			148,500
Payments of term debt		—			(216,520	)		—			(245	)		—			(216,765	)
Distributions paid		(76,856	)		(77,087	)		—			—			76,856			(77,087	)
Proceeds from sale of common shares/units, net of offering costs		288,066			288,066			—			—			(288,066	)		288,066
Lease deposits and other obligations to tenants		—			—			4,217			(550	)		—			3,667
Debt issuance costs paid and other financing activities		—			(9,498	)		—			—			—			(9,498	)

Net cash provided by (used in) financing activities		211,210			37,461			4,217			(41,995	)		(211,210	)		(317	)

Increase in cash and cash equivalents for period		—			82,008			—			1,093			—			83,101
Cash and cash equivalents at beginning of period		—			14,814			—			493			—			15,307

Cash and cash equivalents at end of period	$	—		$	96,822		$	—		$	1,586		$	—		$	98,408

Condensed Consolidated Statements of Cash Flows

For the Year Ended December 31, 2009

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(268	)	$	(35,554	)	$	76,583		$	21,990		$	—		$	62,751

Investing Activities
Real estate acquired		—			—			(421	)		—			—			(421	)
Principal received on loans receivable		—			—			—			4,305			—			4,305
Proceeds from sales of real estate		—			—			—			15,000			—			15,000
Investments in and advances to subsidiaries		(6,699	)		89,642			(60,656	)		(28,871	)		6,584			—
Investments in loans receivable and other investments		—			—			(15,000	)		(8,243	)		—			(23,243	)
Construction in progress and other		—			—			(3,067	)		(4,710	)		—			(7,777	)

Net cash provided by (used in) investing activities		(6,699	)		89,642			(79,144	)		(22,519	)		6,584			(12,136	)

Financing Activities
Revolving credit facilities, net		—			(55,000	)		—			(800	)		—			(55,800	)
Proceeds from term debt, net of discount		—			—			—			—			—			—
Payments of term debt		—			(960	)		—			(272	)					(1,232	)
Distributions paid		(61,419	)		(61,649	)		—			—			61,419			(61,649	)
Proceeds from sale of common shares/units, net of offering costs		68,003			68,003			—			—			(68,003	)		68,003
Lease deposits and other obligations to tenants		—			—			2,561			829			—			3,390
Debt issuance costs paid and other financing activities		378			(149	)		—			3			—			232

Net cash provided by (used in) financing activities		6,962			(49,755	)		2,561			(240	)		(6,584	)		(47,056	)

Increase in cash and cash equivalents for period		(5	)		4,333			—			(769	)		—			3,559
Cash and cash equivalents at beginning of period		5			10,481			—			1,262			—			11,748

Cash and cash equivalents at end of period	$	—		$	14,814		$	—		$	493		$	—		$	15,307

Condensed Consolidated Statements of Cash Flows

For the Year Ended December 31, 2008

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	363		$	(28,412	)	$	72,841		$	25,125		$	—		$	69,917

Investing Activities
Real estate acquired		—			—			(354,392	)		(76,318	)		—			(430,710	)
Principal received on loans receivable		—			—			45,000			26,941			—			71,941
Proceeds from sales of real estate		—			—			—			89,959			—			89,959
Investments in and advances to subsidiaries		(63,549	)		(251,773	)		282,544			(30,765	)		63,543			—
Investments in loans receivable and other investments		—			—			(45,000	)		(50,567	)		—			(95,567	)
Construction in progress and other		—			(605	)		(3,179	)		(502	)		—			(4,286	)

Net cash provided by (used in) investing activities		(63,549	)		(252,378	)		(75,027	)		(41,252	)		63,543			(368,663	)

Financing Activities
Revolving credit facilities, net		—			31,014			—			7,000			—			38,014
Proceeds from term debt, net of discount		—			110,093			—			8,908			—			119,001
Payments of term debt		—			(810	)		—			(50	)		—			(860	)
Distributions paid		(64,788	)		(65,098	)		—			—			64,788			(65,098	)
Proceeds from sale of common shares/units, net of offering costs		128,331			128,331			—			—			(128,331	)		128,331
Lease deposits and other obligations to tenants		—			—			2,186			777			—			2,963
Debt issuance costs paid and other financing activities		(378	)		(5,674	)		—			(20	)		—			(6,072	)

Net cash provided by financing activities		63,165			197,856			2,186			16,615			(63,543	)		216,279

Increase in cash and cash equivalents for period		(21	)		(82,934	)		—			488			—			(82,467	)
Cash and cash equivalents at beginning of period		26			93,415			—			774			—			94,215

Cash and cash equivalents at end of period	$	5		$	10,481		$	—		$	1,262		$	—		$	11,748

Summary Of Significant Accounting Policies (Narrative) (Details)	12 Months Ended
	Dec. 31, 2010 USD ($) years months
Summary Of Significant Accounting Policies [Line Items]
Minimum percentage of equity method investment owned in order for company to eliminate all company balances and transactions	100.00%
CompanyMustOwnLessThanThisPercentageOfEquityMethodInvestmentInOrderToReportEquityAsNoncontrollingInterest \| $	$ 100
Expected lease-up periods for estimating lost rentals, in months \| months	6
Percentage of ordinary taxable income to be distributed for real estate investment trust qualification	90.00%
Number of years of federal income tax at corporate rates on failure to qualify as REIT \| years	4
Stock award vesting period in years, minimum	three
Stock award vesting period in years, maximum	seven
Vibra [Member]
Summary Of Significant Accounting Policies [Line Items]
Percentage of investments in outstanding loans and other receivables	3.00%
Monroe Hospital [Member]
Summary Of Significant Accounting Policies [Line Items]
Percentage of investments in outstanding loans and other receivables	2.00%
Other Smaller Tenants [Member]
Summary Of Significant Accounting Policies [Line Items]
Percentage of investments in outstanding loans and other receivables	1.00%
Time-Based Awards [Member]
Summary Of Significant Accounting Policies [Line Items]
Stock award vesting period in years, minimum	three
Stock award vesting period in years, maximum	seven
Market Conditions Based Awards [Member]
Summary Of Significant Accounting Policies [Line Items]
Stock award vesting period in years, minimum	three
Stock award vesting period in years, maximum	seven

Real Estate And Loans Receivable (Narrative) (Details) $ in Thousands			1 Months Ended						3 Months Ended							9 Months Ended	12 Months Ended
	Nov. 02, 2008 USD ($)	May 07, 2008 USD ($)	Oct. 31, 2010 USD ($)	Sep. 30, 2010 USD ($)	Jun. 30, 2009 USD ($)	Apr. 30, 2009 USD ($)	Dec. 31, 2008 USD ($)	Jun. 30, 2008 USD ($)	Dec. 31, 2010 USD ($)	Jun. 30, 2010 USD ($)	Dec. 31, 2009 USD ($)	Dec. 28, 2009 USD ($)	Jun. 30, 2009 USD ($)	Sep. 30, 2008 USD ($)	Jun. 30, 2008 USD ($)	Dec. 31, 2010 USD ($)	Dec. 31, 2010 USD ($)	Dec. 31, 2009 USD ($)	Dec. 31, 2008 USD ($)	Mar. 31, 2010	Jul. 31, 2008 USD ($)	May 31, 2008 USD ($)	Dec. 31, 2007 USD ($)	Dec. 31, 2004 USD ($)
Real Estate And Lending Activities [Line Items]
Purchase price of real estate							$ 430,710		$ 137,808		$ 421					$ 137,808	$ 137,808	$ 421	$ 430,710
Gain on sale of real estate																	10,566	278	9,305
Intangible lease assets									35,004		24,097					35,004	$ 35,004	24,097
Capitalized lease intangibles, weighted average life (in years)																	14.3
Impairment charges against real estate																	$ 3,694	1,111	14,037
Total revenues																	130,470	129,454
Revenues contributed by acquired entity																	130,470	129,454
Income contributed by the acquired entity																	18,026	37,884
Existing mortgage loan							185,000		$ 165,000		200,164					$ 165,000	165,000	200,164	185,000				$ 185,000
Mortgage loans expansion																	$ (43,000)
Equity method investment, ownership percentage									99.90%							99.90%	99.90%
Acquisition related costs																	$ 2,000
Commited mortgage loan									$ 215,985		311,006					$ 215,985	215,985	311,006
Mortgage loan advance																	11,637	23,243	$ 95,567
Percentage of entity revenue from affiliates																			26.90%
Mortgage loans on real estate, new																	7,836	$ 15,164
Triumph Hospital Clear Lake [Member]
Real Estate And Lending Activities [Line Items]
Number of lease renewals									2
Triumph Hospital Tomball [Member]
Real Estate And Lending Activities [Line Items]
Number of lease renewals									2
Rehabilitation Hospitals [Member]
Real Estate And Lending Activities [Line Items]
Number of properties										3
Redding Hospital [Member]
Real Estate And Lending Activities [Line Items]
Existing mortgage loan							$ 20,000												$ 20,000
Centinela Hospital [Member]
Real Estate And Lending Activities [Line Items]
Mortgage loans expansion																	2,800
Mortgage loans on real estate, new																	$ 43,000
Prime Health Care Services [Member]
Real Estate And Lending Activities [Line Items]
Percentage of entity revenue from affiliates																	32.70%	33.70%
Repayment of loans and accrued interest from affiliates																	$ 40,000
Vibra Health Care [Member]
Real Estate And Lending Activities [Line Items]
Existing mortgage loan																								$ 41,400
Percentage of entity revenue from affiliates																	14.50%	15.10%	17.40%
Repayment of loans and accrued interest from affiliates																	$ 19,600
Affiliate Of Prime [Member]
Real Estate And Lending Activities [Line Items]
Commited mortgage loan											$ 20,000							$ 20,000
Mortgage loan advance																		$ 15,000
Expansion and renovation cost																	35,000
Business Acquisitions [Member]
Real Estate And Lending Activities [Line Items]
Number of properties							2							20					2
Purchase price of real estate									$ 64,000					$ 357,200		64,000	$ 64,000
Total revenues																4,300
Revenues contributed by acquired entity																4,300
Income contributed by the acquired entity																$ 3,400
Business Acquisitions [Member] \| Triumph Hospital Clear Lake [Member]
Real Estate And Lending Activities [Line Items]
Number of beds acquired									110							110	110
Lease expiration date									2025
Business Acquisitions [Member] \| Triumph Hospital Tomball [Member]
Real Estate And Lending Activities [Line Items]
Number of beds acquired									75							75	75
Lease expiration date									2026
Business Acquisitions [Member] \| Acute Care Hospitals [Member]
Real Estate And Lending Activities [Line Items]
Number of properties														6
Business Acquisitions [Member] \| Long Term Acute Care Hospitals [Member]
Real Estate And Lending Activities [Line Items]
Number of properties														3
Purchase price of real estate																						$ 10,800
Business Acquisitions [Member] \| Rehabilitation Hospitals [Member]
Real Estate And Lending Activities [Line Items]
Number of properties														5
Term of lease, years										10
Number of lease extension options in current lease contract										2
Purchase price of real estate										$ 74,000
Lease expiration date										2033
Business Acquisitions [Member] \| Wellness Centers [Member]
Real Estate And Lending Activities [Line Items]
Number of properties														6
Business Acquisitions [Member] \| Southern California Hospital Campuses [Member]
Real Estate And Lending Activities [Line Items]
Number of properties								3							3						1
Term of lease, years							10												10
Purchase price of real estate							$ 45,000												$ 45,000		$ 15,000
Loan with affiliates								$ 60,000
Business Disposals [Member] \| Acute Care Medical Center [Member]
Real Estate And Lending Activities [Line Items]
Number of beds sold										369
Selling price of real estate										$ 75,000
Gain on sale of real estate										6,000
Business Disposals [Member] \| Acute Care Facility [Member]
Real Estate And Lending Activities [Line Items]
Number of properties											1							1
Selling price of real estate											$ 15,000
Gain on sale of real estate												$ 300
Business Disposals [Member] \| Sharpstown Facility [Member
Real Estate And Lending Activities [Line Items]
Selling price of real estate			$ 2,700
Gain on sale of real estate			$ 700
Business Disposals [Member] \| Montclair Hospital [Member]
Real Estate And Lending Activities [Line Items]
Selling price of real estate									$ 20,000
Gain on sale of real estate									2,200
Business Disposals [Member] \| Inpatient Rehabilitation Facilities [Member]
Real Estate And Lending Activities [Line Items]
Number of properties								3							3
Selling price of real estate															$ 105,000
Gain on sale of real estate		$ 9,300
Early lease termination fees															7,000
Loan with affiliates															$ 8,000
Valuation allowance for rent		$ 9,500
Intangible Assets [Member]
Real Estate And Lending Activities [Line Items]
Intangible lease assets									35,000		24,100					$ 35,000	$ 35,000	$ 24,100
Intangible lease assets net of accumulated amortization									27,600		$ 19,000					27,600	27,600	19,000
Amortization expense related to intangible lease assets																	3,200	4,500	8,100
Accelerated amortization																		500	4,500
Leasing Operations [Member]
Real Estate And Lending Activities [Line Items]
Term of lease, years																				15
Number of lease extension options in current lease contract																				3
Term of lease extension, years																				5
Early lease termination fees						$ 1,100
Accelerated amortization													$ 500
Revenue contributed by the acquired entity																	$ 1,400
Rate of increase in annual rent																	2.00%
Gain resulted in exchange of real estate property				$ 1,300
Straight line rent receivables write-off				$ 200
Leasing Operations [Member] \| Bucks County Facility [Member]
Real Estate And Lending Activities [Line Items]
Term of lease, years					5								5
Number of lease extension options in current lease contract					15								15
Term of lease extension, years					1								1
Uncollectible rent and other receivables write-off in lease termination							4,700
Receivables guaranteed by former tenant's parent company							$ 3,800												$ 3,800
Agreement to settle unpaid rent									3,800							3,800	$ 3,800
Unpaid rent									1,400
Charge to earnings from unpaid rent									2,400
Initial cash rent					$ 2,000
Rate of increase in annual rent					2.00%
Additional rent received from lease agreement					$ 1,000
Leasing Operations [Member] \| General Acute Care Hospitals [Member]
Real Estate And Lending Activities [Line Items]
Number of properties														2
Accelerated amortization														$ 4,500
Straight line rent receivables write-off														$ 1,500
Leasing Operations [Member] \| Redding Hospital [Member]
Real Estate And Lending Activities [Line Items]
Income expected to be recognized from remaining lease period including previous values																	1,200	$ 1,200
Lease base, previous	$ 60,000
Lease base	63,000
Additional rent received from lease agreement	12,000									$ 12,000
Estimated future rent amount expected from lease agreement	$ 8,000
Income recognized from lease inception through current period																	2,600
Income recognized from remaining lease period																	9,400
Leasing Operations [Member] \| Monroe Hospital [Member]
Real Estate And Lending Activities [Line Items]
Lease advance									28,000							28,000	28,000
Operating leases rent, interest and other charges outstanding																	11,500
Accrued operating leases rent, interest and other charges outstanding																	1,900
Advanced amount of working capital loan agreement									1,300							1,300	1,300
Interest receivables									5,400							5,400	5,400
Impairment of working capital loan recognized																	12,000
Impairment of working capital loan estimation-cash balance considered for first priority secured interest																	$ 4,000
Impairment of working capital loan estimation-membership interest of operator/lessee considered for first priority secured interest																	100.00%
Net investment, maximum exposure									$ 27,600							$ 27,600	$ 27,600
Impairment of working capital loan estimation-patient receivables considered for first priority secured interest																	4,000
Straight line rent receivables write-off																	$ 2,500
Interest receivables past due (in days)																	90
Consummated Acquisitions [Member]
Real Estate And Lending Activities [Line Items]
Acquisition related costs																	$ 900

Real Estate And Loans Receivable (List Of Assets Purchased As Part Of Acquisitions) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2010 USD ($)	Dec. 31, 2008 USD ($)	Dec. 31, 2009 USD ($)
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Total	$ 137,808	$ 430,710	$ 421
Land [Member]
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Significant acquisitions and disposals of acquisition	8,227	45,293	$ 421
Buildings [Member]
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Significant acquisitions and disposals of acquisition	119,626	373,472
Intangible Lease Assets [Member]
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Significant acquisitions and disposals of acquisition	$ 9,955	$ 11,945
Weighted-average useful life of acquired intangible assets (in years)	19.4	10.7

Real Estate And Loans Receivable (Pro Forma Consolidated Financial Data) (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2010	Dec. 31, 2009
Real Estate And Loans Receivable [Abstract]
Total revenues	$ 130,470	$ 129,454
Net income	$ 18,026	$ 37,884
Net income per share/unit diluted	$ 0.17	$ 0.47

Real Estate And Loans Receivable (Summary Of Amortization Expense From Lease Intangible Assets) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2010 USD ($)
Real Estate And Loans Receivable [Abstract]
2011	$ 2,957
2012	2,592
2013	2,559
2014	2,494
2015	$ 2,305

Real Estate And Loans Receivable (Summary Of Minimum Rental Payments) (Details) $ in Thousands	Dec. 31, 2010 USD ($)
2011	$ 2,128
2012	2,135
2013	2,021
2014	1,657
2015	1,657
Thereafter	38,971
Minimum rental payments, Total	48,569
Minimum Rental Payments [Member]
2011	93,799
2012	90,443
2013	90,980
2014	89,291
2015	86,392
Thereafter	653,621
Minimum rental payments, Total	$ 1,104,526

Real Estate And Loans Receivable (Summary Of Loans) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2010	Dec. 31, 2009
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, Balance	$ 215,985	$ 311,006
Mortgage Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, Balance	$ 165,000	$ 200,164
Loans, Weighted Average Interest Rate	10.00%	9.90%
Other Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, Balance	$ 50,985	$ 110,842
Loans, Weighted Average Interest Rate	10.80%	10.60%

Debt (Narrative) (Details)	1 Months Ended								12 Months Ended
Debt (Narrative) (Details)	Sep. 30, 2010 USD ($)	May 31, 2010 USD ($)	Nov. 30, 2008 USD ($)	Jun. 30, 2008 USD ($)	Apr. 30, 2008 USD ($) $ / shares	Mar. 31, 2008 USD ($)	Jun. 30, 2007 USD ($)	Nov. 30, 2006 USD ($) $ / shares shares	Dec. 31, 2010 USD ($)	Dec. 31, 2009 USD ($)	Dec. 31, 2008 USD ($)	Jun. 30, 2010 USD ($)	Apr. 30, 2010	Dec. 31, 2006 USD ($)
Debt Instrument [Line Items]
Repaid and terminated term loan facility									$ 216,765,000	$ 1,232,000	$ 860,000
Interest rate swap, amount fixed												$ 65,000,000
Total senior notes available									$ 369,970,000	576,678,000		$ 125,000,000
Dividend rate as percentage of normalized adjusted funds from operations									90.00%
Hedge ineffectiveness and income statement effect in period									$ 0
Parent [Member]
Debt Instrument [Line Items]
Total senior notes available									369,970,000	576,678,000
Interest Rate Contract [Member]
Debt Instrument [Line Items]
Fair value of the interest rate swaps									$ 3,600,000
Interest Rate Contract One [Member]
Debt Instrument [Line Items]
Interest rate of interest rate derivative instrument									5.507%
Interest Rate Contract Two [Member]
Debt Instrument [Line Items]
Interest rate swap, amount fixed									$ 60,000,000
Interest rate of interest rate derivative instrument									5.675%
Secured Credit Facility [Member]
Debt Instrument [Line Items]
New secured credit facility		$ 450,000,000
Repaid and terminated term loan facility		$ 220,000,000
Percentage of outstanding notes purchased from senior unsecured notes offering		93.00%
Unsecured senior notes, interest rate		6.125%
Paid off term loan		$ 30,000,000
Charge of refinancing activities		6,700,000
Revolving Credit Facilities [Member]
Debt Instrument [Line Items]
Credit facilities, amount outstanding										$ 96,000,000
Credit facilities, maturity date									May 17, 2013
Credit facilities, basis spread of interest rate									2.00%	1.99%
Maximum percentage of borrowing under credit facilities									55.00%
Credit facilities, remaining borrowing capacity									$ 322,400,000
Credit facilities, weighted average interest rate										2.21%
Debt face amount										$ 137,200,000
Collateralized Revolving Bank Credit Facility [Member]
Debt Instrument [Line Items]
Credit facilities, amount outstanding							$ 42,000,000		$ 0	$ 41,200,000
Credit facilities, repayment term (in years)							five years
Credit facilities, basis spread of interest rate									1.77%	1.73%
Credit facilities, remaining borrowing capacity									$ 40,400,000
Credit facilities, weighted average interest rate									1.74%	1.86%
Credit facilities, decrease									$ 800,000
Collateralized real estate property									$ 56,500,000	$ 57,900,000
2006 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Fixed rate, minimum									7.333%	7.333%
Fixed rate, maximum									7.871%	7.871%
Senior unsecured notes														$ 125,000,000
Debt face amount									$ 125,000,000	$ 125,000,000
Senior Notes Issuance 1 [Member]
Debt Instrument [Line Items]
Unsecured senior notes, interest rate									7.871%
Senior unsecured notes									$ 65,000,000
Senior Notes Remaining Issuance [Member]
Debt Instrument [Line Items]
Fixed rate, minimum									7.333%
Fixed rate, maximum									7.715%
Exchangeable Senior Notes [Member]
Debt Instrument [Line Items]
Unsecured senior notes, interest rate													9.25%
Fixed rate, minimum									6.125%	6.125%
Fixed rate, maximum									9.25%	9.25%
Percent of outstanding notes repurchased									93.00%
Senior Notes					$ 7,000,000	$ 75,000,000		$ 138,000,000	$ 9,200,000
Senior Notes, maturity date					Apr. 01, 2013			Nov. 15, 2011
Initial exchange rate of notes					80.8898			60.3346
Principal amount of exchangeable senior notes					$ 1,000			$ 1,000
Exchange price of notes per common share \| $ / shares					$ 12.36			$ 16.57
Senior Notes, maturity date, start					January 1, 2013			August 15, 2011
Proceeds from senior notes					$ 6,800,000	$ 72,800,000		$ 134,000,000
Price of principal amount plus accrued and unpaid interest, in percentage									103.00%
Price of principal amount plus accrued and unpaid interest, in amount									$ 136,300,000
Debt face amount									91,175,000	$ 220,000,000
Term Loans [Member]
Debt Instrument [Line Items]
Repaid and terminated term loan facility				$ 30,000,000					220,000,000
Credit facilities, amount outstanding									$ 149,300,000	$ 29,600,000
Credit facilities, repayment term (in years)									6
Credit facilities, basis spread of interest rate									5.00%	2.26%
Senior Notes, maturity date									May 17, 2016
Debt face amount									$ 157,683,000	$ 102,743,000
Quarterly principal payments of loans									375,000
Debt instrument basis spread on variable interest rate										400
Collateralized Term Loan [Member]
Debt Instrument [Line Items]
Unsecured senior notes, interest rate			5.66%
Credit facilities, amount outstanding			$ 9,000,000						8,400,000
Credit facilities, maturity date			November 2013
Collateralized real estate property									$ 18,200,000
Minimum [Member] \| Revolving Credit Facilities [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate									2.00%
Credit facilities, percentage of commitment fee on unused capacity									0.375%	0.20%
Maximum [Member] \| Revolving Credit Facilities [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate									2.75%
Credit facilities, percentage of commitment fee on unused capacity									0.50%	0.35%
LIBOR [Member] \| Revolving Credit Facilities [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate									3.00%	1.75%
LIBOR [Member] \| Collateralized Revolving Bank Credit Facility [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate									1.50%
LIBOR [Member] \| 2006 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate									2.30%
LIBOR [Member] \| Term Loans [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate									3.50%	4.23%
Debt instrument basis spread on variable interest rate										200
LIBOR [Member] \| Minimum [Member] \| Revolving Credit Facilities [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate									3.00%
LIBOR [Member] \| Maximum [Member] \| Revolving Credit Facilities [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate									3.75%
Capped Call [Member] \| Exchangeable Senior Notes [Member]
Debt Instrument [Line Items]
Exchange price of notes per common share \| $ / shares								$ 18.94
Shares reserved for future settlement of exchangeable note \| shares								8,300,000
Premium paid for capped call transaction								$ 6,300,000
Federal Funds Rate [Member] \| Revolving Credit Facilities [Member]
Debt Instrument [Line Items]
Unsecured senior notes, interest rate									0.50%
Federal Funds Rate [Member] \| Term Loans [Member]
Debt Instrument [Line Items]
Unsecured senior notes, interest rate									0.50%
Credit facilities, basis spread of interest rate									2.50%
LIBOR Floor [Member] \| Term Loans [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate									1.50%
2010 Term Loan [Member] \| Secured Credit Facility [Member]
Debt Instrument [Line Items]
Credit facilities, additional borrowing	$ 330,000,000
Debt face amount		150,000,000
2010 Term Loan [Member] \| Term Loans [Member]
Debt Instrument [Line Items]
Credit facilities, amount outstanding										$ 64,500,000
2010 Revolving Facility [Member] \| Secured Credit Facility [Member]
Debt Instrument [Line Items]
Credit facilities, amount outstanding		$ 300,000,000
Credit facilities, additional borrowing	$ 375,000,000

Debt (Summary Of Debt) (Details) - USD ($)	12 Months Ended
Debt (Summary Of Debt) (Details) - USD ($)	Dec. 31, 2010	Dec. 31, 2009	Jun. 30, 2010	Apr. 30, 2010
Debt Instrument [Line Items]
Total senior notes available	$ 369,970,000	$ 576,678,000	$ 125,000,000
Parent [Member]
Debt Instrument [Line Items]
Total senior notes available	369,970,000	576,678,000
Revolving Credit Facilities [Member]
Debt Instrument [Line Items]
Principal amount		$ 137,200,000
Interest rate terms	Variable	Variable
2006 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Principal amount	$ 125,000,000	$ 125,000,000
Interest rate, minimum	7.333%	7.333%
Interest rate, maximum	7.871%	7.871%
Exchangeable Senior Notes [Member]
Debt Instrument [Line Items]
Principal amount	$ 91,175,000	$ 220,000,000
Unamortized discount	(2,585,000)	(8,265,000)
Debt instrument, net	$ 88,590,000	$ 211,735,000
Unsecured senior notes, interest rate				9.25%
Interest rate, minimum	6.125%	6.125%
Interest rate, maximum	9.25%	9.25%
Term Loans [Member]
Debt Instrument [Line Items]
Principal amount	$ 157,683,000	$ 102,743,000
Unamortized discount	(1,303,000)
Debt instrument, net	$ 156,380,000	$ 102,743,000
Interest rate terms	Various	Various

Debt (Principal Payments Due For Debt) (Details) $ in Thousands	Dec. 31, 2010 USD ($)
Debt [Abstract]
2011	$ 25,608
2012	1,500
2013	83,500
2014	1,500
2015	1,500
Thereafter	260,250
Total	$ 373,858

Income Taxes (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
Income Taxes (Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Income Taxes [Abstract]
Percentage of ordinary taxable income to be distributed for real estate investment trust qualification	90.00%
Percentage of taxable income to be distributed for federal income tax exemption	100.00%
Tax expense (benefit)	$ 1.6	$ 0.3	$ (1.1)
U.S. federal NOLs	7.4
U.S. state NOLs	7.9
Net deferred tax assets	$ 6.7	1.8
U.S. federal and state NOLs, expiration date	2020 through 2030
Valuation allowance	$ 6.8	$ 0.3

- Definition

The tax effect as of the balance sheet date of the amount of excess of tax deductions over gross income in a year which cannot be used on the tax return of a state or local jurisdiction in the current year but can be carried forward to reduce taxable income or income taxes payable in a future year, for which there must be sufficient tax-basis income to utilize a portion or all of the carryforward amount to realize the deferred tax asset.

+ References + Details

Income Taxes (Schedule Of Per Share Distributions) (Details) - $ / shares

12 Months Ended

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Income Taxes [Abstract]

Common share distribution

$ 0.800000

$ 1.080000

Ordinary income

0.388128

0.471792

0.677940

Capital gains

^[1]

0.027724

0.003708

0.145400

Unrecaptured Sec. 1250 gain

0.022784

0.003708

0.138168

Return of capital

0.384148

0.324500

0.256660

Allocable to next year

[1]	Capital gains include unrecaptured Sec. 1250 gains.

Earnings Per Share/Unit (Calculation Of Earnings Per Share) (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2009	Sep. 30, 2009	Jun. 30, 2009	Mar. 31, 2009	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income from continuing operations	$ 8,309	$ 8,654	$ (236)	$ (3,424)	$ 9,330	$ 9,525	$ 6,608	$ 8,270	$ 13,228	$ 33,670	$ 18,590
Non-controlling interests' share in continuing operations									(99)	(36)	(29)
Participating securities' share in earnings									(1,254)	(1,506)	(1,745)
Income from continuing operations, less participating securities' share in earnings									11,875	32,128	16,816
Income from discontinued operations	$ 2,321	$ 301	$ 6,537	$ 625	$ (1,924)	$ 859	$ 1,251	$ 2,511	9,784	2,697	14,143
Non-controlling interests' share in discontinued operations										(1)	(4)
Income from discontinued operations attributable to MPT common stockholders									9,784	2,696	14,139
Net income, less participating securities' share in earnings									$ 21,659	$ 34,824	$ 30,955
Basic weighted-average common shares/units	110,103	110,046	103,498	79,176	78,755	78,655	78,616	76,432	100,706	78,117	62,027
Dilutive stock options									2		8
Dilutive weighted-average common shares/units	110,108	110,046	103,498	79,176	78,755	78,655	78,616	76,432	100,708	78,117	62,035
MPT Operating Partnership, L.P. [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income from continuing operations									$ 13,303	$ 33,733	$ 18,590
Non-controlling interests' share in continuing operations									(99)	(36)	(29)
Participating securities' share in earnings									(1,254)	(1,506)	(1,745)
Income from continuing operations, less participating securities' share in earnings									11,950	32,191	16,816
Income from discontinued operations									9,784	2,697	14,143
Non-controlling interests' share in discontinued operations										(1)	(4)
Income from discontinued operations attributable to MPT common stockholders									9,784	2,696	14,139
Net income, less participating securities' share in earnings									$ 21,734	$ 34,887	$ 30,955
Basic weighted-average common shares/units									100,706	78,117	62,027
Dilutive stock options									2		8
Dilutive weighted-average common shares/units									100,708	78,117	62,035
MPT Operating Partnership, L.P. [Member] \| Stock Options [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Stock options excluded from earnings per share computation									100	100	100

Stock Awards (Narrative) (Details)	12 Months Ended
Stock Awards (Narrative) (Details)	Dec. 31, 2010 USD ($) $ / shares shares	Dec. 31, 2009 USD ($) $ / shares shares	Dec. 31, 2008 USD ($) $ / shares	Dec. 31, 2007 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved shares of common stock for awards under the Equity Incentive Plan	7,441,180
Common stock remaining for future stock awards	3,716,379
Maximum number of shares of common stock that may be awarded	1,000,000
Stock award vesting period (in years)	ten			four
Number of stock options awarded				50,000
Stock award payment award, exercise price, per share \| $ / shares				$ 12.09
Stock award payment award, estimated grant date fair value, per share \| $ / shares				$ 1.36
Share based payment award, expiration period				2012
Share based payment award, expected volatility rate				28.34%
Share based payment award, weighted average risk-free rate of return				4.62%
Common stock options awarded, dividend yield				8.93%
Common stock options awarded, intrinsic value of options exercisable and outstanding \| $	$ 0
Common stock options awarded, options outstanding and exercisable	130,000
Common stock options awarded, weighted-average exercise price, per option \| $ / shares	$ 10.80
Common stock options awarded, weighted average remaining contractual term (in years)	3.0
Stock award vesting period in years, maximum	seven
Stock award vesting period in years, minimum	three
Percentage of shareholder return annually	9.50%
Percentage of shareholder return annually achieving period (in years)	3
Percentage of SPRE awards earned when the Company performed at or above the 50th percentile of real estate trusts included in the Morgan Stanley REIT Index in terms of return to shareholders	33.334%
Percentage of superior performance awards deemed forfeited	66.666%
Percentage of dividend per share	20.00%
Common share distribution \| $ / shares		$ 1.13	$ 1.10	$ 1.08
Percentage of increase in dividend per share		3.00%
Stock-based compensation expense \| $	$ 6,600,000	$ 5,500,000	$ 6,400,000
Stock-based compensation expense, unrecognized cost \| $	$ 9,600,000
Stock-based compensation expense, unrecognized cost, weighted average period (in years)	2.4
Restricted equity awards, fair value \| $	$ 6,100,000
Time-Based Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock award vesting period (in years)				three
Stock award vesting period in years, maximum	seven
Stock award vesting period in years, minimum	three
Service-Based Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock award vesting period (in years)				seven
Superior Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock award vesting period (in years)	three
Share based payment award, expected volatility rate	27.00%
Share based payment award, weighted average risk-free rate of return	4.55%
Share-based compensation arrangement by share based payment award, expected term (in years)	3.4
Core Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock award vesting period (in years)				seven
Number of stock options awarded	79,287	79,287
Share based payment award, expected volatility rate	26.00%
Share based payment award, weighted average risk-free rate of return	4.65%
Percentage of shareholder return annually				9.00%
Percentage of shareholder return on a prorated basis				7.50%
Share-based compensation arrangement by share based payment award, expected term (in years)	6.4

Stock Awards (Restricted Equity Awards Activity) (Details) - $ / shares	12 Months Ended
	Dec. 31, 2010	Dec. 31, 2009
Vesting Based On Service [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Nonvested awards at beginning of the year, Shares	962,350	828,106
Awarded, Shares	277,680	441,134
Vested, Shares	(454,323)	(299,167)
Forfeited, Shares	(2,402)	(7,723)
Nonvested awards at end of year, Shares	783,305	962,350
Nonvested awards at beginning of the year, Weighted Average Value at Award Date	$ 10.22	$ 12.24
Awarded, Weighted Average Value at Award Date	10.39	6.30
Vested, Weighted Average Value at Award Date	9.97	10.08
Forfeited, Weighted Average Value at Award Date	8.66	8.16
Nonvested awards at end of year, Weighted Average Value at Award Date	$ 10.43	$ 10.22
Vesting Based On Market/Performance Conditions [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Nonvested awards at beginning of the year, Shares	1,301,088	1,380,375
Awarded, Shares	182,600
Vested, Shares	(175,279)	(79,287)
Forfeited, Shares	(480,000)
Nonvested awards at end of year, Shares	828,409	1,301,088
Nonvested awards at beginning of the year, Weighted Average Value at Award Date	$ 6.90	$ 7.15
Awarded, Weighted Average Value at Award Date	9.25
Vested, Weighted Average Value at Award Date	10.64	11.29
Forfeited, Weighted Average Value at Award Date	3.31
Nonvested awards at end of year, Weighted Average Value at Award Date	$ 8.70	$ 6.90

Commitments And Contingencies (Narrative) (Details) - USD ($)	3 Months Ended	12 Months Ended
	Jun. 30, 2010	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Commitments And Contingencies [Abstract]
Lease and rental expense		$ 989,170	$ 859,570	$ 919,735
Sublease rental income		520,090	$ 520,090	$ 498,733
Total amount to be received in the future from non-cancellable subleases		$ 31,100,000
Proceeds from the settlement of the indemnification claim with Stealth	$ 875,000

Commitments And Contingencies (Minimum Payments Due Under Operating Leases) (Details) $ in Thousands	Dec. 31, 2010 USD ($)
Commitments And Contingencies [Abstract]
2011	$ 2,128
2012	2,135
2013	2,021
2014	1,657
2015	1,657
Thereafter	38,971
Minimum rental payments, Total	$ 48,569

Common Stock (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended			3 Months Ended		12 Months Ended
	Apr. 30, 2010	Jan. 31, 2009	Mar. 31, 2008	Mar. 31, 2010	Dec. 31, 2009	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008	Nov. 30, 2009	Jan. 09, 2009
Class of Stock [Line Items]
Common stock, shares issued					78,725,000	110,225,000	78,725,000
Proceeds from issuance of common stock						$ 288,066	$ 68,003	$ 128,331
Common stock, par value					$ 0.001	$ 0.001	$ 0.001
Common stock, shares authorized					150,000,000	150,000,000	150,000,000
Parent [Member]
Class of Stock [Line Items]
Common stock, shares issued			12,650,000
Public offering price for common stock per share			$ 10.75
Proceeds from issuance of common stock			$ 128,300			$ 288,066	$ 68,003	$ 128,331
Common stock, par value										$ 0.001
Parent [Member] \| Public Offering [Member]
Class of Stock [Line Items]
Common stock, shares issued	26,000,000	12,000,000
Public offering price for common stock per share	$ 9.75	$ 5.40
Underwriters' purchase of shares to cover over allotments	3,900,000	1,300,000
Proceeds from issuance of common stock	$ 279,100	$ 67,800
Parent [Member] \| Market Equity Offering Program [Member]
Class of Stock [Line Items]
Common stock, shares issued				900,000	30,000		30,000
Public offering price for common stock per share					$ 10.25
Proceeds from issuance of common stock				$ 9,500	$ 300
Average price of common stock under market equity offering program per share				$ 10.77
Sales commission				2.00%	2.00%
Number of shares that can be sold									$ 50,000
Maximum [Member] \| Parent [Member]
Class of Stock [Line Items]
Common stock, shares authorized										150,000,000
Minimum [Member] \| Parent [Member]
Class of Stock [Line Items]
Common stock, shares authorized										100,000,000

Partner's Capital (Details)	Dec. 31, 2010
Partners' Capital [Abstract]
Limited partners including the Company	100.00%
Ownership interest in Operating Partnership	99.90%

Fair Value Of Financial Instruments (Summary Of Fair Value Information Of Financial Instruments) (Details) - USD ($) $ in Thousands	Dec. 31, 2010	Jun. 30, 2010	Dec. 31, 2009
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest and rent receivables, Book Value	$ 26,176		$ 19,845
Debt, net, Book Value	(369,970)	$ (125,000)	(576,678)
Parent [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest and rent receivables, Book Value	26,176		19,845
Loans, Book Value	215,985		311,006
Debt, net, Book Value	(369,970)		(576,678)
Interest and rent receivables, Fair Value	20,265		16,712
Loans, Fair Value	209,126		299,123
Debt, net, Fair Value	$ (359,910)		$ (547,242)

Discontinued Operations (Narrative) (Details) $ in Thousands	1 Months Ended		3 Months Ended				12 Months Ended
	Oct. 31, 2010 USD ($)	Jan. 31, 2007 USD ($)	Dec. 31, 2010 USD ($)	Jun. 30, 2010 USD ($)	Dec. 31, 2009 USD ($)	Jun. 30, 2008 USD ($)	Dec. 31, 2010 USD ($)	Dec. 31, 2009 USD ($)	Dec. 31, 2008 USD ($)	Dec. 31, 2007 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of real estate							$ 97,669	$ 15,000	$ 89,959
Real estate held for sale					$ 89,973			$ 89,973
Parent [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of real estate					15,000	$ 105,000
Gain on sale of real estate		$ 4,100			300	9,300
Number of beds sold				369
Real estate held for sale									$ 15,000
Sale of real estate, early lease termination fees						7,000
Sale of real estate, loan pre-payment						8,000
Write off in related straight-line rent receivables						9,500
Working capital loans included in assets of discontinued operations										$ 4,200
Wrote off remaining uncollectible receivables from the operator						2,100
Income tax benefit related to uncollectible receivables						$ 1,200
Litigation expenses related to this discontinued operation					$ 2,700
Montclair Hospital [Member] \| Parent [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of real estate			$ 20,000
Gain on sale of real estate			$ 2,200
Sharpstown Hospital [Member] \| Parent [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of real estate	$ 3,000
Gain on sale of real estate	$ 700
Inglewood Hospital [Member] \| Parent [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of real estate				$ 75,000
Gain on sale of real estate				$ 6,000

Discontinued Operations (Schedule Of Discontinued Operations) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2009	Sep. 30, 2009	Jun. 30, 2009	Mar. 31, 2009	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Income from discontinued operations	$ 2,321	$ 301	$ 6,537	$ 625	$ (1,924)	$ 859	$ 1,251	$ 2,511	$ 9,784	$ 2,697	$ 14,143
Income from discontinued operations attributable to MPT common stockholders - diluted per share									$ 0.10	$ 0.04	$ 0.23
Parent [Member]
Revenues									$ 3,838	$ 3,269	$ 12,970
Gain on sale									9,072	278	9,305
Income from discontinued operations	$ 2,321	$ 301	$ 6,537	$ 625	$ (1,924)	$ 859	$ 1,251	$ 2,511	$ 9,784	$ 2,697	$ 14,143
Income from discontinued operations attributable to MPT common stockholders - diluted per share									$ 0.10	$ 0.04	$ 0.23

- Definition

Gain (loss) after tax expense or benefit, not previously recognized and resulting from the sale of a business component, which is recognized at the date of sale. A gain (loss) reflects the amount by which the consideration received exceeds (is exceeded by) the net carrying amount (reflecting previous provisions for loss on disposal, if any) of the disposal group.

+ References + Details

- Definition

This element represents the overall income (loss) from a disposal group that is classified as a component of the entity, net of income tax, reported as a separate component of income before extraordinary items before deduction or consideration of the amount which may be allocable to noncontrolling interests, if any. Includes the following (net of tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 43
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 47
-Subparagraph c
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 29
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 5
-Section 03
-Paragraph 15

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 13
-Article 7

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.12)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.14)
-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Quarterly Financial Data (Summary Of The Unaudited Quarterly Financial Information) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2009	Sep. 30, 2009	Jun. 30, 2009	Mar. 31, 2009	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Revenues	$ 31,752	$ 28,644	$ 30,593	$ 30,858	$ 30,069	$ 30,639	$ 28,640	$ 29,460	$ 121,847	$ 118,809	$ 107,070
Income (loss) from continuing operations	8,309	8,654	(236)	(3,424)	9,330	9,525	6,608	8,270	13,228	33,670	18,590
Income (loss) from discontinued operations	2,321	301	6,537	625	(1,924)	859	1,251	2,511	9,784	2,697	14,143
Net income (loss)	10,630	8,955	6,301	(2,799)	7,406	10,384	7,859	10,781	23,012	36,367	32,733
Net income (loss) attributable to MPT common stockholders/Operating Partnership partners	$ 10,593	$ 8,910	$ 6,292	$ (2,807)	$ 7,399	$ 10,374	$ 7,846	$ 10,773	$ 22,913	$ 36,330	$ 32,700
Net income (loss) attributable to MPT common stockholders per share - basic	$ 0.09	$ 0.08	$ 0.06	$ (0.04)	$ 0.09	$ 0.13	$ 0.09	$ 0.14	$ 0.22	$ 0.45	$ 0.50
Weighted average shares/units outstanding - basic	110,103	110,046	103,498	79,176	78,755	78,655	78,616	76,432	100,706	78,117	62,027
Net income (loss) attributable to MPT common stockholders per share - diluted	$ 0.09	$ 0.08	$ 0.06	$ (0.04)	$ 0.09	$ 0.13	$ 0.09	$ 0.14	$ 0.22	$ 0.45	$ 0.50
Weighted average shares/units outstanding - diluted	110,108	110,046	103,498	79,176	78,755	78,655	78,616	76,432	100,708	78,117	62,035
Parent [Member]
Revenues	$ 31,752	$ 28,644	$ 30,593	$ 30,858	$ 30,069	$ 30,639	$ 28,640	$ 29,460
Income (loss) from continuing operations	8,309	8,663	(305)	(3,439)	9,330	9,525	6,608	8,207	$ (75)	$ (63)
Income (loss) from discontinued operations	2,321	301	6,537	625	(1,924)	859	1,251	2,511	9,784	2,697	$ 14,143
Net income (loss)	10,630	8,964	6,232	(2,814)	7,406	10,384	7,859	10,718	23,012	36,367	32,733
Net income (loss) attributable to MPT common stockholders/Operating Partnership partners	$ 10,593	$ 8,919	$ 6,223	$ (2,822)	$ 7,399	$ 10,374	$ 7,846	$ 10,710	$ 22,913	$ 36,330	$ 32,700
Net income (loss) attributable to MPT common stockholders per share - basic	$ 0.09	$ 0.08	$ 0.06	$ (0.04)	$ 0.09	$ 0.13	$ 0.09	$ 0.14
Weighted average shares/units outstanding - basic	110,103	110,046	103,498	79,176	78,755	78,655	78,616	76,432
Net income (loss) attributable to MPT common stockholders per share - diluted	$ 0.09	$ 0.08	$ 0.06	$ (0.04)	$ 0.09	$ 0.13	$ 0.09	$ 0.14
Weighted average shares/units outstanding - diluted	110,108	110,046	103,498	79,176	78,755	78,655	78,616	76,432

Subsequent Events (Details) - USD ($) $ in Thousands	12 Months Ended
Subsequent Events (Details) - USD ($) $ in Thousands	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Investment in health care real estate	$ 146,854	$ 421	$ 418,766
Parent [Member]
Investment in health care real estate	$ 210,000

Condensed Consolidating Financial Information (Consolidated Balance Sheet) (Details) - USD ($) $ / shares in Units, $ in Thousands	Dec. 31, 2010	Jun. 30, 2010	Dec. 31, 2009	Jan. 09, 2009	Dec. 31, 2008	Mar. 31, 2008	Dec. 31, 2007
Real estate assets
Land, buildings and improvements and intangible lease assets	$ 1,032,369		$ 976,271
Mortgage loans	165,000		200,164
Gross investment in real estate assets	1,197,369		1,176,435
Accumulated depreciation and amortization	(76,094)		(53,098)
Net investment in real estate assets	1,121,275		1,123,337
Cash and cash equivalents	98,408		15,307		$ 11,748		$ 94,215
Interest and rent receivables	26,176		19,845
Straight-line rent receivables	28,912		27,539
Other loans	50,985		110,842
Other assets	23,058		13,028
Total Assets	1,348,814		1,309,898
Liabilities
Debt, net	369,970	$ 125,000	576,678
Accounts payable and accrued expenses	35,974		29,247
Deferred revenue	23,137		15,350
Lease deposits and other obligations to tenants	20,157		17,048
Total liabilities	449,238		638,323
Total Medical Properties Trust, Inc. stockholders' equity	899,462		671,445		626,343		519,327
Non-controlling interests	114		130
Total equity	899,576		671,575
Total Liabilities and Equity	1,348,814		1,309,898
Equity
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding
Common stock, $0.001 par value. Authorized 150,000 shares; issued and outstanding - 110,225 shares at December 31, 2010 and 78,725 shares at December 31, 2009	110		79
Additional paid-in capital	1,051,785		759,721
Distributions in excess of net income	(148,530)		(88,093)
Accumulated other comprehensive loss	(3,641)
Treasury shares, at cost	$ (262)		$ (262)
Preferred stock, par value	$ 0.001		$ 0.001
Preferred stock, shares authorized	10,000,000		10,000,000
Preferred stock, shares outstanding	0		0
Common stock, par value	$ 0.001		$ 0.001
Common stock, shares authorized	150,000,000		150,000,000
Common stock, shares issued	110,225,000		78,725,000
Common stock, shares outstanding	110,225,000		78,725,000
Parent [Member]
Real estate assets
Cash and cash equivalents					5		26
Interest and rent receivables	$ 26,176		$ 19,845
Net intercompany receivable (payable)	21,944		15,740
Investment in subsidiaries	899,949		671,872
Total Assets	921,893		687,612
Liabilities
Debt, net	369,970		576,678
Accounts payable and accrued expenses	22,317		16,037
Total liabilities	22,317		16,037
Total Medical Properties Trust, Inc. stockholders' equity	899,462		671,445
Non-controlling interests	114		130
Total equity	899,576		671,575
Total Liabilities and Equity	921,893		687,612
Equity
Common stock, par value				$ 0.001
Common stock, shares issued						12,650,000
MPT Operating Partnership, L.P. [Member]
Real estate assets
Mortgage loans	165,000		200,164
Gross investment in real estate assets	1,197,369		1,176,435
Net investment in real estate assets	1,121,275		1,123,337
Cash and cash equivalents	98,408		15,307		11,743		94,189
Interest and rent receivables	26,176		19,845
Straight-line rent receivables	28,912		27,539
Other loans	50,985		110,842
Other assets	23,058		13,028
Total Assets	1,348,814		1,309,898
Liabilities
Debt, net	369,970		576,678
Accounts payable and accrued expenses	13,658		13,208
Deferred revenue	23,137		15,350
Lease deposits and other obligations to tenants	20,157		17,048
Total liabilities	448,865		638,026
Total Medical Properties Trust, Inc. stockholders' equity			671,872		626,578		519,562
Non-controlling interests	114		130
Total Liabilities and Equity	1,348,814		1,309,898
Equity
General Partner - issued and outstanding - 1,102 units at December 31, 2010 and 787 units at December 31, 2009	9,035		6,717
Accumulated other comprehensive loss	(3,641)
Total MPT Operating Partnership capital	899,835		671,742
Total capital	$ 899,949		$ 671,872
General Partner, units issued	1,102,000		787,000
General Partner, units outstanding	1,102,000		787,000
Subsidiary Issuer [Member]
Real estate assets
Land, buildings and improvements and intangible lease assets	$ 297		$ 2
Gross investment in real estate assets	297		2
Net investment in real estate assets	297		2
Cash and cash equivalents	96,822		14,814		10,481		93,415
Interest and rent receivables	157		185
Other loans	178		178
Net intercompany receivable (payable)	774,771		872,702
Investment in subsidiaries	390,232		313,877
Other assets	10,289		6,986
Total Assets	1,272,746		1,208,743
Liabilities
Debt, net	361,537		526,800
Accounts payable and accrued expenses	10,824		9,596
Deferred revenue	436		475
Total liabilities	372,797		536,871
Total Medical Properties Trust, Inc. stockholders' equity	899,835		671,742
Non-controlling interests	114		130
Total equity	899,949		671,872
Total Liabilities and Equity	1,272,746		1,208,743
Subsidiaries Guarantor [Member]
Real estate assets
Land, buildings and improvements and intangible lease assets	903,630		760,711
Mortgage loans	165,000		160,000
Gross investment in real estate assets	1,068,630		920,711
Accumulated depreciation and amortization	(65,767)		(45,918)
Net investment in real estate assets	1,002,863		874,793
Interest and rent receivables	20,727		15,512
Straight-line rent receivables	21,180		20,859
Other loans			1,000
Net intercompany receivable (payable)	(767,395)		(718,409)
Investment in subsidiaries	42,970		44,908
Other assets	1,215		1,315
Total Assets	321,560		239,978
Liabilities
Accounts payable and accrued expenses	2,430		3,044
Deferred revenue	17,826		9,623
Lease deposits and other obligations to tenants	18,539		14,880
Total liabilities	38,795		27,547
Total Medical Properties Trust, Inc. stockholders' equity	282,765		212,431
Total equity	282,765		212,431
Total Liabilities and Equity	321,560		239,978
Non-Guarantor Subsidiaries [Member]
Real estate assets
Land, buildings and improvements and intangible lease assets	128,442		215,558
Mortgage loans			40,164
Gross investment in real estate assets	128,442		255,722
Accumulated depreciation and amortization	(10,327)		(7,180)
Net investment in real estate assets	118,115		248,542
Cash and cash equivalents	1,586		493		1,262		774
Interest and rent receivables	5,292		4,148
Straight-line rent receivables	7,732		6,680
Other loans	50,807		109,664
Net intercompany receivable (payable)	(29,320)		(170,033)
Other assets	11,554		4,727
Total Assets	165,766		204,222
Liabilities
Debt, net	8,433		49,878
Accounts payable and accrued expenses	403		570
Deferred revenue	4,875		5,252
Lease deposits and other obligations to tenants	1,618		2,168
Total liabilities	15,329		57,868
Total Medical Properties Trust, Inc. stockholders' equity	150,437		146,354
Total equity	150,437		146,354
Total Liabilities and Equity	165,766		204,222
Eliminations [Member]
Real estate assets
Investment in subsidiaries	(1,333,151)		(1,030,657)
Total Assets	(1,333,151)		(1,030,657)
Liabilities
Total Medical Properties Trust, Inc. stockholders' equity	(1,333,037)		(1,030,527)
Non-controlling interests	(114)		(130)
Total equity	(1,333,151)		(1,030,657)
Total Liabilities and Equity	(1,333,151)		(1,030,657)
Common Units [Member]
Liabilities
Total Medical Properties Trust, Inc. stockholders' equity	110		79		65		52
Common Units [Member] \| MPT Operating Partnership, L.P. [Member]
Liabilities
Total Medical Properties Trust, Inc. stockholders' equity	894,441		664,952		$ 619,886		$ 514,179
Equity
Limited Partners Capital	$ 894,441		$ 664,952
Limited Partners, units issued	109,123,000		77,938,000
Limited Partners, units outstanding	109,123,000		77,938,000
LTIP Units [Member] \| MPT Operating Partnership, L.P. [Member]
Equity
Limited Partners Capital			$ 73
Limited Partners, units issued	94,000		63,000
Limited Partners, units outstanding	94,000		63,000

Condensed Consolidating Financial Information (Consolidated Statements Of Income) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2009	Sep. 30, 2009	Jun. 30, 2009	Mar. 31, 2009	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Revenues
Rent billed									$ 92,785	$ 81,865	$ 74,146
Straight-line rent									2,074	8,221	3,742
Interest and fee income									26,988	28,723	29,182
Total revenues	$ 31,752	$ 28,644	$ 30,593	$ 30,858	$ 30,069	$ 30,639	$ 28,640	$ 29,460	121,847	118,809	107,070
Expenses
Real estate depreciation and amortization									24,486	22,628	22,385
Impairment charge									12,000
Property-related									4,407	3,802	4,242
General and administrative									28,535	21,096	19,515
Total operating expenses									69,428	47,526	46,142
Operating income									52,419	71,283	60,928
Other income (expense)
Interest and other income									1,518	43	86
Debt refinancing costs									(6,716)
Interest expense									(33,993)	(37,656)	(42,424)
Net other expenses									(39,191)	(37,613)	(42,338)
Income from continuing operations	8,309	8,654	(236)	(3,424)	9,330	9,525	6,608	8,270	13,228	33,670	18,590
Income from discontinued operations	2,321	301	6,537	625	(1,924)	859	1,251	2,511	9,784	2,697	14,143
Net income	10,630	8,955	6,301	(2,799)	7,406	10,384	7,859	10,781	23,012	36,367	32,733
Net income attributable to non-controlling interests									(99)	(37)	(33)
Net income (loss) attributable to MPT common stockholders/Operating Partnership partners	$ 10,593	$ 8,910	$ 6,292	$ (2,807)	$ 7,399	$ 10,374	$ 7,846	$ 10,773	$ 22,913	$ 36,330	$ 32,700
Earnings per share/unit - basic
Income from continuing operations attributable to MPT common stockholders/Operating Partnership partners									$ 0.12	$ 0.41	$ 0.27
Income from discontinued operations attributable to MPT common stockholders/Operating Partnership partners									0.10	0.04	0.23
Net income attributable to MPT common stockholders/Operating Partnership partners	$ 0.09	$ 0.08	$ 0.06	$ (0.04)	$ 0.09	$ 0.13	$ 0.09	$ 0.14	$ 0.22	$ 0.45	$ 0.50
Weighted average shares/units outstanding - basic	110,103	110,046	103,498	79,176	78,755	78,655	78,616	76,432	100,706	78,117	62,027
Earnings per share/unit - diluted
Income from continuing operations attributable to MPT common stockholders/Operating Partnership partners									$ 0.12	$ 0.41	$ 0.27
Income from discontinued operations attributable to MPT common stockholders/Operating Partnership partners									0.10	0.04	0.23
Net income attributable to MPT common stockholders/Operating Partnership partners	$ 0.09	$ 0.08	$ 0.06	$ (0.04)	$ 0.09	$ 0.13	$ 0.09	$ 0.14	$ 0.22	$ 0.45	$ 0.50
Weighted average shares/units outstanding - diluted	110,108	110,046	103,498	79,176	78,755	78,655	78,616	76,432	100,708	78,117	62,035
Parent [Member]
Revenues
Total revenues	$ 31,752	$ 28,644	$ 30,593	$ 30,858	$ 30,069	$ 30,639	$ 28,640	$ 29,460
Expenses
General and administrative									$ 75	$ 63
Total operating expenses									75	63
Operating income									(75)	(63)
Other income (expense)
Income from continuing operations	8,309	8,663	(305)	(3,439)	9,330	9,525	6,608	8,207	(75)	(63)
Income from discontinued operations	2,321	301	6,537	625	(1,924)	859	1,251	2,511	9,784	2,697	$ 14,143
Equity in earnings of consolidated subsidiaries net of income taxes									23,087	36,430	32,733
Net income	10,630	8,964	6,232	(2,814)	7,406	10,384	7,859	10,718	23,012	36,367	32,733
Net income attributable to non-controlling interests									(99)	(37)	(33)
Net income (loss) attributable to MPT common stockholders/Operating Partnership partners	$ 10,593	$ 8,919	$ 6,223	$ (2,822)	$ 7,399	$ 10,374	$ 7,846	$ 10,710	$ 22,913	$ 36,330	$ 32,700
Earnings per share/unit - basic
Net income attributable to MPT common stockholders/Operating Partnership partners	$ 0.09	$ 0.08	$ 0.06	$ (0.04)	$ 0.09	$ 0.13	$ 0.09	$ 0.14
Weighted average shares/units outstanding - basic	110,103	110,046	103,498	79,176	78,755	78,655	78,616	76,432
Earnings per share/unit - diluted
Income from discontinued operations attributable to MPT common stockholders/Operating Partnership partners									$ 0.10	$ 0.04	$ 0.23
Net income attributable to MPT common stockholders/Operating Partnership partners	$ 0.09	$ 0.08	$ 0.06	$ (0.04)	$ 0.09	$ 0.13	$ 0.09	$ 0.14
Weighted average shares/units outstanding - diluted	110,108	110,046	103,498	79,176	78,755	78,655	78,616	76,432
Subsidiary Issuer [Member]
Revenues
Straight-line rent											$ (543)
Interest and fee income									$ 6,964	$ 10,010	8,627
Total revenues									6,964	10,010	8,084
Expenses
Property-related									(4)	(20)	69
General and administrative									27,867	20,631	19,357
Total operating expenses									27,863	20,611	19,426
Operating income									(20,899)	(10,601)	(11,342)
Other income (expense)
Interest and other income									(13)	51	85
Debt refinancing costs									(6,716)
Interest expense									(33,623)	(36,761)	(40,671)
Net other expenses									(40,352)	(36,710)	(40,586)
Income from continuing operations									(61,251)	(47,311)	(51,928)
Equity in earnings of consolidated subsidiaries net of income taxes									84,338	83,741	84,661
Net income									23,087	36,430	32,733
Net income attributable to non-controlling interests									(99)	(37)	(33)
Net income (loss) attributable to MPT common stockholders/Operating Partnership partners									22,988	36,393	32,700
Subsidiaries Guarantor [Member]
Revenues
Rent billed									79,388	69,327	63,399
Straight-line rent									186	6,244	2,323
Interest and fee income									16,772	14,400	15,879
Total revenues									96,346	89,971	81,601
Expenses
Real estate depreciation and amortization									21,339	19,571	19,741
Property-related									4,376	3,780	4,183
General and administrative											8
Total operating expenses									25,715	23,351	23,932
Operating income									70,631	66,620	57,669
Other income (expense)
Interest and other income									1,493		2
Interest expense									26	(4)	(167)
Net other expenses									1,519	(4)	(165)
Income from continuing operations									72,150	66,616	57,504
Income from discontinued operations									122	(1,254)	(437)
Equity in earnings of consolidated subsidiaries net of income taxes									4,273	3,918	2,861
Net income									76,545	69,280	59,928
Net income (loss) attributable to MPT common stockholders/Operating Partnership partners									76,545	69,280	59,928
Non-Guarantor Subsidiaries [Member]
Revenues
Rent billed									14,427	12,538	10,747
Straight-line rent									1,888	1,977	1,962
Interest and fee income									10,766	14,732	12,387
Total revenues									27,081	29,247	25,096
Expenses
Real estate depreciation and amortization									3,147	3,057	2,644
Impairment charge									12,000
Property-related									1,065	42	(10)
General and administrative									593	402	150
Total operating expenses									16,805	3,501	2,784
Operating income									10,276	25,746	22,312
Other income (expense)
Interest and other income									38	(8)	(1)
Interest expense									(7,910)	(11,310)	(9,297)
Net other expenses									(7,872)	(11,318)	(9,298)
Income from continuing operations									2,404	14,428	13,014
Income from discontinued operations									9,662	3,951	14,580
Net income									12,066	18,379	27,594
Net income (loss) attributable to MPT common stockholders/Operating Partnership partners									12,066	18,379	27,594
Eliminations [Member]
Revenues
Rent billed									(1,030)
Interest and fee income									(7,514)	(10,419)	(7,711)
Total revenues									(8,544)	(10,419)	(7,711)
Expenses
Property-related									(1,030)
Total operating expenses									(1,030)
Operating income									(7,514)	(10,419)	(7,711)
Other income (expense)
Interest expense									7,514	10,419	7,711
Net other expenses									7,514	10,419	7,711
Equity in earnings of consolidated subsidiaries net of income taxes									(111,698)	(124,089)	(120,255)
Net income									(111,698)	(124,089)	(120,255)
Net income attributable to non-controlling interests									99	37	33
Net income (loss) attributable to MPT common stockholders/Operating Partnership partners									$ (111,599)	$ (124,052)	$ (120,222)

Condensed Consolidating Financial Information (Condensed Consolidated Statements Of Cash Flows) (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended									12 Months Ended
	Mar. 31, 2008	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2009	Sep. 30, 2009	Jun. 30, 2009	Mar. 31, 2009	Jun. 30, 2008	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Operating activities
Net income		$ 10,630	$ 8,955	$ 6,301	$ (2,799)	$ 7,406	$ 10,384	$ 7,859	$ 10,781		$ 23,012	$ 36,367	$ 32,733
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization											26,312	26,309	26,535
Amortization and write-off of deferred financing costs and debt discount											6,110	5,824	7,961
Premium paid on extinguishment of debt											3,833
Straight-line rent revenue											(4,932)	(9,536)	(9,402)
Share/Unit-based compensation											6,616	5,488	6,386
(Gain) loss from sale of real estate											(10,566)	(278)	(9,305)
Deferred revenue and fee income											(4,393)	(847)	(7,583)
Provision for uncollectible receivables and loans											14,400		5,700
Rent and interest income added to loans												(921)	(5,556)
Straight-line rent write-off											3,694	1,111	14,037
Payment of interest on early prepayment of debt											(7,324)
Other adjustments											(30)	(246)	(57)
Decrease (increase) in:
Interest and rent receivable											(5,490)	(2,433)	(4,392)
Other assets											(566)	126	5,249
Accounts payable and accrued expenses											(3,177)	1,700	4,757
Deferred revenue											13,138	87	2,854
Net cash provided by operating activities											60,637	62,751	69,917
Investing activities
Real estate acquired											(137,808)	(421)	(430,710)
Principal received on loans receivable											90,486	4,305	71,941
Proceeds from sale of real estate											97,669	15,000	89,959
Investment in loans receivable											(11,637)	(23,243)	(95,567)
Construction in progress and other											(15,929)	(7,777)	(4,286)
Net cash provided by (used for) investing activities											22,781	(12,136)	(368,663)
Financing activities
Payment of deferred financing costs											(6,796)	232	(6,072)
Revolving credit facilities, net											(137,200)	(55,800)	38,014
Proceeds from term debt, net of discount											148,500		119,001
Payments of term debt											(216,765)	(1,232)	(860)
Distributions paid											(77,087)	(61,649)	(65,098)
Proceeds from sale of common shares, net of offering costs											288,066	68,003	128,331
Lease deposits and other obligations to tenants											3,667	3,390	2,963
Debt issuance costs paid and other financing activities											(9,498)	232	(6,072)
Other											(2,702)
Net cash provided by (used in) financing activities											(317)	(47,056)	216,279
Increase (decrease) in cash and cash equivalents for the year											83,101	3,559	(82,467)
Cash and cash equivalents at beginning of year					15,307				11,748		15,307	11,748	94,215
Cash and cash equivalents at end of year		98,408				15,307					98,408	15,307	11,748
Interest paid											29,679	33,272	31,277
Supplemental schedule of non-cash financing activities:
Other common stock transactions												5	48
Interest paid, capitalized											63
Parent [Member]
Operating activities
Net income		10,630	$ 8,964	$ 6,232	(2,814)	7,406	$ 10,384	$ 7,859	10,718		23,012	36,367	32,733
Decrease (increase) in:
Net cash provided by operating activities											(29)	(268)	363
Investing activities
Proceeds from sale of real estate						15,000				$ 105,000
Investments in and advances to subsidiaries		(211,181)				(6,699)					(211,181)	(6,699)	(63,549)
Net cash provided by (used for) investing activities											(211,181)	(6,699)	(63,549)
Financing activities
Distributions paid											(76,856)	(61,419)	(64,788)
Proceeds from sale of common shares, net of offering costs	$ 128,300										288,066	68,003	128,331
Debt issuance costs paid and other financing activities												378	(378)
Net cash provided by (used in) financing activities											211,210	6,962	63,165
Increase (decrease) in cash and cash equivalents for the year												(5)	(21)
Cash and cash equivalents at beginning of year									5			5	26
Cash and cash equivalents at end of year													5
Subsidiary Issuer [Member]
Operating activities
Net income											23,087	36,430	32,733
Decrease (increase) in:
Net cash provided by operating activities											(54,909)	(35,554)	(28,412)
Investing activities
Investments in and advances to subsidiaries		99,564				89,642					99,564	89,642	(251,773)
Construction in progress and other											(108)		(605)
Net cash provided by (used for) investing activities											99,456	89,642	(252,378)
Financing activities
Revolving credit facilities, net											(96,000)	(55,000)	31,014
Proceeds from term debt, net of discount											148,500		110,093
Payments of term debt											(216,520)	(960)	(810)
Distributions paid											(77,087)	(61,649)	(65,098)
Proceeds from sale of common shares, net of offering costs											288,066	68,003	128,331
Debt issuance costs paid and other financing activities											(9,498)	(149)	(5,674)
Net cash provided by (used in) financing activities											37,461	(49,755)	197,856
Increase (decrease) in cash and cash equivalents for the year											82,008	4,333	(82,934)
Cash and cash equivalents at beginning of year					14,814				10,481		14,814	10,481	93,415
Cash and cash equivalents at end of year		96,822				14,814					96,822	14,814	10,481
Subsidiaries Guarantor [Member]
Operating activities
Net income											76,545	69,280	59,928
Decrease (increase) in:
Net cash provided by operating activities											95,203	76,583	72,841
Investing activities
Real estate acquired											(137,808)	(421)	(354,392)
Principal received on loans receivable													45,000
Proceeds from sale of real estate											2,669
Investments in and advances to subsidiaries		48,986				(60,656)					48,986	(60,656)	282,544
Investment in loans receivable											(5,000)	(15,000)	(45,000)
Construction in progress and other											(8,267)	(3,067)	(3,179)
Net cash provided by (used for) investing activities											(99,420)	(79,144)	(75,027)
Financing activities
Lease deposits and other obligations to tenants											4,217	2,561	2,186
Net cash provided by (used in) financing activities											4,217	2,561	2,186
Non-Guarantor Subsidiaries [Member]
Operating activities
Net income											12,066	18,379	27,594
Decrease (increase) in:
Net cash provided by operating activities											20,372	21,990	25,125
Investing activities
Real estate acquired													(76,318)
Principal received on loans receivable											90,486	4,305	26,941
Proceeds from sale of real estate											95,000	15,000	89,959
Investments in and advances to subsidiaries		(148,579)				(28,871)					(148,579)	(28,871)	(30,765)
Investment in loans receivable											(6,637)	(8,243)	(50,567)
Construction in progress and other											(7,554)	(4,710)	(502)
Net cash provided by (used for) investing activities											22,716	(22,519)	(41,252)
Financing activities
Revolving credit facilities, net											(41,200)	(800)	7,000
Proceeds from term debt, net of discount													8,908
Payments of term debt											(245)	(272)	(50)
Lease deposits and other obligations to tenants											(550)	829	777
Debt issuance costs paid and other financing activities												3	(20)
Net cash provided by (used in) financing activities											(41,995)	(240)	16,615
Increase (decrease) in cash and cash equivalents for the year											1,093	(769)	488
Cash and cash equivalents at beginning of year					$ 493				$ 1,262		493	1,262	774
Cash and cash equivalents at end of year		1,586				493					1,586	493	1,262
Eliminations [Member]
Operating activities
Net income											(111,698)	(124,089)	(120,255)
Investing activities
Investments in and advances to subsidiaries		$ 211,210				$ 6,584					211,210	6,584	63,543
Net cash provided by (used for) investing activities											211,210	6,584	63,543
Financing activities
Distributions paid											76,856	61,419	64,788
Proceeds from sale of common shares, net of offering costs											(288,066)	(68,003)	(128,331)
Net cash provided by (used in) financing activities											$ (211,210)	$ (6,584)	$ (63,543)

Valuation And Qualifying Accounts (Schedule Of Valuation And Qualifying Accounts) (Details) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Valuation And Qualifying Accounts Disclosure [Line Items]

Balance at Beginning of Year

^[1]

$ 4,339

$ 397

$ 4,202

Additions Charged Against Operations

^[1]

22,245

^[2]

5,107

397

Net Recoveries

^[1]

2,658

1,165

4,202

^[3]

Balance at End of Year

^[1]

23,926

$ 4,339

397

Increase in valuation allowances

6,500

West Houston Property [Member]

Valuation And Qualifying Accounts Disclosure [Line Items]

Allowance for Loan and Lease Losses, write offs

$ 3,200

Monroe Property [Member]

Valuation And Qualifying Accounts Disclosure [Line Items]

Allowance for Loan and Lease Losses, write offs

$ 12,000

[1]	Includes allowance for doubtful accounts, straight-line rent reserves, allowance for loan losses, tax valuation allowances and other reserves.
[2]	Includes $12 million loan loss reserve related to our Monroe property and a $6.5 million increase in valuation allowances to fully reserve for the net deferred tax asset of one of our taxable REIT subsidiaries.
[3]	Includes $3.2 million of write offs associated with our West Houston property that was sold in 2007.

Real Estate Investments And Accumulated Depreciation (Schedule Of Real Estate Investments And Accumulated Depreciation) (Details)
Unit13 in Thousands, $ in Thousands

12 Months Ended

Dec. 31, 2010

USD ($)

years

Dec. 31, 2009

USD ($)

Dec. 31, 2008

USD ($)

^[1]

Dec. 31, 2007

USD ($)

Real Estate and Accumulated Depreciation [Line Items]

Initial Costs, Land

$ 94,258

Initial Costs, Buildings

887,967

Additions Subsequent to Acquisition, Improvements

2,493

Additions Subsequent to Acquisition, Carrying Costs

5,918

Land at Cost

96,894

Buildings at Cost

893,741

Total at Cost

990,635

$ 934,601

$ 943,700

$ 614,088

Accumulated Depreciation

$ 68,662

$ 47,965

Thornton, CO [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acute care hospital

Initial Costs, Land

$ 2,130

Initial Costs, Buildings

6,013

Additions Subsequent to Acquisition, Improvements

2,237

Land at Cost

2,130

Buildings at Cost

8,250

Total at Cost

10,380

Accumulated Depreciation

$ 1,068

Date of Construction

1962

Date Acquired

August 17, 2004

Life on which depreciation in latest income statements is computed (Years) | years

New Bedford, MA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acute care hospital

Initial Costs, Land

$ 1,400

Initial Costs, Buildings

19,772

Additions Subsequent to Acquisition, Improvements

256

Land at Cost

1,400

Buildings at Cost

20,028

Total at Cost

21,428

Accumulated Depreciation

$ 3,159

Date of Construction

1942

Date Acquired

August 17, 2004

Life on which depreciation in latest income statements is computed (Years) | years

Covington, LA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acute care hospital

Initial Costs, Land

$ 821

Initial Costs, Buildings

10,238

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

821

Buildings at Cost

10,252

Total at Cost

11,073

Accumulated Depreciation

$ 1,431

Date of Construction

1984

Date Acquired

June 9, 2005

Life on which depreciation in latest income statements is computed (Years) | years

Denham Springs, LA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acute care hospital

Initial Costs, Land

$ 429

Initial Costs, Buildings

5,340

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

429

Buildings at Cost

5,389

Total at Cost

5,818

Accumulated Depreciation

$ 686

Date of Construction

1960

Date Acquired

June 9, 2005

Life on which depreciation in latest income statements is computed (Years) | years

Redding, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acute care hospital

Initial Costs, Buildings

$ 19,952

Additions Subsequent to Acquisition, Carrying Costs

4,361

Land at Cost

1,629

Buildings at Cost

22,684

Total at Cost

24,313

Accumulated Depreciation

$ 2,919

Date of Construction

1991

Date Acquired

June 30, 2005

Life on which depreciation in latest income statements is computed (Years) | years

Sherman Oaks, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute care general hospital

Initial Costs, Land

$ 5,290

Initial Costs, Buildings

13,587

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

5,290

Buildings at Cost

13,618

Total at Cost

18,908

Accumulated Depreciation

$ 1,706

Date of Construction

1956

Date Acquired

December 30, 2005

Life on which depreciation in latest income statements is computed (Years) | years

Bloomington, IN [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute care general hospital

Initial Costs, Land

$ 2,457

Initial Costs, Buildings

31,209

Additions Subsequent to Acquisition, Carrying Costs

408

Land at Cost

2,576

Buildings at Cost

31,498

Total at Cost

34,074

Accumulated Depreciation

$ 3,435

Date of Construction

2006

Date Acquired

August 8, 2006

Life on which depreciation in latest income statements is computed (Years) | years

Dallas, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acute care hospital

Initial Costs, Land

$ 1,000

Initial Costs, Buildings

13,589

Additions Subsequent to Acquisition, Carrying Costs

368

Land at Cost

1,421

Buildings at Cost

13,536

Total at Cost

14,957

Accumulated Depreciation

$ 1,466

Date of Construction

2006

Date Acquired

September 5, 2006

Life on which depreciation in latest income statements is computed (Years) | years

Huntington Beach, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute care general hospital

Initial Costs, Land

$ 937

Initial Costs, Buildings

10,907

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

937

Buildings at Cost

10,910

Total at Cost

11,847

Accumulated Depreciation

$ 1,136

Date of Construction

1965

Date Acquired

November 8, 2006

Life on which depreciation in latest income statements is computed (Years) | years

La Palma, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute care general hospital

Initial Costs, Land

$ 937

Initial Costs, Buildings

10,907

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

937

Buildings at Cost

10,910

Total at Cost

11,847

Accumulated Depreciation

$ 1,136

Date of Construction

1971

Date Acquired

November 8, 2006

Life on which depreciation in latest income statements is computed (Years) | years

Anaheim, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute care general hospital

Initial Costs, Land

$ 1,875

Initial Costs, Buildings

21,814

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

1,875

Buildings at Cost

21,824

Total at Cost

23,699

Accumulated Depreciation

$ 2,273

Date of Construction

1964

Date Acquired

November 8, 2006

Life on which depreciation in latest income statements is computed (Years) | years

Luling, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acute care hospital

Initial Costs, Land

$ 811

Initial Costs, Buildings

9,345

Land at Cost

811

Buildings at Cost

9,345

Total at Cost

10,156

Accumulated Depreciation

$ 954

Date of Construction

2002

Date Acquired

December 1, 2006

Life on which depreciation in latest income statements is computed (Years) | years

San Antonio, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Rehabilitation hospital

Initial Costs, Buildings

$ 10,198

Buildings at Cost

10,198

Total at Cost

10,198

Accumulated Depreciation

$ 1,041

Date of Construction

1987

Date Acquired

December 1, 2006

Life on which depreciation in latest income statements is computed (Years) | years

Victoria, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acute care hospital

Initial Costs, Land

$ 625

Initial Costs, Buildings

7,197

Land at Cost

625

Buildings at Cost

7,197

Total at Cost

7,822

Accumulated Depreciation

$ 735

Date of Construction

1998

Date Acquired

December 1, 2006

Life on which depreciation in latest income statements is computed (Years) | years

Houston, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute care general hospital

Initial Costs, Land

$ 4,757

Initial Costs, Buildings

56,238

Additions Subsequent to Acquisition, Carrying Costs

1,259

Land at Cost

5,464

Buildings at Cost

56,790

Total at Cost

62,254

Accumulated Depreciation

$ 5,742

Date of Construction

2006

Date Acquired

December 1, 2006

Life on which depreciation in latest income statements is computed (Years) | years

Bensalem, PA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute care general hospital

Initial Costs, Land

$ 6,911

Initial Costs, Buildings

38,185

Additions Subsequent to Acquisition, Carrying Costs

(352)

Land at Cost

6,912

Buildings at Cost

37,832

Total at Cost

44,744

Accumulated Depreciation

$ 3,670

Date of Construction

2006

Date Acquired

March 19, 2007

Life on which depreciation in latest income statements is computed (Years) | years

Portland, OR [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acute care hospital

Initial Costs, Land

$ 3,085

Initial Costs, Buildings

17,859

Additions Subsequent to Acquisition, Carrying Costs

2,559

Land at Cost

3,071

Buildings at Cost

20,432

Total at Cost

23,503

Accumulated Depreciation

$ 1,815

Date of Construction

1964

Date Acquired

April 18, 2007

Life on which depreciation in latest income statements is computed (Years) | years

San Diego, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute care general hospital

Initial Costs, Land

$ 6,550

Initial Costs, Buildings

15,653

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

6,550

Buildings at Cost

15,730

Total at Cost

22,280

Accumulated Depreciation

$ 1,439

Date of Construction

1964

Date Acquired

May 9, 2007

Life on which depreciation in latest income statements is computed (Years) | years

Redding, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute care general hospital

Initial Costs, Land

$ 1,555

Initial Costs, Buildings

53,863

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

1,555

Buildings at Cost

53,876

Total at Cost

55,431

Accumulated Depreciation

$ 4,613

Date of Construction

1974

Date Acquired

August 10, 2007

Life on which depreciation in latest income statements is computed (Years) | years

Houston, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute care general hospital

Initial Costs, Land

$ 3,501

Initial Costs, Buildings

34,530

Additions Subsequent to Acquisition, Carrying Costs

(7,319)

Land at Cost

3,274

Buildings at Cost

27,438

Total at Cost

30,712

Accumulated Depreciation

$ 2,312

Date of Construction

1960

Date Acquired

August 10, 2007

Life on which depreciation in latest income statements is computed (Years) | years

Bennettsville, SC [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute care general hospital

Initial Costs, Land

$ 794

Initial Costs, Buildings

15,772

Land at Cost

794

Buildings at Cost

15,772

Total at Cost

16,566

Accumulated Depreciation

$ 1,085

Date of Construction

1984

Date Acquired

April 1, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Bossier City, LA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acute care hospital

Initial Costs, Land

$ 900

Initial Costs, Buildings

17,818

Land at Cost

900

Buildings at Cost

17,818

Total at Cost

18,718

Accumulated Depreciation

$ 1,222

Date of Construction

1982

Date Acquired

April 1, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Bristol, CT [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Wellness Center

Initial Costs, Land

$ 485

Initial Costs, Buildings

2,267

Land at Cost

485

Buildings at Cost

2,267

Total at Cost

2,752

Accumulated Depreciation

$ 429

Date of Construction

1975

Date Acquired

April 22, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Cheraw, SC [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute care general hospital

Initial Costs, Land

$ 657

Initial Costs, Buildings

19,576

Land at Cost

657

Buildings at Cost

19,576

Total at Cost

20,233

Accumulated Depreciation

$ 1,345

Date of Construction

1982

Date Acquired

April 1, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Detroit, MI [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acute care hospital

Initial Costs, Land

$ 1,220

Initial Costs, Buildings

8,687

Additions Subsequent to Acquisition, Carrying Costs

(365)

Land at Cost

1,220

Buildings at Cost

8,322

Total at Cost

9,542

Accumulated Depreciation

$ 624

Date of Construction

1956

Date Acquired

May 22, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Enfield, CT [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Wellness Center

Initial Costs, Land

$ 384

Initial Costs, Buildings

2,257

Land at Cost

384

Buildings at Cost

2,257

Total at Cost

2,641

Accumulated Depreciation

$ 427

Date of Construction

1974

Date Acquired

April 22, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Fayetteville, AR [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Rehabilitation hospital

Initial Costs, Land

$ 909

Initial Costs, Buildings

18,332

Land at Cost

909

Buildings at Cost

18,332

Total at Cost

19,241

Accumulated Depreciation

$ 1,146

Date of Construction

1991

Date Acquired

July 14, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Fort Lauderdale, FL [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Rehabilitation hospital

Initial Costs, Land

$ 3,499

Initial Costs, Buildings

21,939

Land at Cost

3,499

Buildings at Cost

21,940

Total at Cost

25,439

Accumulated Depreciation

$ 1,465

Date of Construction

1985

Date Acquired

April 22, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Garden Grove, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute care general hospital

Initial Costs, Land

$ 5,502

Initial Costs, Buildings

10,748

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

5,502

Buildings at Cost

10,799

Total at Cost

16,301

Accumulated Depreciation

$ 574

Date of Construction

1982

Date Acquired

November 25, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Garden Grove, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Medical Office Building

Initial Costs, Land

$ 862

Initial Costs, Buildings

7,888

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

862

Buildings at Cost

7,916

Total at Cost

8,778

Accumulated Depreciation

$ 413

Date of Construction

1982

Date Acquired

November 25, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Idaho Falls, ID [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute care general hospital

Initial Costs, Land

$ 1,822

Initial Costs, Buildings

37,467

Additions Subsequent to Acquisition, Carrying Costs

4,665

Land at Cost

1,822

Buildings at Cost

42,132

Total at Cost

43,954

Accumulated Depreciation

$ 2,741

Date of Construction

2002

Date Acquired

April 1, 2008

Life on which depreciation in latest income statements is computed (Years)

Morgantown, WV [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Rehabilitation hospital

Initial Costs, Buildings

$ 21,552

Buildings at Cost

21,552

Total at Cost

21,552

Accumulated Depreciation

$ 2,010

Date of Construction

1989

Date Acquired

May 19, 2008

Life on which depreciation in latest income statements is computed (Years)

Newington, CT [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Wellness Center

Initial Costs, Land

$ 270

Initial Costs, Buildings

1,615

Land at Cost

270

Buildings at Cost

1,615

Total at Cost

1,885

Accumulated Depreciation

$ 308

Date of Construction

1979

Date Acquired

April 22, 2008

Life on which depreciation in latest income statements is computed (Years)

Petersburg, VA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Rehabilitation hospital

Initial Costs, Land

$ 1,302

Initial Costs, Buildings

9,121

Land at Cost

1,302

Buildings at Cost

9,121

Total at Cost

10,423

Accumulated Depreciation

$ 570

Date of Construction

2006

Date Acquired

July 1, 2008

Life on which depreciation in latest income statements is computed (Years)

West Valley City, UT [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute care general hospital

Initial Costs, Land

$ 5,516

Initial Costs, Buildings

58,314

Land at Cost

5,516

Buildings at Cost

58,314

Total at Cost

63,830

Accumulated Depreciation

$ 3,895

Date of Construction

1980

Date Acquired

April 22, 2008

Life on which depreciation in latest income statements is computed (Years)

Poplar Bluff, MO [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute care general hospital

Initial Costs, Land

$ 2,659

Initial Costs, Buildings

38,694

Land at Cost

2,659

Buildings at Cost

38,694

Total at Cost

41,353

Accumulated Depreciation

$ 2,584

Date of Construction

1980

Date Acquired

April 22, 2008

Life on which depreciation in latest income statements is computed (Years)

East Providence, RI [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Wellness Center

Initial Costs, Land

$ 209

Initial Costs, Buildings

1,265

Land at Cost

209

Buildings at Cost

1,265

Total at Cost

1,474

Accumulated Depreciation

$ 241

Date of Construction

1979

Date Acquired

April 22, 2008

Life on which depreciation in latest income statements is computed (Years)

San Dimas, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute care general hospital

Initial Costs, Land

$ 6,160

Initial Costs, Buildings

6,839

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

6,160

Buildings at Cost

6,873

Total at Cost

13,033

Accumulated Depreciation

$ 358

Date of Construction

1972

Date Acquired

November 25, 2008

Life on which depreciation in latest income statements is computed (Years)

San Dimas, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Medical Office Building

Initial Costs, Land

$ 1,915

Initial Costs, Buildings

5,085

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

1,915

Buildings at Cost

5,103

Total at Cost

7,018

Accumulated Depreciation

$ 266

Date of Construction

1979

Date Acquired

November 25, 2008

Life on which depreciation in latest income statements is computed (Years)

West Springfield, MA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Wellness Center

Initial Costs, Land

$ 583

Initial Costs, Buildings

3,185

Land at Cost

583

Buildings at Cost

3,185

Total at Cost

3,768

Accumulated Depreciation

$ 608

Date of Construction

1976

Date Acquired

April 22, 2008

Life on which depreciation in latest income statements is computed (Years)

Tucson, AZ [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acute care hospital

Initial Costs, Land

$ 920

Initial Costs, Buildings

6,078

Land at Cost

920

Buildings at Cost

6,078

Total at Cost

6,998

Accumulated Depreciation

$ 418

Date of Construction

1987

Date Acquired

April 1, 2008

Life on which depreciation in latest income statements is computed (Years)

Warwick, RI [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Wellness Center

Initial Costs, Land

$ 1,265

Initial Costs, Buildings

759

Land at Cost

1,265

Buildings at Cost

759

Total at Cost

2,024

Accumulated Depreciation

$ 144

Date of Construction

1979

Date Acquired

April 22, 2008

Life on which depreciation in latest income statements is computed (Years)

Webster, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acute care hospital

Initial Costs, Land

$ 988

Initial Costs, Buildings

10,432

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

988

Buildings at Cost

10,433

Total at Cost

11,421

Accumulated Depreciation

$ 717

Date of Construction

1986

Date Acquired

April 1, 2008

Life on which depreciation in latest income statements is computed (Years)

Wichita, KS [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Rehabilitation hospital

Initial Costs, Land

$ 1,019

Initial Costs, Buildings

18,373

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

1,019

Buildings at Cost

18,374

Total at Cost

19,393

Accumulated Depreciation

$ 1,262

Date of Construction

1992

Date Acquired

April 4, 2008

Life on which depreciation in latest income statements is computed (Years)

Addison, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Rehabilitation hospital

Initial Costs, Land

$ 2,013

Initial Costs, Buildings

22,531

Land at Cost

2,013

Buildings at Cost

22,531

Total at Cost

24,544

Accumulated Depreciation

$ 282

Date of Construction

2008

Date Acquired

June 17, 2010

Life on which depreciation in latest income statements is computed (Years)

Shenandoah, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Rehabilitation hospital

Initial Costs, Land

$ 2,033

Initial Costs, Buildings

21,943

Land at Cost

2,033

Buildings at Cost

21,943

Total at Cost

23,976

Accumulated Depreciation

$ 274

Date of Construction

2008

Date Acquired

June 17, 2010

Life on which depreciation in latest income statements is computed (Years)

Richardson, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Rehabilitation hospital

Initial Costs, Land

$ 2,219

Initial Costs, Buildings

17,419

Land at Cost

2,219

Buildings at Cost

17,419

Total at Cost

19,638

Accumulated Depreciation

$ 218

Date of Construction

2008

Date Acquired

June 17, 2010

Life on which depreciation in latest income statements is computed (Years)

Hill County, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute care general hospital

Initial Costs, Land

$ 1,120

Initial Costs, Buildings

17,882

Land at Cost

1,120

Buildings at Cost

17,882

Total at Cost

19,002

Accumulated Depreciation

$ 300

Date of Construction

1980

Date Acquired

September 17, 2010

Life on which depreciation in latest income statements is computed (Years)

Webster, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acute care hospital

Initial Costs, Land

$ 664

Initial Costs, Buildings

33,751

664

33,751

$ 34,414

2004

December 21, 2010

Life on which depreciation in latest income statements is computed (Years)

Tomball, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acute care hospital

Initial Costs, Land

$ 1,298

Initial Costs, Buildings

23,982

1,298

23,982

$ 25,280

2005

December 21, 2010

Life on which depreciation in latest income statements is computed (Years)

[1]	Includes real estate cost included in real estate held for sale of $72,691 and $87,807 for 2009 and 2008, respectively. Excludes intangible lease assets that are included in real estate held for sale of $24,487 and $24,615 for 2009 and 2008, respectively.

Real Estate Investments And Accumulated Depreciation (Changes In Total Real Estate Assets Including Real Estate Held For Sale) (Details) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Balance at beginning of period

$ 934,601

$ 943,700

^[1]

$ 614,088

Acquisitions

146,854

421

418,766

Transfers from construction in progress

2,475

Additions

1,709

5,550

308

Dispositions

(92,529)

(15,070)

(85,648)

Other

(6,289)

Balance at end of period

990,635

934,601

943,700

^[1]

Real estate cost

72,691

87,807

Real estate held for sale, intangible lease assets

$ 24,487

$ 24,615

Parent [Member]

Acquisitions

$ 210,000

[1]	Includes real estate cost included in real estate held for sale of $72,691 and $87,807 for 2009 and 2008, respectively. Excludes intangible lease assets that are included in real estate held for sale of $24,487 and $24,615 for 2009 and 2008, respectively.

Real Estate Investments And Accumulated Depreciation (Changes In Accumulated Depreciation Including Real Estate Assets Held For Sale) (Details) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Real Estate Investments And Accumulated Depreciation [Abstract]

Balance at beginning of period

$ 51,638

$ 30,581

^[1]

$ 20,214

Depreciation

22,664

21,389

18,118

Depreciation on disposed property

(5,640)

(332)

(7,751)

Balance at end of period

$ 68,662

51,638

30,581

^[1]

Accumulated depreciation of real estate held for sale

3,673

2,396

Accumulated amortization of intangible lease assets

$ 3,532

$ 2,020

[1]	Includes accumulated depreciation in real estate held for sale of $3,673 and $2,396 for 2009 and 2008 respectively. Excludes accumulated amortization related to intangible lease assets that are included in real estate held for sale of $3,532 and $2,020 for 2009 and 2008, respectively.

Mortgage Loan On Real Estate (Schedule Of Mortgage Loan On Real Estate) (Details)
$ in Thousands

12 Months Ended

Dec. 31, 2010

USD ($)

Mortgage Loans on Real Estate [Line Items]

Carrying Amount of Mortgages, Federal income tax purposes

$ 165,000

Long-Term First Mortgage Loan [Member]

Mortgage Loans on Real Estate [Line Items]

Prior Liens

Face Amount of Mortgages

165,000

Carrying Amount of Mortgages

165,000

^[1]

Principal Amount of Loans Subject to Delinquent Principal or Interest

Long-Term First Mortgage Loan [Member] | Desert Valley Hospital [Member]

Mortgage Loans on Real Estate [Line Items]

Mortgage loan assumed, Interest rate

9.90%

Final Maturity Date

2022

Prior Liens

$ (1)

Face Amount of Mortgages

70,000

Carrying Amount of Mortgages

70,000

^[1]

Principal Amount of Loans Subject to Delinquent Principal or Interest

$ (2)

Long-Term First Mortgage Loan [Member] | Desert Valley Hospital [Member]

Mortgage Loans on Real Estate [Line Items]

Mortgage loan assumed, Interest rate

10.70%

Final Maturity Date

2022

Prior Liens

$ (1)

Face Amount of Mortgages

20,000

Carrying Amount of Mortgages

20,000

^[1]

Principal Amount of Loans Subject to Delinquent Principal or Interest

$ (2)

Long-Term First Mortgage Loan [Member] | Chino Valley Medical Center [Member]

Mortgage Loans on Real Estate [Line Items]

Mortgage loan assumed, Interest rate

9.90%

Final Maturity Date

2022

Prior Liens

$ (1)

Face Amount of Mortgages

50,000

Carrying Amount of Mortgages

50,000

^[1]

Principal Amount of Loans Subject to Delinquent Principal or Interest

$ (2)

Long-Term First Mortgage Loan [Member] | Paradise Valley Hospital [Member]

Mortgage Loans on Real Estate [Line Items]

Mortgage loan assumed, Interest rate

9.60%

Final Maturity Date

2022

Prior Liens

$ (1)

Face Amount of Mortgages

25,000

Carrying Amount of Mortgages

25,000

^[1]

Principal Amount of Loans Subject to Delinquent Principal or Interest

$ (2)

[1]	The aggregate cost for Federal income tax purposes is $165,000.

Mortgage Loan On Real Estate (Changes In Mortgage Loans) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Mortgage Loan On Real Estate [Abstract]
Balance at beginning of year	$ 200,164	$ 185,000	$ 185,000
New mortgage loans and additional advances on existing loans	7,836	15,164
Mortgage loans on real estate including additions during year	208,000	200,164	185,000
Collection of principal	(43,000)
Deductions during year	(43,000)
Balance at end of year	$ 165,000	$ 200,164	$ 185,000